{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 41735, "items": [{"indexed": {"date-parts": [[2018, 5, 4]], "date-time": "2018-05-04T14:25:11Z", "timestamp": 1525443911969}, "reference-count": 0, "publisher": "S. Karger AG", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Pharmacology"], "published-print": {"date-parts": [[2008]]}, "DOI": "10.1159/000156485", "type": "journal-article", "created": {"date-parts": [[2008, 9, 29]], "date-time": "2008-09-29T14:49:58Z", "timestamp": 1222699798000}, "page": "193-200", "source": "Crossref", "is-referenced-by-count": 12, "title": ["Effect of Cannabinoid Receptor Agonists on Streptozotocin-Induced Hyperalgesia in Diabetic Neuropathy"], "prefix": "10.1159", "volume": "82", "author": [{"given": "Magdalena", "family": "Bujalska", "sequence": "first", "affiliation": []}], "member": "127", "container-title": ["Pharmacology"], "language": "en", "link": [{"URL": "http://www.karger.com/Article/Pdf/156485", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 10, 25]], "date-time": "2017-10-25T22:12:55Z", "timestamp": 1508969575000}, "score": 28.573334, "issued": {"date-parts": [[2008]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2008]]}, "issue": "3"}, "URL": "http://dx.doi.org/10.1159/000156485", "ISSN": ["1423-0313", "0031-7012"], "issn-type": [{"value": "0031-7012", "type": "print"}, {"value": "1423-0313", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 4, 17]], "date-time": "2018-04-17T17:08:03Z", "timestamp": 1523984883684}, "reference-count": 0, "publisher": "InTech", "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.5772/64453", "type": "book-chapter", "created": {"date-parts": [[2016, 10, 14]], "date-time": "2016-10-14T13:11:59Z", "timestamp": 1476450719000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Acute Valproic Acid Intoxication: An Attempt at Estimating the Correlation Between Serum Level and Clinical Manifestations"], "prefix": "10.5772", "author": [{"given": "Anna", "family": "Staniszewska", "sequence": "first", "affiliation": []}, {"given": "Magdalena", "family": "Bujalska-Zadrozny", "sequence": "additional", "affiliation": []}], "member": "3774", "published-online": {"date-parts": [[2016, 10, 12]]}, "container-title": ["Epileptology - The Modern State of Science"], "link": [{"URL": "http://www.intechopen.com/download/pdf/52403", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 29]], "date-time": "2016-12-29T10:22:57Z", "timestamp": 1483006977000}, "score": 24.270683, "issued": {"date-parts": [[2016, 10, 12]]}, "ISBN": ["9789535126980", "9789535126997"], "references-count": 0, "URL": "http://dx.doi.org/10.5772/64453"}, {"indexed": {"date-parts": [[2018, 5, 8]], "date-time": "2018-05-08T08:20:52Z", "timestamp": 1525767652427}, "reference-count": 26, "publisher": "S. Karger AG", "issue": "3-4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Pharmacology"], "published-print": {"date-parts": [[2014]]}, "DOI": "10.1159/000358255", "type": "journal-article", "created": {"date-parts": [[2014, 2, 26]], "date-time": "2014-02-26T13:10:05Z", "timestamp": 1393420205000}, "page": "113-119", "source": "Crossref", "is-referenced-by-count": 3, "title": ["Additive Effect of Combined Application of Magnesium and MK-801 on Analgesic Action of Morphine"], "prefix": "10.1159", "volume": "93", "author": [{"given": "Magdalena", "family": "Bujalska-Zadro\u017cny", "sequence": "first", "affiliation": []}, {"given": "Kamila", "family": "Duda", "sequence": "additional", "affiliation": []}], "member": "127", "published-online": {"date-parts": [[2014, 2, 26]]}, "reference": [{"key": "sref_1", "author": "Bujalska M", "volume": "82", "first-page": "180", "year": "2008", "journal-title": "Pharmacology", "DOI": "10.1159/000151346", "doi-asserted-by": "crossref"}, {"key": "sref_2", "author": "Bujalska M", "volume": "61", "first-page": "1096", "year": "2009", "journal-title": "Pharmacol Rep", "DOI": "10.1016/S1734-1140(09)70172-0", "doi-asserted-by": "crossref"}, {"key": "sref_3", "author": "Begon S", "volume": "96", "first-page": "627", "year": "2002", "journal-title": "Anesthesiology", "DOI": "10.1097/00000542-200203000-00019", "doi-asserted-by": "crossref"}, {"key": "sref_4", "author": "Ulugol A", "volume": "943", "first-page": "101", "year": "2002", "journal-title": "Brain Res", "DOI": "10.1016/S0006-8993(02)02618-5", "doi-asserted-by": "crossref"}, {"key": "sref_5", "author": "Mert T", "volume": "380", "first-page": "415", "year": "2009", "journal-title": "Naunyn Schmiedebergs Arch Pharmacol", "DOI": "10.1007/s00210-009-0447-3", "doi-asserted-by": "crossref"}, {"key": "sref_6", "author": "Nakhoda A", "volume": "35", "first-page": "1679", "year": "1979", "journal-title": "Experientia", "DOI": "10.1007/BF01953269", "doi-asserted-by": "crossref"}, {"key": "sref_7", "author": "Randall LO", "volume": "111", "first-page": "409", "year": "1957", "journal-title": "Arch Int Pharmacodyn Ther"}, {"key": "sref_8", "author": "D'Amour FE", "volume": "72", "first-page": "74", "year": "1941", "journal-title": "J Pharmacol Exp Ther"}, {"key": "sref_10", "author": "Dellemijn P", "volume": "80", "first-page": "453", "year": "1999", "journal-title": "Pain", "DOI": "10.1016/S0304-3959(98)00256-5", "doi-asserted-by": "crossref"}, {"key": "sref_11", "author": "Begon S", "volume": "887", "first-page": "436", "year": "2000", "journal-title": "Brain Res", "DOI": "10.1016/S0006-8993(00)03028-6", "doi-asserted-by": "crossref"}, {"key": "sref_12", "author": "Bordi F", "volume": "84", "first-page": "213", "year": "2000", "journal-title": "Pain", "DOI": "10.1016/S0304-3959(99)00205-5", "doi-asserted-by": "crossref"}, {"key": "sref_13", "author": "Dickenson AH", "volume": "41", "first-page": "112", "year": "1997", "journal-title": "Acta Anaesthesiol Scand", "DOI": "10.1111/j.1399-6576.1997.tb04624.x", "doi-asserted-by": "crossref"}, {"key": "sref_14", "author": "Mao J", "volume": "605", "first-page": "164", "year": "1993", "journal-title": "Brain Res", "DOI": "10.1016/0006-8993(93)91368-3", "doi-asserted-by": "crossref"}, {"key": "sref_15", "author": "Medvedev IO", "volume": "47", "first-page": "175", "year": "2004", "journal-title": "Neuropharmacology", "DOI": "10.1016/j.neuropharm.2004.01.019", "doi-asserted-by": "crossref"}, {"key": "sref_16", "author": "Parsons CG", "volume": "429", "first-page": "71", "year": "2001", "journal-title": "Eur J Pharmacol", "DOI": "10.1016/S0014-2999(01)01307-3", "doi-asserted-by": "crossref"}, {"key": "sref_17", "author": "Christensen D", "volume": "83", "first-page": "433", "year": "1999", "journal-title": "Pain", "DOI": "10.1016/S0304-3959(99)00126-8", "doi-asserted-by": "crossref"}, {"key": "sref_18", "author": "Martinez V", "volume": "99", "first-page": "537", "year": "2002", "journal-title": "Pain", "DOI": "10.1016/S0304-3959(02)00270-1", "doi-asserted-by": "crossref"}, {"key": "sref_19", "author": "Nichols ML", "volume": "69", "first-page": "317", "year": "1997", "journal-title": "Pain", "DOI": "10.1016/S0304-3959(96)03282-4", "doi-asserted-by": "crossref"}, {"key": "sref_20", "author": "Yamamoto T", "volume": "135", "first-page": "67", "year": "1992", "journal-title": "Neurosci Lett", "DOI": "10.1016/0304-3940(92)90137-V", "doi-asserted-by": "crossref"}, {"key": "sref_21", "author": "Fischer BD", "volume": "6", "first-page": "425", "year": "2005", "journal-title": "J Pain", "DOI": "10.1016/j.jpain.2005.02.003", "doi-asserted-by": "crossref"}, {"key": "sref_22", "author": "Grass S", "volume": "158", "first-page": "269", "year": "1996", "journal-title": "Acta Physiol Scand", "DOI": "10.1046/j.1365-201X.1996.566309000.x", "doi-asserted-by": "crossref"}, {"key": "sref_23", "author": "Redwine KE", "volume": "76", "first-page": "361", "year": "2003", "journal-title": "Pharmacol Biochem Behav", "DOI": "10.1016/j.pbb.2003.08.009", "doi-asserted-by": "crossref"}, {"key": "sref_24", "author": "Swartjes M", "volume": "115", "first-page": "165", "year": "2011", "journal-title": "Anaesthesiology", "DOI": "10.1097/ALN.0b013e31821bdb9b", "doi-asserted-by": "crossref"}, {"key": "sref_25", "author": "Bespalov A", "volume": "351", "first-page": "299", "year": "1998", "journal-title": "Eur J Pharmacol", "DOI": "10.1016/S0014-2999(98)00324-0", "doi-asserted-by": "crossref"}, {"key": "sref_26", "author": "Dyck PJ", "volume": "23", "first-page": "510", "year": "2000", "journal-title": "Diabetes Care", "DOI": "10.2337/diacare.23.4.510", "doi-asserted-by": "crossref"}, {"key": "sref_27", "author": "Obrosova IG", "volume": "1792", "first-page": "931", "year": "2009", "journal-title": "Biochim Biophys Acta", "DOI": "10.1016/j.bbadis.2008.11.005", "doi-asserted-by": "crossref"}], "container-title": ["Pharmacology"], "language": "en", "link": [{"URL": "https://www.karger.com/Article/Pdf/358255", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 10, 25]], "date-time": "2017-10-25T19:45:31Z", "timestamp": 1508960731000}, "score": 24.270683, "issued": {"date-parts": [[2014]]}, "references-count": 26, "journal-issue": {"published-online": {"date-parts": [[2014, 6, 1]]}, "published-print": {"date-parts": [[2014, 6, 20]]}, "issue": "3-4"}, "alternative-id": ["000358255"], "URL": "http://dx.doi.org/10.1159/000358255", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["0031-7012", "1423-0313"], "issn-type": [{"value": "0031-7012", "type": "print"}, {"value": "1423-0313", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 10, 6]], "date-time": "2018-10-06T14:10:18Z", "timestamp": 1538835018622}, "reference-count": 45, "publisher": "Elsevier BV", "issue": "4", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2009, 7, 1]], "date-time": "2009-07-01T00:00:00Z", "timestamp": 1246406400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Pharmacological Reports"], "published-print": {"date-parts": [[2009, 7]]}, "DOI": "10.1016/s1734-1140(09)70115-x", "type": "journal-article", "created": {"date-parts": [[2014, 2, 19]], "date-time": "2014-02-19T22:34:29Z", "timestamp": 1392849269000}, "page": "631-640", "source": "Crossref", "is-referenced-by-count": 7, "title": ["Bradykinin receptor antagonists and cyclooxygenase inhibitors in vincristine-and streptozotocin-induced hyperalgesia"], "prefix": "10.1016", "volume": "61", "author": [{"given": "Magdalena", "family": "Bujalska", "sequence": "first", "affiliation": []}, {"given": "Helena", "family": "Makulska-Nowak", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Pharmacological Reports"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S173411400970115X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S173411400970115X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 10, 6]], "date-time": "2018-10-06T13:54:08Z", "timestamp": 1538834048000}, "score": 24.270683, "issued": {"date-parts": [[2009, 7]]}, "references-count": 45, "journal-issue": {"published-print": {"date-parts": [[2009, 7]]}, "issue": "4"}, "alternative-id": ["S173411400970115X"], "URL": "http://dx.doi.org/10.1016/s1734-1140(09)70115-x", "ISSN": ["1734-1140"], "issn-type": [{"value": "1734-1140", "type": "print"}], "subject": ["Pharmacology", "General Medicine"]}, {"indexed": {"date-parts": [[2018, 5, 4]], "date-time": "2018-05-04T01:00:47Z", "timestamp": 1525395647585}, "reference-count": 29, "publisher": "S. Karger AG", "issue": "2", "license": [{"URL": "https://www.karger.com/Services/SiteLicenses", "start": {"date-parts": [[2007, 11, 7]], "date-time": "2007-11-07T00:00:00Z", "timestamp": 1194393600000}, "delay-in-days": 0, "content-version": "vor"}, {"URL": "https://www.karger.com/Services/SiteLicenses", "start": {"date-parts": [[2007, 11, 7]], "date-time": "2007-11-07T00:00:00Z", "timestamp": 1194393600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Pharmacology"], "published-print": {"date-parts": [[2008]]}, "DOI": "10.1159/000110788", "type": "journal-article", "created": {"date-parts": [[2007, 11, 7]], "date-time": "2007-11-07T10:12:54Z", "timestamp": 1194430374000}, "page": "158-163", "source": "Crossref", "is-referenced-by-count": 10, "title": ["Effect of Bradykinin Receptor Antagonists on Vincristine- and Streptozotocin-Induced Hyperalgesia in a Rat Model of Chemotherapy-Induced and Diabetic Neuropathy"], "prefix": "10.1159", "volume": "81", "author": [{"given": "Magdalena", "family": "Bujalska", "sequence": "first", "affiliation": []}, {"given": "Jan", "family": "Tatarkiewicz", "sequence": "additional", "affiliation": []}, {"given": "Stanis\u0142aw Witold", "family": "Gumu\u0142ka", "sequence": "additional", "affiliation": []}], "member": "127", "published-online": {"date-parts": [[2007, 11, 7]]}, "reference": [{"key": "sref_1_189", "author": "Dray A", "volume": "75", "first-page": "704", "year": "1997", "journal-title": "Can J Physiol Pharmacol"}, {"key": "sref_2_190", "author": "Dray A", "volume": "16", "first-page": "99", "year": "1993", "journal-title": "Trends Neurosci"}, {"key": "sref_3_191", "DOI": "10.1093/brain/awh078", "doi-asserted-by": "publisher"}, {"key": "sref_4_192", "author": "Wang H", "volume": "387", "first-page": "11", "year": "2006", "journal-title": "Biol Chem"}, {"key": "sref_5_193", "author": "Geppetti P", "volume": "47", "first-page": "1", "year": "1993", "journal-title": "Regul Pept"}, {"key": "sref_6_194", "author": "Calixto JB", "volume": "87", "first-page": "1", "year": "2000", "journal-title": "Pain"}, {"key": "sref_7_195", "DOI": "10.1016/S0301-0082(98)00048-3", "doi-asserted-by": "publisher"}, {"key": "sref_8_196", "unstructured": "Nakhoda A, Wong HA: The induction of diabetes in rats by intramuscular administration of streptozotocin. Experientia 35. Basel, Birkhauser, 1979, vol 35, pp 1679-1680."}, {"key": "sref_9_197", "author": "Aley KO", "volume": "73", "first-page": "259", "year": "1996", "journal-title": "Neuroscience"}, {"key": "sref_10_198", "author": "Randall LO", "volume": "111", "first-page": "409", "year": "1957", "journal-title": "Arch Int Pharmacodyn Ther"}, {"key": "sref_11_199", "unstructured": "Tallarida RJ, Murray RB: Manual of Pharmacologic Calculation with Computer Programs, ed 2. New York, Springer, 1986, pp 113-117."}, {"key": "sref_12_200", "author": "Dyck PJ", "volume": "23", "first-page": "510", "year": "2000", "journal-title": "Diabetes Care"}, {"key": "sref_13_201", "author": "Hong S", "volume": "280", "first-page": "618", "year": "2005", "journal-title": "J Biol Chem", "DOI": "10.1074/jbc.M408500200", "doi-asserted-by": "crossref"}, {"key": "sref_14_202", "author": "Hong S", "volume": "279", "first-page": "29341", "year": "2004", "journal-title": "J Biol Chem"}, {"key": "sref_15_203", "author": "Suzuki Y", "volume": "43", "first-page": "171", "year": "2002", "journal-title": "Neurosci Res"}, {"key": "sref_16_204", "author": "Dobretsov M", "volume": "960", "first-page": "174", "year": "2003", "journal-title": "Brain Res"}, {"key": "sref_17_205", "author": "Aley KO", "volume": "111", "first-page": "389", "year": "2002", "journal-title": "Neuroscience"}, {"key": "sref_18_206", "unstructured": "Chabner BA, Allegra CJ, Curt GA, Calabresi P: Antineoplastic agents; in Goodman and Gilman's The Pharmacological Basis of Therapeutics, ed 9. New York, McGraw-Hill, 1996, chapt 51, pp 1233-1287."}, {"key": "sref_19_207", "unstructured": "Micromedex (2002): Drugdex Drug Evaluations: Vincristine. Monograph in database on CD: 'MicromedexR Healthcare Series', vol 112 (2002). Copyright: Micromedex Thomson Health Care."}, {"key": "sref_20_208", "author": "Tanner KD", "volume": "395", "first-page": "481", "year": "1998", "journal-title": "J Comp Neurol"}, {"key": "sref_21_209", "author": "Topp KS", "volume": "424", "first-page": "563", "year": "2000", "journal-title": "J Comp Neurol"}, {"key": "sref_22_210", "author": "Tang HB", "volume": "97", "first-page": "1412", "year": "2006", "journal-title": "J Neurochem"}, {"key": "sref_23_211", "author": "Campos MM", "volume": "58", "first-page": "184", "year": "2005", "journal-title": "Synapse"}, {"key": "sref_24_212", "author": "Pesquero JB", "volume": "97", "first-page": "8140", "year": "2000", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "sref_25_213", "author": "Gabra BH", "volume": "387", "first-page": "127", "year": "2006", "journal-title": "Biol Chem"}, {"key": "sref_26_214", "author": "Gabra BH", "volume": "64", "first-page": "782", "year": "2005", "journal-title": "J Neuropathol Exp Neurol"}, {"key": "sref_27_215", "author": "Gabra BH", "volume": "514", "first-page": "61", "year": "2005", "journal-title": "Eur J Pharmacol"}, {"key": "sref_28_216", "author": "Gabra BH", "volume": "127", "first-page": "245", "year": "2005", "journal-title": "Regul Pept"}, {"key": "sref_29_217", "author": "Gabra BH", "volume": "24", "first-page": "1131", "year": "2003", "journal-title": "Peptides"}], "container-title": ["Pharmacology"], "language": "en", "link": [{"URL": "https://www.karger.com/Article/Pdf/110788", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://www.karger.com/Article/Pdf/110788", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 11, 8]], "date-time": "2017-11-08T23:10:43Z", "timestamp": 1510182643000}, "score": 21.93223, "issued": {"date-parts": [[2007, 11, 7]]}, "references-count": 29, "journal-issue": {"published-online": {"date-parts": [[2008, 1, 1]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.1159/000110788", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["0031-7012", "1423-0313"], "issn-type": [{"value": "0031-7012", "type": "print"}, {"value": "1423-0313", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 10, 6]], "date-time": "2018-10-06T14:40:39Z", "timestamp": 1538836839417}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2013, 5, 1]], "date-time": "2013-05-01T00:00:00Z", "timestamp": 1367366400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Pharmacological Reports"], "published-print": {"date-parts": [[2013, 5]]}, "DOI": "10.1016/s1734-1140(13)71316-1", "type": "journal-article", "created": {"date-parts": [[2014, 2, 19]], "date-time": "2014-02-19T22:11:19Z", "timestamp": 1392847879000}, "page": "40", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Effect of the magnesium ions on analgesic activity of methadone in acute pain"], "prefix": "10.1016", "volume": "65", "author": [{"given": "Anna de", "family": "Cord\u00e9", "sequence": "first", "affiliation": []}, {"given": "Magdalena", "family": "Bujalska-Zadro\u017cny", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Pharmacological Reports"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1734114013713161?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1734114013713161?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 10, 6]], "date-time": "2018-10-06T14:20:43Z", "timestamp": 1538835643000}, "score": 21.93223, "issued": {"date-parts": [[2013, 5]]}, "references-count": 0, "alternative-id": ["S1734114013713161"], "URL": "http://dx.doi.org/10.1016/s1734-1140(13)71316-1", "ISSN": ["1734-1140"], "issn-type": [{"value": "1734-1140", "type": "print"}], "subject": ["Pharmacology", "General Medicine"]}, {"indexed": {"date-parts": [[2018, 10, 6]], "date-time": "2018-10-06T14:40:55Z", "timestamp": 1538836855302}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2010, 9, 1]], "date-time": "2010-09-01T00:00:00Z", "timestamp": 1283299200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Pharmacological Reports"], "published-print": {"date-parts": [[2010, 9]]}, "DOI": "10.1016/s1734-1140(10)71119-1", "type": "journal-article", "created": {"date-parts": [[2014, 2, 19]], "date-time": "2014-02-19T22:18:59Z", "timestamp": 1392848339000}, "page": "28", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Opioids and neuropathic pain"], "prefix": "10.1016", "volume": "62", "author": [{"given": "Magdalena", "family": "Bujalska-Zadro\u017cny", "sequence": "first", "affiliation": []}, {"given": "Helena E.", "family": "Makulska-Nowak", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Pharmacological Reports"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1734114010711191?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1734114010711191?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 10, 6]], "date-time": "2018-10-06T13:58:08Z", "timestamp": 1538834288000}, "score": 21.93223, "issued": {"date-parts": [[2010, 9]]}, "references-count": 0, "alternative-id": ["S1734114010711191"], "URL": "http://dx.doi.org/10.1016/s1734-1140(10)71119-1", "ISSN": ["1734-1140"], "issn-type": [{"value": "1734-1140", "type": "print"}], "subject": ["Pharmacology", "General Medicine"]}, {"indexed": {"date-parts": [[2018, 11, 28]], "date-time": "2018-11-28T20:42:39Z", "timestamp": 1543437759382}, "reference-count": 0, "publisher": "Termedia Sp. z.o.o.", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["aoms"], "published-print": {"date-parts": [[2016]]}, "DOI": "10.5114/aoms.2016.59838", "type": "journal-article", "created": {"date-parts": [[2016, 5, 20]], "date-time": "2016-05-20T14:34:40Z", "timestamp": 1463754880000}, "page": "1327-1336", "source": "Crossref", "is-referenced-by-count": 5, "title": ["New agents approved for treatment of acute staphylococcal skin infections"], "prefix": "10.5114", "volume": "6", "author": [{"given": "Jan", "family": "Tatarkiewicz", "sequence": "first", "affiliation": []}, {"given": "Anna", "family": "Staniszewska", "sequence": "additional", "affiliation": []}, {"given": "Magdalena", "family": "Bujalska-Zadro\u017cny", "sequence": "additional", "affiliation": []}], "member": "3061", "container-title": ["Archives of Medical Science"], "link": [{"URL": "http://www.termedia.pl/doi_ft/10.5114/aoms.2016.59838", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 10, 28]], "date-time": "2016-10-28T10:01:31Z", "timestamp": 1477648891000}, "score": 21.93223, "issued": {"date-parts": [[2016]]}, "references-count": 0, "alternative-id": ["59838"], "URL": "http://dx.doi.org/10.5114/aoms.2016.59838", "ISSN": ["1734-1922"], "issn-type": [{"value": "1734-1922", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 5, 9]], "date-time": "2018-05-09T07:15:28Z", "timestamp": 1525850128842}, "reference-count": 36, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Behavioural Pharmacology"], "published-print": {"date-parts": [[2015, 4]]}, "DOI": "10.1097/fbp.0000000000000117", "type": "journal-article", "created": {"date-parts": [[2014, 12, 8]], "date-time": "2014-12-08T09:41:52Z", "timestamp": 1418031712000}, "page": "282-288", "source": "Crossref", "is-referenced-by-count": 6, "title": ["Tapentadol and nitric oxide synthase systems"], "prefix": "10.1097", "volume": "26", "author": [{"given": "Magdalena", "family": "Bujalska-Zadro\u017cny", "sequence": "first", "affiliation": []}, {"given": "Renata", "family": "Woli\u0144ska", "sequence": "additional", "affiliation": []}, {"given": "Emilia", "family": "G\u0105si\u0144ska", "sequence": "additional", "affiliation": []}, {"given": "\u0141ukasz", "family": "Nagraba", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Behavioural Pharmacology"], "language": "en", "deposited": {"date-parts": [[2017, 6, 23]], "date-time": "2017-06-23T01:40:32Z", "timestamp": 1498182032000}, "score": 18.910501, "subtitle": [""], "issued": {"date-parts": [[2015, 4]]}, "references-count": 36, "journal-issue": {"issue": "3"}, "URL": "http://dx.doi.org/10.1097/fbp.0000000000000117", "ISSN": ["0955-8810"], "issn-type": [{"value": "0955-8810", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 7, 27]], "date-time": "2018-07-27T13:11:31Z", "timestamp": 1532697091945}, "reference-count": 181, "publisher": "Springer Nature", "issue": "1", "funder": [{"name": "National Science Centre, Cracow, Poland", "award": ["UMO-2012/05/B/NZ7/02589"]}, {"name": "statutory funds from the Jagiellonian University", "award": ["K/ZDS/004127"]}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Neurotox Res"], "published-print": {"date-parts": [[2016, 1]]}, "DOI": "10.1007/s12640-015-9555-7", "type": "journal-article", "created": {"date-parts": [[2015, 9, 9]], "date-time": "2015-09-09T13:31:35Z", "timestamp": 1441805495000}, "page": "173-196", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 3, "title": ["Cannabinoid Ligands and Alcohol Addiction: A Promising Therapeutic Tool or a Humbug?"], "prefix": "10.1007", "volume": "29", "author": [{"given": "Patrycja", "family": "Kleczkowska", "sequence": "first", "affiliation": []}, {"given": "Irena", "family": "Smaga", "sequence": "additional", "affiliation": []}, {"given": "Ma\u0142gorzata", "family": "Filip", "sequence": "additional", "affiliation": []}, {"given": "Magdalena", "family": "Bujalska-Zadrozny", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2015, 9, 9]]}, "reference": [{"key": "9555_CR1", "doi-asserted-by": "crossref", "first-page": "210", "DOI": "10.1111/j.1600-0404.1993.tb04103.x", "volume": "87", "author": "J Aasly", "year": "1993", "unstructured": "Aasly J, Storsaeter O, Nilsen G, Smevik O, Rinck P (1993) Minor structural brain changes in young drug abusers. A magnetic resonance study. Acta Neurol Scand 87:210\u2013214", "journal-title": "Acta Neurol Scand"}, {"key": "9555_CR2", "doi-asserted-by": "crossref", "first-page": "e31731", "DOI": "10.1371/journal.pone.0031731", "volume": "7", "author": "H Abush", "year": "2012", "unstructured": "Abush H, Akirav I (2012) Short- and long-term cognitive effects of chronic cannabinoids administration in late-adolescence rats. PLoS One 7:e31731", "journal-title": "PLoS One"}, {"key": "9555_CR3", "doi-asserted-by": "crossref", "first-page": "789", "DOI": "10.1016/j.drugalcdep.2013.08.023", "volume": "133", "author": "M Agudelo", "year": "2013", "unstructured": "Agudelo M, Yndart A, Morrison M, Figueroa G, Munoz K, Samikkannu T, Nair MP (2013) Differential expression and functional role of cannabinoid genes in alcohol users. Drug Alcohol Depend 133:789\u2013793", "journal-title": "Drug Alcohol Depend"}, {"key": "9555_CR4", "doi-asserted-by": "crossref", "first-page": "1687", "DOI": "10.1021/cr0782067", "volume": "108", "author": "K Ahn", "year": "2008", "unstructured": "Ahn K, McKinney MK, Cravatt BF (2008) Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. Chem Rev 108:1687\u20131707", "journal-title": "Chem Rev"}, {"key": "9555_CR5", "doi-asserted-by": "crossref", "first-page": "465", "DOI": "10.1016/j.neuroscience.2008.10.002", "volume": "158", "author": "F Alen", "year": "2009", "unstructured": "Alen F, Santos A, Moreno-Sanz G, Gonzalez-Cuevas G, Gine E, Franco-Ruiz L, Navarro M, Lopez-Moreno JA (2009) Cannabinoid-induced increase in relapse-like drinking is prevented by the blockade of the glycine-binding site of N-methyl-d-aspartate receptors. Neuroscience 158:465\u2013473", "journal-title": "Neuroscience"}, {"key": "9555_CR6", "doi-asserted-by": "crossref", "first-page": "54", "DOI": "10.1016/j.drugalcdep.2014.01.022", "volume": "138", "author": "DJ Allsop", "year": "2014", "unstructured": "Allsop DJ, Dunlop AJ, Saddler C, Rivas GR, McGregor IS, Copeland J (2014) Changes in cigarette and alcohol use during cannabis abstinence. Drug Alcohol Depend 138:54\u201360", "journal-title": "Drug Alcohol Depend"}, {"key": "9555_CR7", "doi-asserted-by": "crossref", "first-page": "315", "DOI": "10.1016/S0301-0082(98)00087-2", "volume": "58", "author": "A Ameri", "year": "1999", "unstructured": "Ameri A (1999) The effects of cannabinoids on the brain. Prog Neurobiol 58:315\u2013348", "journal-title": "Prog Neurobiol"}, {"key": "9555_CR8", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1016/S0014-2999(98)00433-6", "volume": "354", "author": "JC Arnold", "year": "1998", "unstructured": "Arnold JC, Topple AN, Hunt GE, McGregor IS (1998) Effects of pre-exposure and co-administration of the cannabinoid receptor agonist CP 55,940 on behavioral sensitization to cocaine. Eur J Pharmacol 354:9\u201316", "journal-title": "Eur J Pharmacol"}, {"key": "9555_CR9", "doi-asserted-by": "crossref", "first-page": "522", "DOI": "10.1046/j.1471-4159.1999.0720522.x", "volume": "72", "author": "BS Basavarajappa", "year": "1999", "unstructured": "Basavarajappa BS, Hungund BL (1999a) Chronic ethanol increases the cannabinoid receptor agonist anandamide and its precursor N-arachidonoylphosphatidylethanolamine in SK-N-SH cells. J Neurochem 72:522\u2013528", "journal-title": "J Neurochem"}, {"key": "9555_CR10", "doi-asserted-by": "crossref", "first-page": "89", "DOI": "10.1016/S0006-8993(98)01072-5", "volume": "815", "author": "BS Basavarajappa", "year": "1999", "unstructured": "Basavarajappa BS, Hungund BL (1999b) Down-regulation of cannabinoid receptor agonist-stimulated [35S]GTP gamma S binding in synaptic plasma membrane from chronic ethanol exposed mouse. Brain Res 815:89\u201397", "journal-title": "Brain Res"}, {"key": "9555_CR11", "doi-asserted-by": "crossref", "first-page": "212", "DOI": "10.1016/S0006-8993(98)00175-9", "volume": "793", "author": "BS Basavarajappa", "year": "1998", "unstructured": "Basavarajappa BS, Cooper TB, Hungund BL (1998a) Chronic ethanol administration down-regulates cannabinoid receptors in mouse brain synaptic plasma membrane. Brain Res 793:212\u2013218", "journal-title": "Brain Res"}, {"key": "9555_CR12", "doi-asserted-by": "crossref", "first-page": "515", "DOI": "10.1016/S0006-2952(97)00501-7", "volume": "55", "author": "BS Basavarajappa", "year": "1998", "unstructured": "Basavarajappa BS, Cooper TB, Hungund BL (1998b) Effect of chronic ethanol exposure on mouse brain arachidonic acid specific phospholipase A2. Biochem Pharmacol 55:515\u2013521", "journal-title": "Biochem Pharmacol"}, {"key": "9555_CR13", "first-page": "78", "volume": "1535", "author": "BS Basavarajappa", "year": "2000", "unstructured": "Basavarajappa BS, Saito M, Cooper TB, Hungund BL (2000a) Stimulation of cannabinoid receptor agonist 2-arachidonoylglycerol by chronic ethanol and its modulation by specific neuromodulators in cerebellar granule neurons. Biochim Biophys Acta 1535:78\u201386", "journal-title": "Biochim Biophys Acta"}, {"key": "9555_CR14", "doi-asserted-by": "crossref", "first-page": "78", "DOI": "10.1016/S0925-4439(00)00085-5", "volume": "1535", "author": "BS Basavarajappa", "year": "2000", "unstructured": "Basavarajappa BS, Saito M, Cooper TB, Hungund BL (2000b) Stimulation of cannabinoid receptor agonist 2-arachidonylglycerol by chronic ethanol and its modulation by specific neuromodulators in cerebellar granule neurons. Biochim Biophys Acta 1535:78\u201386", "journal-title": "Biochim Biophys Acta"}, {"key": "9555_CR15", "doi-asserted-by": "crossref", "first-page": "73", "DOI": "10.1016/S0014-2999(03)01557-7", "volume": "466", "author": "BS Basavarajappa", "year": "2003", "unstructured": "Basavarajappa BS, Saito M, Cooper TB, Hungund BL (2003) Chronic ethanol inhibits the anandamide transport and increases extracellular anandamide levels in cerebellar granule neurons. Eur J Pharmacol 466:73\u201383", "journal-title": "Eur J Pharmacol"}, {"key": "9555_CR16", "doi-asserted-by": "crossref", "first-page": "834", "DOI": "10.1016/j.neuropharm.2005.12.005", "volume": "50", "author": "BS Basavarajappa", "year": "2006", "unstructured": "Basavarajappa BS, Yalamanchili R, Cravatt BF, Cooper TB, Hungund BL (2006) Increased ethanol consumption and preference and decreased ethanol sensitivity in female FAAH knockout mice. Neuropharmacology 50:834\u2013844", "journal-title": "Neuropharmacology"}, {"key": "9555_CR17", "first-page": "1001", "volume": "107", "author": "BS Basavarajappa", "year": "2008", "unstructured": "Basavarajappa BS, Ninan I, Arancio O (2008) Acute ethanol suppresses glutamatergic neurotransmission through endocannabinoids in hippocampal neurons. J Neurochem 107:1001\u20131013", "journal-title": "J Neurochem"}, {"key": "9555_CR18", "doi-asserted-by": "crossref", "first-page": "305", "DOI": "10.1016/0376-8716(85)90008-0", "volume": "15", "author": "C Baum-Baicker", "year": "1985", "unstructured": "Baum-Baicker C (1985) The psychological benefits of moderate alcohol consumption: a review of the literature. Drug Alcohol Depend 15:305\u2013322", "journal-title": "Drug Alcohol Depend"}, {"key": "9555_CR19", "doi-asserted-by": "crossref", "first-page": "89", "DOI": "10.1016/0885-3924(94)00117-4", "volume": "10", "author": "JE Beal", "year": "1995", "unstructured": "Beal JE, Olson R, Laubenstein L, Morales JO, Bellman P, Yangco B, Lefkowitz L, Plasse TF, Shepard KV (1995) Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. J Pain Symptom Manage 10:89\u201397", "journal-title": "J Pain Symptom Manage"}, {"key": "9555_CR20", "doi-asserted-by": "crossref", "first-page": "53", "DOI": "10.1007/BF00426035", "volume": "62", "author": "BE Belgrave", "year": "1979", "unstructured": "Belgrave BE, Bird KD, Chesher GB, Jackson DM, Lubbe KE, Starmer GA, Teo RK (1979) The effect of (-) trans-delta9-tetrahydrocannabinol, alone and in combination with ethanol, on human performance. Psychopharmacology 62:53\u201360", "journal-title": "Psychopharmacology"}, {"key": "9555_CR21", "doi-asserted-by": "crossref", "first-page": "1570", "DOI": "10.1038/sj.npp.1301274", "volume": "32", "author": "YA Blednov", "year": "2007", "unstructured": "Blednov YA, Cravatt BF, Boehm SL 2nd, Walker D, Harris RA (2007) Role of endocannabinoids in alcohol consumption and intoxication: studies of mice lacking fatty acid amide hydrolase. Neuropsychopharmacology 32:1570\u20131582", "journal-title": "Neuropsychopharmacology"}, {"key": "9555_CR22", "doi-asserted-by": "crossref", "first-page": "1306", "DOI": "10.1016/j.bcp.2013.01.017", "volume": "85", "author": "F Borrelli", "year": "2013", "unstructured": "Borrelli F, Fasolino I, Romano B, Capasso R, Maiello F, Coppola D, Orlando P, Battista G, Pagano E, Di Marzo V, Izzo AA (2013) Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease. Biochem Pharmacol 85:1306\u20131316", "journal-title": "Biochem Pharmacol"}, {"key": "9555_CR23", "doi-asserted-by": "crossref", "first-page": "1080", "DOI": "10.1111/j.1360-0443.2010.02911.x", "volume": "105", "author": "JG Bramness", "year": "2010", "unstructured": "Bramness JG, Khiabani HZ, Morland J (2010) Impairment due to cannabis and ethanol: clinical signs and additive effects. Addiction 105:1080\u20131087", "journal-title": "Addiction"}, {"key": "9555_CR24", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/j.pnpbp.2013.12.002", "volume": "50", "author": "B Bystrowska", "year": "2014", "unstructured": "Bystrowska B, Smaga I, Frankowska M, Filip M (2014) Changes in endocannabinoid and N-acylethanolamine levels in rat brain structures following cocaine self-administration and extinction training. Prog Neuropsychopharmacol Biol Psychiatry 50:1\u201310", "journal-title": "Prog Neuropsychopharmacol Biol Psychiatry"}, {"key": "9555_CR25", "doi-asserted-by": "crossref", "first-page": "3695", "DOI": "10.1523/JNEUROSCI.4403-06.2007", "volume": "27", "author": "S Caille", "year": "2007", "unstructured": "Caille S, Alvarez-Jaimes L, Polis I, Stouffer DG, Parsons LH (2007) Specific alterations of extracellular endocannabinoid levels in the nucleus accumbens by ethanol, heroin, and cocaine self-administration. J Neurosci 27:3695\u20133702", "journal-title": "J Neurosci"}, {"key": "9555_CR26", "doi-asserted-by": "crossref", "first-page": "448", "DOI": "10.1016/j.pbb.2006.03.006", "volume": "83", "author": "YM Cha", "year": "2006", "unstructured": "Cha YM, White AM, Kuhn CM, Wilson WA, Swartzwelder HS (2006) Differential effects of delta9-THC on learning in adolescent and adult rats. Pharmacol Biochem Behav 83:448\u2013455", "journal-title": "Pharmacol Biochem Behav"}, {"key": "9555_CR27", "doi-asserted-by": "crossref", "first-page": "340", "DOI": "10.1007/BF02245075", "volume": "115", "author": "LD Chait", "year": "1994", "unstructured": "Chait LD, Perry JL (1994) Acute and residual effects of alcohol and marijuana, alone and in combination, on mood and performance. Psychopharmacology 115:340\u2013349", "journal-title": "Psychopharmacology"}, {"key": "9555_CR28", "doi-asserted-by": "crossref", "first-page": "161", "DOI": "10.1016/j.aat.2013.10.004", "volume": "51", "author": "LC Chiou", "year": "2013", "unstructured": "Chiou LC, Hu SS, Ho YC (2013) Targeting the cannabinoid system for pain relief? Acta Anaesthesiol Taiwan 51:161\u2013170", "journal-title": "Acta Anaesthesiol Taiwan"}, {"key": "9555_CR29", "doi-asserted-by": "crossref", "first-page": "1706", "DOI": "10.1016/S0140-6736(07)61721-8", "volume": "370", "author": "R Christensen", "year": "2007", "unstructured": "Christensen R, Kristensen PK, Bartels EM, Bliddal H, Astrup A (2007) Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet 370:1706\u20131713", "journal-title": "Lancet"}, {"key": "9555_CR30", "doi-asserted-by": "crossref", "first-page": "245", "DOI": "10.1016/S0014-2999(02)01999-4", "volume": "449", "author": "R Ciccocioppo", "year": "2002", "unstructured": "Ciccocioppo R, Antonelli L, Biondini M, Perfumi M, Pompei P, Massi M (2002) Memory impairment following combined exposure to delta(9)-tetrahydrocannabinol and ethanol in rats. Eur J Pharmacol 449:245\u2013252", "journal-title": "Eur J Pharmacol"}, {"key": "9555_CR31", "doi-asserted-by": "crossref", "first-page": "2243", "DOI": "10.1111/j.1460-9568.2005.04056.x", "volume": "21", "author": "A Cippitelli", "year": "2005", "unstructured": "Cippitelli A, Bilbao A, Hansson AC, del Arco I, Sommer W, Heilig M, Massi M, Bermudez-Silva FJ, Navarro M, Ciccocioppo R, Rodriguez de Fonseca F (2005) Cannabinoid CB1 receptor antagonism reduces conditioned reinstatement of ethanol-seeking behavior in rats. Eur J Neurosci 21:2243\u20132251", "journal-title": "Eur J Neurosci"}, {"key": "9555_CR32", "doi-asserted-by": "crossref", "first-page": "476", "DOI": "10.1111/j.1460-9568.2007.05665.x", "volume": "26", "author": "A Cippitelli", "year": "2007", "unstructured": "Cippitelli A, Bilbao A, Gorriti MA, Navarro M, Massi M, Piomelli D, Ciccocioppo R, Rodriguez de Fonseca F (2007) The anandamide transport inhibitor AM404 reduces ethanol self-administration. Eur J Neurosci 26:476\u2013486", "journal-title": "Eur J Neurosci"}, {"key": "9555_CR33", "doi-asserted-by": "crossref", "first-page": "449", "DOI": "10.1007/s00213-008-1104-0", "volume": "198", "author": "A Cippitelli", "year": "2008", "unstructured": "Cippitelli A, Cannella N, Braconi S, Duranti A, Tontini A, Bilbao A, Rodriguez de Fonseca F, Piomelli D, Ciccocioppo R (2008) Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat. Psychopharmacology 198:449\u2013460", "journal-title": "Psychopharmacology"}, {"key": "9555_CR34", "doi-asserted-by": "crossref", "first-page": "126", "DOI": "10.1093/oxfordjournals.alcalc.a008368", "volume": "33", "author": "G Colombo", "year": "1998", "unstructured": "Colombo G, Agabio R, Fa M, Guano L, Lobina C, Loche A, Reali R, Gessa GL (1998) Reduction of voluntary ethanol intake in ethanol-preferring sP rats by the cannabinoid antagonist SR-141716. Alcohol 33:126\u2013130", "journal-title": "Alcohol"}, {"key": "9555_CR35", "doi-asserted-by": "crossref", "first-page": "181", "DOI": "10.1007/s002130100887", "volume": "159", "author": "G Colombo", "year": "2002", "unstructured": "Colombo G, Serra S, Brunetti G, Gomez R, Melis S, Vacca G, Carai MM, Gessa L (2002) Stimulation of voluntary ethanol intake by cannabinoid receptor agonists in ethanol-preferring sP rats. Psychopharmacology 159:181\u2013187", "journal-title": "Psychopharmacology"}, {"key": "9555_CR36", "doi-asserted-by": "crossref", "first-page": "45", "DOI": "10.1007/BF00431988", "volume": "66", "author": "P Consroe", "year": "1979", "unstructured": "Consroe P, Carlini EA, Zwicker AP, Lacerda LA (1979) Interaction of cannabidiol and alcohol in humans. Psychopharmacology 66:45\u201350", "journal-title": "Psychopharmacology"}, {"key": "9555_CR37", "doi-asserted-by": "crossref", "first-page": "277", "DOI": "10.3109/00207458608985678", "volume": "30", "author": "P Consroe", "year": "1986", "unstructured": "Consroe P, Sandyk R, Snider SR (1986) Open label evaluation of cannabidiol in dystonic movement disorders. Int J Neurosci 30:277\u2013282", "journal-title": "Int J Neurosci"}, {"key": "9555_CR38", "doi-asserted-by": "crossref", "first-page": "373", "DOI": "10.1007/s002130000591", "volume": "153", "author": "RJ Croft", "year": "2001", "unstructured": "Croft RJ, Mackay AJ, Mills AT, Gruzelier JG (2001) The relative contributions of ecstasy and cannabis to cognitive impairment. Psychopharmacology 153:373\u2013379", "journal-title": "Psychopharmacology"}, {"key": "9555_CR39", "doi-asserted-by": "crossref", "first-page": "287", "DOI": "10.1016/j.bbr.2014.05.039", "volume": "270", "author": "MS Dar", "year": "2014", "unstructured": "Dar MS (2014) Functional interaction and cross-tolerance between ethanol and Delta9-THC: possible modulation by mouse cerebellar adenosinergic A1/GABAergic-A receptors. Behav Brain Res 270:287\u2013294", "journal-title": "Behav Brain Res"}, {"key": "9555_CR40", "doi-asserted-by": "crossref", "first-page": "408", "DOI": "10.1016/j.bbr.2010.11.013", "volume": "217", "author": "NM Bruin de", "year": "2011", "unstructured": "de Bruin NM, Lange JH, Kruse CG, Herremans AH, Schoffelmeer AN, van Drimmelen M, De Vries TJ (2011) SLV330, a cannabinoid CB(1) receptor antagonist, attenuates ethanol and nicotine seeking and improves inhibitory response control in rats. Behav Brain Res 217:408\u2013415", "journal-title": "Behav Brain Res"}, {"key": "9555_CR41", "first-page": "605", "volume": "34", "author": "WA Devane", "year": "1988", "unstructured": "Devane WA, Dysarz FA 3rd, Johnson MR, Melvin LS, Howlett AC (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34:605\u2013613", "journal-title": "Mol Pharmacol"}, {"key": "9555_CR42", "doi-asserted-by": "crossref", "first-page": "1946", "DOI": "10.1126/science.1470919", "volume": "258", "author": "WA Devane", "year": "1992", "unstructured": "Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946\u20131949", "journal-title": "Science"}, {"key": "9555_CR43", "first-page": "94", "volume": "248c", "author": "S Dubois", "year": "2014", "unstructured": "Dubois S, Mullen N, Weaver B, Bedard M (2014) The combined effects of alcohol and cannabis on driving: impact on crash risk. Forensic Sci Int 248c:94\u2013100", "journal-title": "Forensic Sci Int"}, {"key": "9555_CR44", "doi-asserted-by": "crossref", "first-page": "509", "DOI": "10.1016/j.alcohol.2008.04.001", "volume": "42", "author": "W Dyr", "year": "2008", "unstructured": "Dyr W, Ligieza J, Kostowski W (2008) The effect of cannabinoid CB(1) receptor antagonist rimonabant (SR-141716) on ethanol drinking in high-preferring rats. Alcohol 42:509\u2013512", "journal-title": "Alcohol"}, {"key": "9555_CR45", "doi-asserted-by": "crossref", "first-page": "2151", "DOI": "10.1016/j.addbeh.2007.01.031", "volume": "32", "author": "CJ Easton", "year": "2007", "unstructured": "Easton CJ, Mandel D, Babuscio T, Rounsaville BJ, Carroll KM (2007) Differences in treatment outcome between male alcohol dependent offenders of domestic violence with and without positive drug screens. Addict Behav 32:2151\u20132163", "journal-title": "Addict Behav"}, {"key": "9555_CR46", "doi-asserted-by": "crossref", "first-page": "394", "DOI": "10.1007/s00213-005-0199-9", "volume": "183", "author": "D Economidou", "year": "2006", "unstructured": "Economidou D, Mattioli L, Cifani C, Perfumi M, Massi M, Cuomo V, Trabace L, Ciccocioppo R (2006) Effect of the cannabinoid CB1 receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behaviour in rats. Psychopharmacology 183:394\u2013403", "journal-title": "Psychopharmacology"}, {"key": "9555_CR47", "doi-asserted-by": "crossref", "first-page": "102", "DOI": "10.1016/j.drugalcdep.2011.02.003", "volume": "117", "author": "AM Erdozain", "year": "2011", "unstructured": "Erdozain AM, Callado LF (2011) Involvement of the endocannabinoid system in alcohol dependence: The biochemical, behavioral and genetic evidence. Drug Alcohol Depend 117:102\u2013110", "journal-title": "Drug Alcohol Depend"}, {"key": "9555_CR48", "doi-asserted-by": "crossref", "first-page": "531", "DOI": "10.1007/s00213-009-1612-6", "volume": "206", "author": "E Fernandez-Espejo", "year": "2009", "unstructured": "Fernandez-Espejo E, Viveros MP, Nunez L, Ellenbroek BA, Rodriguez de Fonseca F (2009) Role of cannabis and endocannabinoids in the genesis of schizophrenia. Psychopharmacology 206:531\u2013549", "journal-title": "Psychopharmacology"}, {"key": "9555_CR49", "doi-asserted-by": "crossref", "first-page": "2956", "DOI": "10.1161/STROKEAHA.110.599357", "volume": "41", "author": "D Fernandez-Lopez", "year": "2010", "unstructured": "Fernandez-Lopez D, Pradillo JM, Garcia-Yebenes I, Martinez-Orgado JA, Moro MA, Lizasoain I (2010) The cannabinoid WIN55212-2 promotes neural repair after neonatal hypoxia-ischemia. Stroke 41:2956\u20132964", "journal-title": "Stroke"}, {"key": "9555_CR50", "doi-asserted-by": "crossref", "first-page": "97", "DOI": "10.1042/BJ20061898", "volume": "404", "author": "B Ferrer", "year": "2007", "unstructured": "Ferrer B, Bermudez-Silva FJ, Bilbao A, Alvarez-Jaimes L, Sanchez-Vera I, Giuffrida A, Serrano A, Baixeras E, Khaturia S, Navarro M, Parsons LH, Piomelli D, Rodriguez de Fonseca F (2007) Regulation of brain anandamide by acute administration of ethanol. Biochem J 404:97\u2013104", "journal-title": "Biochem J"}, {"key": "9555_CR51", "doi-asserted-by": "crossref", "first-page": "361", "DOI": "10.1007/BF00915771", "volume": "4", "author": "EA Formukong", "year": "1988", "unstructured": "Formukong EA, Evans AT, Evans FJ (1988) Analgesic and anti-inflammatory activity of constituents of cannabis Sativa L. Inflammation 4:361\u2013371", "journal-title": "Inflammation"}, {"key": "9555_CR52", "doi-asserted-by": "crossref", "first-page": "265", "DOI": "10.1016/S0091-3057(00)00359-2", "volume": "67", "author": "CS Freedland", "year": "2000", "unstructured": "Freedland CS, Poston JS, Porrino LJ (2000) Effects of SR141716A, a central cannabinoid receptor antagonist, on food-maintained responding. Pharmacol Biochem Behav 67:265\u2013270", "journal-title": "Pharmacol Biochem Behav"}, {"key": "9555_CR53", "doi-asserted-by": "crossref", "first-page": "277", "DOI": "10.1111/j.1530-0277.2001.tb02209.x", "volume": "25", "author": "CS Freedland", "year": "2001", "unstructured": "Freedland CS, Sharpe AL, Samson HH, Porrino LJ (2001) Effects of SR141716A on ethanol and sucrose self-administration. Alcohol Clin Exp Res 25:277\u2013282", "journal-title": "Alcohol Clin Exp Res"}, {"key": "9555_CR54", "doi-asserted-by": "crossref", "first-page": "233", "DOI": "10.1016/S0014-2999(99)00170-3", "volume": "370", "author": "JE Gallate", "year": "1999", "unstructured": "Gallate JE, Saharov T, Mallet PE, McGregor IS (1999) Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist. Eur J Pharmacol 370:233\u2013240", "journal-title": "Eur J Pharmacol"}, {"key": "9555_CR55", "doi-asserted-by": "crossref", "first-page": "37", "DOI": "10.1007/s00213-009-1704-3", "volume": "208", "author": "DT George", "year": "2010", "unstructured": "George DT, Herion DW, Jones CL, Phillips MJ, Hersh J, Hill D, Heilig M, Ramchandani VA, Geyer C, Spero DE, Singley ED, O\u2019Malley SS, Bishai R, Rawlings RR, Kunos G (2010) Rimonabant (SR141716) has no effect on alcohol self-administration or endocrine measures in nontreatment-seeking heavy alcohol drinkers. Psychopharmacology 208:37\u201344", "journal-title": "Psychopharmacology"}, {"key": "9555_CR56", "first-page": "351", "volume": "27", "author": "C Gillet", "year": "2001", "unstructured": "Gillet C, Polard E, Mauduit N, Allain H (2001) Acting out and psychoactive substances: alcohol, drugs, illicit substances. Encephale 27:351\u2013359", "journal-title": "Encephale"}, {"key": "9555_CR57", "doi-asserted-by": "crossref", "first-page": "10", "DOI": "10.1016/j.brainres.2005.11.035", "volume": "107", "author": "JP Gong", "year": "2006", "unstructured": "Gong JP, Onaivi ES, Ishiguro H, Liu QR, Tagliaferro PA, Brusco A, Uhl GR (2006) Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res 107:10\u201323", "journal-title": "Brain Res"}, {"key": "9555_CR58", "doi-asserted-by": "crossref", "first-page": "73", "DOI": "10.1016/S0006-8993(02)03344-9", "volume": "954", "author": "S Gonzalez", "year": "2002", "unstructured": "Gonzalez S, Cascio MG, Fernandez-Ruiz J, Fezza F, Di Marzo V, Ramos JA (2002a) Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine. Brain Res 954:73\u201381", "journal-title": "Brain Res"}, {"key": "9555_CR59", "first-page": "77", "volume": "66", "author": "S Gonzalez", "year": "2002", "unstructured": "Gonzalez S, Fernandez-Ruiz J, Sparpaglione V, Parolaro D, Ramos JA (2002b) Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB(1) receptor binding and mRNA levels. Drug Alcohol Depend 66:77\u201384", "journal-title": "Drug Alcohol Depend"}, {"key": "9555_CR60", "doi-asserted-by": "crossref", "first-page": "77", "DOI": "10.1016/S0376-8716(01)00186-7", "volume": "66", "author": "S Gonzalez", "year": "2002", "unstructured": "Gonzalez S, Fern\u00e1ndez-Ruiz JJ, Sparpaglione V, Parolaro D, Ramos JA (2002c) Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB1 receptor binding and mRNA levels. Drug Alcohol Depend 66:77\u201384", "journal-title": "Drug Alcohol Depend"}, {"key": "9555_CR61", "doi-asserted-by": "crossref", "first-page": "300", "DOI": "10.1016/j.pbb.2005.01.028", "volume": "81", "author": "S Gonzalez", "year": "2005", "unstructured": "Gonzalez S, Cebeira M, Fernandez-Ruiz J (2005) Cannabinoid tolerance and dependence: a review of studies in laboratory animals. Pharmacol Biochem Behav 81:300\u2013318", "journal-title": "Pharmacol Biochem Behav"}, {"key": "9555_CR62", "doi-asserted-by": "crossref", "first-page": "1266", "DOI": "10.1046/j.1528-1157.2001.19301.x", "volume": "42", "author": "E Gordon", "year": "2001", "unstructured": "Gordon E, Devinsky O (2001) Alcohol and marijuana: effects on epilepsy and use by patients with epilepsy. Epilepsia 42:1266\u20131272", "journal-title": "Epilepsia"}, {"key": "9555_CR63", "doi-asserted-by": "crossref", "first-page": "772", "DOI": "10.1111/j.1476-5381.2010.00720.x", "volume": "160", "author": "MD Gutierrez-Lopez", "year": "2010", "unstructured": "Gutierrez-Lopez MD, Llopis N, Feng S, Barrett DA, O\u2019Shea E, Colado MI (2010) Involvement of 2-arachidonoyl glycerol in the increased consumption of and preference for ethanol of mice treated with neurotoxic doses of methamphetamine. Br J Pharmacol 160:772\u2013783", "journal-title": "Br J Pharmacol"}, {"key": "9555_CR64", "doi-asserted-by": "crossref", "first-page": "135", "DOI": "10.1016/S0009-3084(00)00192-4", "volume": "108", "author": "HS Hansen", "year": "2000", "unstructured": "Hansen HS, Moesgaard B, Hansen HH, Petersen G (2000) N-Acylethanolamines and precursor phospholipids\u2014relation to cell injury. Chem Phys Lipids 108:135\u2013150", "journal-title": "Chem Phys Lipids"}, {"key": "9555_CR65", "doi-asserted-by": "crossref", "first-page": "117", "DOI": "10.1038/sj.npp.1301034", "volume": "32", "author": "AC Hansson", "year": "2007", "unstructured": "Hansson AC, Bermudez-Silva FJ, Malinen H, Hyytia P, Sanchez-Vera I, Rimondini R, Rodriguez de Fonseca F, Kunos G, Sommer WH, Heilig M (2007) Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference. Neuropsychopharmacology 32:117\u2013126", "journal-title": "Neuropsychopharmacology"}, {"key": "9555_CR66", "first-page": "563", "volume": "11", "author": "M Herkenham", "year": "1991", "unstructured": "Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC (1991) Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 11:563\u2013583", "journal-title": "J Neurosci"}, {"key": "9555_CR67", "doi-asserted-by": "crossref", "first-page": "125", "DOI": "10.1016/S0014-2999(03)01343-8", "volume": "462", "author": "AL Hildebrandt", "year": "2003", "unstructured": "Hildebrandt AL, Kelly-Sullivan DM, Black SC (2003) Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in diet-induced obese mice. Eur J Pharmacol 462:125\u2013132", "journal-title": "Eur J Pharmacol"}, {"key": "9555_CR68", "doi-asserted-by": "crossref", "first-page": "1533", "DOI": "10.1016/j.addbeh.2003.08.033", "volume": "28", "author": "PN Hoaken", "year": "2003", "unstructured": "Hoaken PN, Stewart SH (2003) Drugs of abuse and the elicitation of human aggressive behavior. Addict Behav 28:1533\u20131554", "journal-title": "Addict Behav"}, {"key": "9555_CR69", "doi-asserted-by": "crossref", "first-page": "71", "DOI": "10.1002/(SICI)1098-2396(200007)37:1<71::AID-SYN8>3.0.CO;2-K", "volume": "37", "author": "AG Hohmann", "year": "2000", "unstructured": "Hohmann AG, Herkenham M (2000) Localization of cannabinoid CB(1) receptor mRNA in neuronal subpopulations of rat striatum: a double-label in situ hybridization study. Synapse 37:71\u201380", "journal-title": "Synapse"}, {"key": "9555_CR70", "doi-asserted-by": "crossref", "first-page": "339", "DOI": "10.1038/sj.npp.1300568", "volume": "30", "author": "H Houchi", "year": "2005", "unstructured": "Houchi H, Babovic D, Pierrefiche O, Ledent C, Daoust M, Naassila M (2005) CB1 receptor knockout mice display reduced ethanol-induced conditioned place preference and increased striatal dopamine D2 receptors. Neuropsychopharmacology 30:339\u2013349", "journal-title": "Neuropsychopharmacology"}, {"key": "9555_CR71", "doi-asserted-by": "crossref", "first-page": "161", "DOI": "10.1124/pr.54.2.161", "volume": "54", "author": "AC Howlett", "year": "2002", "unstructured": "Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54:161\u2013202", "journal-title": "Pharmacol Rev"}, {"key": "9555_CR72", "doi-asserted-by": "crossref", "first-page": "42639", "DOI": "10.1074/jbc.M107351200", "volume": "276", "author": "SM Huang", "year": "2001", "unstructured": "Huang SM, Bisogno T, Petros TJ, Chang SY, Zavitsanos PA, Zipkin RE, Sivakumar R, Coop A, Maeda DY, De Petrocellis L, Burstein S, Di Marzo V, Walker JM (2001) Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain. J Biol Chem 276:42639\u201342644", "journal-title": "J Biol Chem"}, {"key": "9555_CR73", "doi-asserted-by": "crossref", "first-page": "126", "DOI": "10.1093/alcalc/35.2.126", "volume": "35", "author": "BL Hungund", "year": "2000", "unstructured": "Hungund BL, Basavarajappa BS (2000) Are anandamide and cannabinoid receptors involved in ethanol tolerance? A review of the evidence. Alcohol Alcohol 35:126\u2013133", "journal-title": "Alcohol Alcohol"}, {"key": "9555_CR74", "doi-asserted-by": "crossref", "first-page": "212", "DOI": "10.1093/brain/84.2.212", "volume": "84", "author": "R Ironside", "year": "1961", "unstructured": "Ironside R, Bosanquet FD, McMenemy WH (1961) Central demyelination of the corpus callosum (Marchiafava-Bignami disease). With report of a second case in Great Britain. Brain 84:212\u2013217", "journal-title": "Brain"}, {"key": "9555_CR75", "doi-asserted-by": "crossref", "first-page": "227", "DOI": "10.1016/j.cmet.2007.12.007", "volume": "7", "author": "WI Jeong", "year": "2008", "unstructured": "Jeong WI, Osei-Hyiaman D, Park O, Liu J, Batkai S, Mukhopadhyay P, Horiguchi N, Harvey-White J, Marsicano G, Lutz B, Gao B, Kunos G (2008) Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver. Cell Metab 7:227\u2013235", "journal-title": "Cell Metab"}, {"key": "9555_CR76", "doi-asserted-by": "crossref", "first-page": "59", "DOI": "10.1016/0009-8981(96)06227-4", "volume": "246", "author": "WB Kannel", "year": "1996", "unstructured": "Kannel WB, Ellison RC (1996) Alcohol and coronary heart disease: the evidence for a protective effect. Clin Chim Acta 246:59\u201376", "journal-title": "Clin Chim Acta"}, {"key": "9555_CR77", "doi-asserted-by": "crossref", "first-page": "502", "DOI": "10.1159/000136944", "volume": "13", "author": "IG Karniol", "year": "1975", "unstructured": "Karniol IG, Shirakawa I, Takahashi RN, Knobel E, Musty RE (1975) Effects of delta9-tetrahydrocannabinol and cannabinol in man. Pharmacology 13:502\u2013512", "journal-title": "Pharmacology"}, {"key": "9555_CR78", "doi-asserted-by": "crossref", "first-page": "627", "DOI": "10.1111/add.12829", "volume": "110", "author": "AB Kelly", "year": "2015", "unstructured": "Kelly AB, Evans-Whipp TJ, Smith R, Chan GC, Toumbourou JW, Patton GC, Hemphill SA, Hall WD, Catalano RF (2015) A longitudinal study of the association of adolescent polydrug use, alcohol use and high school non-completion. Addiction 110:627\u2013635", "journal-title": "Addiction"}, {"key": "9555_CR79", "doi-asserted-by": "crossref", "first-page": "244", "DOI": "10.1016/j.neuropharm.2010.09.004", "volume": "60", "author": "SG Kinsey", "year": "2011", "unstructured": "Kinsey SG, Mahadevan A, Zhao B, Sun H, Naidu PS, Razdan RK, Selley DE, Imad Damaj M, Lichtman AH (2011) The CB2 cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects. Neuropharmacology 60:244\u2013251", "journal-title": "Neuropharmacology"}, {"key": "9555_CR80", "doi-asserted-by": "crossref", "first-page": "237", "DOI": "10.1016/j.phrs.2007.01.011", "volume": "55", "author": "AL Klatsky", "year": "2007", "unstructured": "Klatsky AL (2007) Alcohol, cardiovascular diseases and diabetes mellitus. Pharmacol Res 55:237\u2013247", "journal-title": "Pharmacol Res"}, {"key": "9555_CR81", "doi-asserted-by": "crossref", "first-page": "43", "DOI": "10.1111/dar.12087", "volume": "33", "author": "RA Korcha", "year": "2014", "unstructured": "Korcha RA, Cherpitel CJ, Witbrodt J, Borges G, Hejazi-Bazargan S, Bond JC, Ye Y, Gmel G (2014) Violence-related injury and gender: the role of alcohol and alcohol combined with illicit drugs. Drug Alcohol Rev 33:43\u201350", "journal-title": "Drug Alcohol Rev"}, {"key": "9555_CR82", "doi-asserted-by": "crossref", "first-page": "54", "DOI": "10.1093/alcalc/agh115", "volume": "40", "author": "F Lallemand", "year": "2005", "unstructured": "Lallemand F, de Witte P (2005) Ethanol induces higher BEC in CB1 cannabinoid receptor knockout mice while decreasing ethanol preference. Alcohol Alcohol 40:54\u201362", "journal-title": "Alcohol Alcohol"}, {"key": "9555_CR83", "doi-asserted-by": "crossref", "first-page": "125", "DOI": "10.1016/j.alcohol.2006.08.001", "volume": "39", "author": "F Lallemand", "year": "2006", "unstructured": "Lallemand F, De Witte P (2006) SR147778, a CB1 cannabinoid receptor antagonist, suppresses ethanol preference in chronically alcoholized Wistar rats. Alcohol 39:125\u2013134", "journal-title": "Alcohol"}, {"key": "9555_CR84", "doi-asserted-by": "crossref", "first-page": "118", "DOI": "10.1016/S0028-3908(01)00039-9", "volume": "41", "author": "S Lamarque", "year": "2001", "unstructured": "Lamarque S, Taghzouti K, Simon H (2001) Chronic treatment with Delta(9)-tetrahydrocannabinol enhances the locomotor response to amphetamine and heroin. Implications for vulnerability to drug addiction. Neuropharmacology 41:118\u2013129", "journal-title": "Neuropharmacology"}, {"key": "9555_CR85", "doi-asserted-by": "crossref", "first-page": "760", "DOI": "10.3109/15563650.2011.609822", "volume": "49", "author": "J Lapoint", "year": "2011", "unstructured": "Lapoint J, James LP, Moran CL, Nelson LS, Hoffman RS, Moran JH (2011) Severe toxicity following synthetic cannabinoid ingestion. Clin Toxicol (Phila) 49:760\u2013764", "journal-title": "Clin Toxicol (Phila)"}, {"key": "9555_CR86", "doi-asserted-by": "crossref", "first-page": "253", "DOI": "10.1038/sj.bjp.0705607", "volume": "141", "author": "JD Leggett", "year": "2004", "unstructured": "Leggett JD, Aspley S, Beckett SR, D\u2019Antona AM, Kendall DA (2004) Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors. Br J Pharmacol 141:253\u2013262", "journal-title": "Br J Pharmacol"}, {"key": "9555_CR87", "doi-asserted-by": "crossref", "first-page": "245", "DOI": "10.1016/j.euroneuro.2009.12.008", "volume": "20", "author": "M Lehtonen", "year": "2010", "unstructured": "Lehtonen M, Storvik M, Tupala E, Hyytia P, Tiihonen J, Callaway JC (2010) Endogenous cannabinoids in post-mortem brains of Cloninger type 1 and 2 alcoholics. Eur Neuropsychopharmacol 20:245\u2013252", "journal-title": "Eur Neuropsychopharmacol"}, {"key": "9555_CR88", "doi-asserted-by": "crossref", "first-page": "536", "DOI": "10.1152/jn.00097.2004", "volume": "92", "author": "CH Lemon", "year": "2004", "unstructured": "Lemon CH, Brasser SM, Smith DV (2004) Alcohol activates a sucrose-responsive gustatory neural pathway. J Neurophysiol 92:536\u2013544", "journal-title": "J Neurophysiol"}, {"key": "9555_CR89", "doi-asserted-by": "crossref", "first-page": "759", "DOI": "10.1158/1940-6207.CAPR-09-0048", "volume": "2", "author": "C Liang", "year": "2009", "unstructured": "Liang C, McClean MD, Marsit C, Christensen B, Peters E, Nelson HH, Kelsey KT (2009) A population-based case-control study of marijuana use and head and neck squamous cell carcinoma. Cancer Prev Res (Phila) 2:759\u2013768", "journal-title": "Cancer Prev Res (Phila)"}, {"key": "9555_CR90", "doi-asserted-by": "crossref", "first-page": "235", "DOI": "10.1097/WNF.0b013e3181e77428", "volume": "33", "author": "JA Lile", "year": "2010", "unstructured": "Lile JA, Kelly TH, Hays LR (2010) Substitution profile of the cannabinoid agonist nabilone in human subjects discriminating delta9-tetrahydrocannabinol. Clin Neuropharmacol 33:235\u2013242", "journal-title": "Clin Neuropharmacol"}, {"key": "9555_CR91", "doi-asserted-by": "crossref", "first-page": "424", "DOI": "10.1016/j.neuroscience.2009.08.007", "volume": "164", "author": "DN Linsenbardt", "year": "2009", "unstructured": "Linsenbardt DN, Boehm SL 2nd (2009) Agonism of the endocannabinoid system modulates binge-like alcohol intake in male C57BL/6\u00a0J mice: involvement of the posterior ventral tegmental area. Neuroscience 164:424\u2013434", "journal-title": "Neuroscience"}, {"key": "9555_CR92", "author": "KM Lisdahl", "year": "2013", "unstructured": "Lisdahl KM, Gilbart ER, Wright NE, Shollenbarger S (2013) Dare to delay? The impacts of adolescent alcohol and marijuana use onset on cognition, brain structure, and function. Front Psychiatry. doi: 10.3389/fpsyt.2013.00053", "journal-title": "Front Psychiatry"}, {"key": "9555_CR93", "doi-asserted-by": "crossref", "first-page": "8245", "DOI": "10.1523/JNEUROSCI.2179-04.2004", "volume": "24", "author": "JA Lopez-Moreno", "year": "2004", "unstructured": "Lopez-Moreno JA, Gonzalez-Cuevas G, Rodriguez de Fonseca F, Navarro M (2004) Long-lasting increase of alcohol relapse by the cannabinoid receptor agonist WIN 55,212-2 during alcohol deprivation. J Neurosci 24:8245\u20138252", "journal-title": "J Neurosci"}, {"key": "9555_CR94", "doi-asserted-by": "crossref", "first-page": "1217", "DOI": "10.1002/hep.24524", "volume": "54", "author": "A Louvet", "year": "2011", "unstructured": "Louvet A, Teixeira-Clerc F, Chobert MN, Deveaux V, Pavoine C, Zimmer A, Pecker F, Mallat A, Lotersztajn S (2011) Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice. Hepatology 54:1217\u20131226", "journal-title": "Hepatology"}, {"key": "9555_CR95", "doi-asserted-by": "crossref", "first-page": "639", "DOI": "10.1016/j.bmcl.2008.12.059", "volume": "19", "author": "J LoVerme", "year": "2009", "unstructured": "LoVerme J, Duranti A, Tontini A, Spadoni G, Mor M, Rivara S, Stella N, Xu C, Tarzia G, Piomelli D (2009) Synthesis and characterization of a peripherally restricted CB1 cannabinoid antagonist, URB447, that reduces feeding and body-weight gain in mice. Bioorg Med Chem Lett 19:639\u2013643", "journal-title": "Bioorg Med Chem Lett"}, {"key": "9555_CR96", "doi-asserted-by": "crossref", "first-page": "431", "DOI": "10.1111/j.1365-2354.2008.00917.x", "volume": "17", "author": "FC Machado Rocha", "year": "2008", "unstructured": "Machado Rocha FC, Stefano SC, De Cassia Haiek R, Rosa Oliveira LM, Da Silveira DX (2008) Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis. Eur J Cancer Care (Engl) 17:431\u2013443", "journal-title": "Eur J Cancer Care (Engl)"}, {"key": "9555_CR97", "doi-asserted-by": "crossref", "first-page": "885", "DOI": "10.15288/jsad.2010.71.885", "volume": "71", "author": "OM Mahmood", "year": "2010", "unstructured": "Mahmood OM, Jacobus J, Bava S, Scarlett A, Tapert SF (2010) Learning and memory performances in adolescent users of alcohol and marijuana: interactive effects. J Stud Alcohol Drugs 71:885\u2013894", "journal-title": "J Stud Alcohol Drugs"}, {"key": "9555_CR98", "first-page": "119", "volume": "6", "author": "V Maida", "year": "2008", "unstructured": "Maida V, Ennis M, Irani S, Corbo M, Dolzhykov M (2008) Adjunctive nabilone in cancer pain and symptom management: a prospective observational study using propensity scoring. J Support Oncol 6:119\u2013124", "journal-title": "J Support Oncol"}, {"key": "9555_CR99", "first-page": "22", "volume": "58c", "author": "EA Marinho", "year": "2014", "unstructured": "Marinho EA, Oliveira-Lima AJ, Santos R, Hollais AW, Baldaia MA, Wuo-Silva R, Yokoyama TS, Takatsu-Coleman AL, Patti CL, Longo BM, Berro LF, Frussa-Filho R (2014) Effects of rimonabant on the development of single dose-induced behavioral sensitization to ethanol, morphine and cocaine in mice. Prog Neuropsychopharmacol Biol Psychiatry 58c:22\u201331", "journal-title": "Prog Neuropsychopharmacol Biol Psychiatry"}, {"key": "9555_CR100", "doi-asserted-by": "crossref", "first-page": "35", "DOI": "10.1016/j.jsr.2014.03.009", "volume": "50", "author": "SV Masten", "year": "2014", "unstructured": "Masten SV, Guenzburger GV (2014) Changes in driver cannabinoid prevalence in 12 U.S. states after implementing medical marijuana laws. J Safety Res 50:35\u201352", "journal-title": "J Safety Res"}, {"key": "9555_CR101", "doi-asserted-by": "crossref", "first-page": "803", "DOI": "10.1016/S0091-3057(00)00281-1", "volume": "66", "author": "PJ McLaughlin", "year": "2000", "unstructured": "McLaughlin PJ, Delevan CE, Carnicom S, Robinson JK, Brener J (2000) Fine motor control in rats is disrupted by delta-9-tetrahydrocannabinol. Pharmacol Biochem Behav 66:803\u2013809", "journal-title": "Pharmacol Biochem Behav"}, {"key": "9555_CR102", "doi-asserted-by": "crossref", "first-page": "141", "DOI": "10.1016/j.ntt.2006.10.010", "volume": "29", "author": "KL Medina", "year": "2007", "unstructured": "Medina KL, Schweinsburg AD, Cohen-Zion M, Nagel BJ, Tapert SF (2007) Effects of alcohol and combined marijuana and alcohol use during adolescence on hippocampal volume and asymmetry. Neurotoxicol Teratol 29:141\u2013152", "journal-title": "Neurotoxicol Teratol"}, {"key": "9555_CR103", "doi-asserted-by": "crossref", "first-page": "194", "DOI": "10.1016/j.drugalcdep.2011.06.004", "volume": "119", "author": "J Metrik", "year": "2011", "unstructured": "Metrik J, Spillane NS, Leventhal AM, Kahler CW (2011) Marijuana use and tobacco smoking cessation among heavy alcohol drinkers. Drug Alcohol Depend 119:194\u2013200", "journal-title": "Drug Alcohol Depend"}, {"key": "9555_CR104", "doi-asserted-by": "crossref", "first-page": "72", "DOI": "10.1016/j.drugalcdep.2007.02.024", "volume": "90", "author": "LT Midanik", "year": "2007", "unstructured": "Midanik LT, Tam TW, Weisner C (2007) Concurrent and simultaneous drug and alcohol use: results of the 2000 National Alcohol Survey. Drug Alcohol Depend 90:72\u201380", "journal-title": "Drug Alcohol Depend"}, {"key": "9555_CR105", "doi-asserted-by": "crossref", "first-page": "855", "DOI": "10.1111/j.1530-0277.2007.00366.x", "volume": "31", "author": "S Mitrirattanakul", "year": "2007", "unstructured": "Mitrirattanakul S, Lopez-Valdes HE, Liang J, Matsuka Y, Mackie K, Faull KF, Spigelman I (2007) Bidirectional alterations of hippocampal cannabinoid 1 receptors and their endogenous ligands in a rat model of alcohol withdrawal and dependence. Alcohol Clin Exp Res 31:855\u2013867", "journal-title": "Alcohol Clin Exp Res"}, {"key": "9555_CR500", "doi-asserted-by": "crossref", "first-page": "145", "DOI": "10.1590/S1516-44462009000200012", "volume": "31", "author": "FA Moreira", "year": "2009", "unstructured": "Moreira FA, Crippa JA (2009) The psychiatric side-effects of rimonabant. Rev Bras Psiquiatr 31:145\u2013153", "journal-title": "Rev Bras Psiquiatr"}, {"key": "9555_CR106", "doi-asserted-by": "crossref", "first-page": "429", "DOI": "10.1007/7854_2009_16", "volume": "2", "author": "FA Moreira", "year": "2010", "unstructured": "Moreira FA, Wotjak CT (2010) Cannabinoids and anxiety. Curr Top Behav Neurosci 2:429\u2013450", "journal-title": "Curr Top Behav Neurosci"}, {"key": "9555_CR107", "doi-asserted-by": "crossref", "first-page": "22", "DOI": "10.1093/alcalc/36.1.22", "volume": "36", "author": "CJ Morgan", "year": "2009", "unstructured": "Morgan CJ, Badway A (2009) Alcohol-induced euphoria: exclusion of serotonin. Alcohol Alcohol 36:22\u201325", "journal-title": "Alcohol Alcohol"}, {"key": "9555_CR108", "doi-asserted-by": "crossref", "first-page": "93", "DOI": "10.1016/S0014-2999(01)01309-7", "volume": "429", "author": "V Morisset", "year": "2001", "unstructured": "Morisset V, Ahluwalia J, Nagy I, Urban L (2001) Possible mechanisms of cannabinoid-induced antinociception in the spinal cord. Eur J Pharmacol 429:93\u2013100", "journal-title": "Eur J Pharmacol"}, {"key": "9555_CR109", "doi-asserted-by": "crossref", "first-page": "23", "DOI": "10.1159/000057153", "volume": "3", "author": "KR M\u00fcller-Vahl", "year": "1999", "unstructured": "M\u00fcller-Vahl KR, Kolbe H, Schneider U, Emrich HM (1999) Cannabis in movement disorders. Forsch Komplementarmed 3:23\u201327", "journal-title": "Forsch Komplementarmed"}, {"key": "9555_CR110", "doi-asserted-by": "crossref", "first-page": "S41", "DOI": "10.3747/co.2008.175", "volume": "15", "author": "J Myers", "year": "2008", "unstructured": "Myers J, Shetty N (2008) Going beyond efficacy: strategies for cancer pain management. Curr Oncol 15:S41\u2013S49", "journal-title": "Curr Oncol"}, {"key": "9555_CR111", "doi-asserted-by": "crossref", "first-page": "243", "DOI": "10.1016/j.neuropharm.2003.09.002", "volume": "46", "author": "M Naassila", "year": "2004", "unstructured": "Naassila M, Pierrefiche O, Ledent C, Daoust M (2004) Decreased alcohol self-administration and increased alcohol sensitivity and withdrawal in CB1 receptor knockout mice. Neuropharmacology 46:243\u2013253", "journal-title": "Neuropharmacology"}, {"key": "9555_CR112", "first-page": "2987", "volume": "19", "author": "T Nagayama", "year": "1999", "unstructured": "Nagayama T, Sinor AD, Simon RP, Chen J, Graham SH, Jin K, Greenberg DA (1999) Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures. J Neurosci 19:2987\u20132995", "journal-title": "J Neurosci"}, {"key": "9555_CR113", "doi-asserted-by": "crossref", "first-page": "254", "DOI": "10.1016/j.jpain.2007.10.018", "volume": "9", "author": "S Narang", "year": "2008", "unstructured": "Narang S, Gibson D, Wasan AD, Ross EL, Michna E, Nedeljkovic SS, Jamison RN (2008) Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy. J Pain 9:254\u2013264", "journal-title": "J Pain"}, {"key": "9555_CR114", "doi-asserted-by": "crossref", "first-page": "689", "DOI": "10.1046/j.1360-0443.1998.9356895.x", "volume": "93", "author": "T Norstrom", "year": "1998", "unstructured": "Norstrom T (1998) Effects on criminal violence of different beverage types and private and public drinking. Addiction 93:689\u2013699", "journal-title": "Addiction"}, {"key": "9555_CR115", "doi-asserted-by": "crossref", "first-page": "210", "DOI": "10.1016/j.pain.2007.08.028", "volume": "133", "author": "TJ Nurmikko", "year": "2007", "unstructured": "Nurmikko TJ, Serpell MG, Hoggart B, Toomey PJ, Morlion BJ, Haines D (2007) Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial. Pain 133:210\u2013220", "journal-title": "Pain"}, {"key": "9555_CR116", "doi-asserted-by": "crossref", "first-page": "8796", "DOI": "10.4049/jimmunol.177.12.8796", "volume": "177", "author": "S Oka", "year": "2006", "unstructured": "Oka S, Wakui J, Ikeda S, Yanagimoto S, Kishimoto S, Gokoh M, Nasui M, Sugiura T (2006) Involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in oxazolone-induced contact dermatitis in mice. J Immunol 177:8796\u20138805", "journal-title": "J Immunol"}, {"key": "9555_CR117", "doi-asserted-by": "crossref", "first-page": "514", "DOI": "10.1196/annals.1369.052", "volume": "1074", "author": "ES Onaivi", "year": "2006", "unstructured": "Onaivi ES, Ishiguro H, Gong JP, Patel S, Perchuk A, Meozzi PA, Myers L, Mora Z, Tagliaferro P, Gardner E, Brusco A, Akinshola BE, Liu QR, Hope B, Iwasaki S, Arinami T, Teasenfitz L, Uhl GR (2006) Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Ann NY Acad Sci 1074:514\u2013536", "journal-title": "Ann NY Acad Sci"}, {"key": "9555_CR118", "doi-asserted-by": "crossref", "first-page": "426", "DOI": "10.1196/annals.1432.035", "volume": "1139", "author": "ES Onaivi", "year": "2008", "unstructured": "Onaivi ES, Carpio O, Ishiguro H, Schanz N, Uhl GR, Benno R (2008) Behavioral effects of CB2 cannabinoid receptor activation and its influence on food and alcohol consumption. Ann NY Acad Sci 1139:426\u2013433", "journal-title": "Ann NY Acad Sci"}, {"key": "9555_CR119", "doi-asserted-by": "crossref", "first-page": "88", "DOI": "10.1093/alcalc/agh036", "volume": "39", "author": "S Ortiz", "year": "2004", "unstructured": "Ortiz S, Oliva JM, Perez-Rial S, Palomo T, Manzanares J (2004) Chronic ethanol consumption regulates cannabinoid CB1 receptor gene expression in selected regions of rat brain. Alcohol Alcohol 39:88\u201392", "journal-title": "Alcohol Alcohol"}, {"key": "9555_CR120", "doi-asserted-by": "crossref", "first-page": "38", "DOI": "10.1186/1747-597X-9-38", "volume": "9", "author": "KC Osilla", "year": "2014", "unstructured": "Osilla KC, Pedersen ER, Ewing BA, Miles JN, Ramchand R, D\u2019Amico EJ (2014) The effects of purchasing alcohol and marijuana among adolescents at-risk for future substance use. Subst Abuse Treat Prev Policy 9:38", "journal-title": "Subst Abuse Treat Prev Policy"}, {"key": "9555_CR121", "unstructured": "Palmer E (2014) Sativex: \u2018Life Changing\u2019 cannabis-based multiple sclerosis drug rejected for use in England. http://www.ibtimes.co.uk/sativex-life-changing-cannabis-based-multiple-sclerosis-drug-rejected-use-england-1469080 . Accessed 8 Oct 2014"}, {"key": "9555_CR122", "doi-asserted-by": "crossref", "first-page": "711", "DOI": "10.2147/NDT.S976", "volume": "3", "author": "D Parolaro", "year": "2007", "unstructured": "Parolaro D, Vigano D, Realini N, Rubino T (2007) Role of endocannabinoids in regulating drug dependence. Neuropsychiatr Dis Treat 3:711\u2013721", "journal-title": "Neuropsychiatr Dis Treat"}, {"key": "9555_CR123", "doi-asserted-by": "crossref", "first-page": "185", "DOI": "10.1016/j.alcohol.2012.01.002", "volume": "46", "author": "MJ Pava", "year": "2012", "unstructured": "Pava MJ, Woodward JJ (2012) A review of the interactions between alcohol and the endocannabinoid system: implications for alcohol dependence and future directions for research. Alcohol 46:185\u2013204", "journal-title": "Alcohol"}, {"key": "9555_CR124", "doi-asserted-by": "crossref", "first-page": "137", "DOI": "10.1007/s00213-011-2387-0", "volume": "219", "author": "MJ Pava", "year": "2012", "unstructured": "Pava MJ, Blake EM, Green ST, Mizroch BJ, Mulholland PJ, Woodward JJ (2012) Tolerance to cannabinoid-induced behaviors in mice treated chronically with ethanol. Psychopharmacology 219:137\u2013147", "journal-title": "Psychopharmacology"}, {"key": "9555_CR125", "doi-asserted-by": "crossref", "first-page": "358", "DOI": "10.1016/j.neuropharm.2006.03.029", "volume": "51", "author": "FJ Pavon", "year": "2006", "unstructured": "Pavon FJ, Bilbao A, Hernandez-Folgado L, Cippitelli A, Jagerovic N, Abellan G, Rodriguez-Franco MA, Serrano A, Macias M, Gomez R, Navarro M, Goya P, Rodriguez de Fonseca F (2006) Antiobesity effects of the novel in vivo neutral cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole\u2013LH 21. Neuropharmacology 51:358\u2013366", "journal-title": "Neuropharmacology"}, {"key": "9555_CR126", "doi-asserted-by": "crossref", "first-page": "773", "DOI": "10.1046/j.1360-0443.2002.00158.x", "volume": "97", "author": "EJ Pennings", "year": "2002", "unstructured": "Pennings EJ, Leccese AP, Wolff FA (2002) Effects of concurrent use of alcohol and cocaine. Addiction 97:773\u2013783", "journal-title": "Addiction"}, {"key": "9555_CR127", "doi-asserted-by": "crossref", "first-page": "111", "DOI": "10.1016/j.drugalcdep.2009.07.027", "volume": "106", "author": "EN Peters", "year": "2010", "unstructured": "Peters EN, Hughes JR (2010) Daily marijuana users with past alcohol problems increase alcohol consumption during marijuana abstinence. Drug Alcohol Depend 106:111\u2013118", "journal-title": "Drug Alcohol Depend"}, {"key": "9555_CR128", "doi-asserted-by": "crossref", "first-page": "427", "DOI": "10.1016/j.alcohol.2014.01.013", "volume": "48", "author": "MM Pina", "year": "2014", "unstructured": "Pina MM, Cunningham CL (2014) Effects of the novel cannabinoid CB1 receptor antagonist PF 514273 on the acquisition and expression of ethanol conditioned place preference. Alcohol 48:427\u2013431", "journal-title": "Alcohol"}, {"key": "9555_CR129", "first-page": "449", "volume": "18", "author": "RM Pinder", "year": "2004", "unstructured": "Pinder RM, Sandler M (2004) Alcohol, wine and mental health: focus on dementia and stroke. J Pharmacol 18:449\u2013456", "journal-title": "J Pharmacol"}, {"key": "9555_CR130", "doi-asserted-by": "crossref", "first-page": "216", "DOI": "10.1016/S0304-3940(03)00397-5", "volume": "343", "author": "M Poncelet", "year": "2003", "unstructured": "Poncelet M, Maruani J, Calassi R, Soubrie P (2003) Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice. Neurosci Lett 343:216\u2013218", "journal-title": "Neurosci Lett"}, {"key": "9555_CR131", "doi-asserted-by": "crossref", "first-page": "1020", "DOI": "10.1124/jpet.301.3.1020", "volume": "301", "author": "AC Porter", "year": "2002", "unstructured": "Porter AC, Sauer JM, Knierman MD, Becker GW, Berna MJ, Bao J, Nomikos GG, Carter P, Bymaster FP, Leese AB, Felder CC (2002) Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. J Pharmacol Exp Ther 301:1020\u20131024", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9555_CR132", "doi-asserted-by": "crossref", "first-page": "1034", "DOI": "10.1111/j.1360-0443.2004.00762.x", "volume": "99", "author": "WA Pridemore", "year": "2004", "unstructured": "Pridemore WA (2004) Weekend effects on binge drinking and homicide: the social connection between alcohol and violence in Russia. Addiction 99:1034\u20131041", "journal-title": "Addiction"}, {"key": "9555_CR133", "doi-asserted-by": "crossref", "first-page": "551", "DOI": "10.1002/1099-1077(200010)15:7<551::AID-HUP236>3.0.CO;2-P", "volume": "15", "author": "JG Ramaekers", "year": "2000", "unstructured": "Ramaekers JG, Robbe HW, O\u2019Hanlon JF (2000) Marijuana, alcohol and actual driving performance. Hum Psychopharmacol 15:551\u2013558", "journal-title": "Hum Psychopharmacol"}, {"key": "9555_CR134", "doi-asserted-by": "crossref", "first-page": "27", "DOI": "10.1096/fj.01-0593com", "volume": "16", "author": "R Rimondini", "year": "2002", "unstructured": "Rimondini R, Arlinde C, Sommer W, Heilig M (2002) Long-lasting increase in voluntary ethanol consumption and transcriptional regulation in the rat brain after intermittent exposure to alcohol. FASEB J 16:27\u201335", "journal-title": "FASEB J"}, {"key": "9555_CR135", "doi-asserted-by": "crossref", "first-page": "240", "DOI": "10.1016/0014-5793(94)00773-X", "volume": "350", "author": "M Rinaldi-Carmona", "year": "1994", "unstructured": "Rinaldi-Carmona M, Barth F, Heaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Neliat G, Caput D, Ferrara P, Soubri\u00e9 P, Breli\u00e8re JC, Le Fur G (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350:240\u2013244", "journal-title": "FEBS Lett"}, {"key": "9555_CR136", "first-page": "644", "volume": "284", "author": "M Rinaldi-Carmona", "year": "1998", "unstructured": "Rinaldi-Carmona M, Barth F, Millan J, Derocq JM, Casellas P, Congy C, Oustric D, Sarran M, Bouaboula M, Calandra B, Portier M, Shire D, Breliere JC, Le Fur GL (1998) SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. J Pharmacol Exp Ther 284:644\u2013650", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9555_CR137", "first-page": "1109", "volume": "20", "author": "F Rodriguez de Fonseca", "year": "1999", "unstructured": "Rodriguez de Fonseca F, Roberts AJ, Bilbao A, Koob GF, Navarro M (1999) Cannabinoid receptor antagonist SR141716A decreases operant ethanol self administration in rats exposed to ethanol-vapor chambers. Acta Pharmacol Sin 20:1109\u20131114", "journal-title": "Acta Pharmacol Sin"}, {"key": "9555_CR138", "doi-asserted-by": "crossref", "first-page": "1855", "DOI": "10.1016/j.aap.2010.05.006", "volume": "42", "author": "A Ronen", "year": "2010", "unstructured": "Ronen A, Chassidim HS, Gershon P, Parmet Y, Rabinovich A, Bar-Hamburger R, Cassuto Y, Shinar D (2010) The effect of alcohol, THC and their combination on perceived effects, willingness to drive and performance of driving and non-driving tasks. Accid Anal Prev 42:1855\u20131865", "journal-title": "Accid Anal Prev"}, {"key": "9555_CR139", "first-page": "109", "volume": "21", "author": "D Rubbie", "year": "2001", "unstructured": "Rubbie D, Alonso G, Duchamp F, Bockaert J, Manzoni OJ (2001) Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the nucleus accumbens. J Neurosci 21:109\u2013116", "journal-title": "J Neurosci"}, {"key": "9555_CR140", "doi-asserted-by": "crossref", "first-page": "270", "DOI": "10.1016/j.neulet.2007.05.052", "volume": "421", "author": "M Rubio", "year": "2007", "unstructured": "Rubio M, McHugh D, Fernandez-Ruiz J, Bradshaw H, Walker JM (2007) Short-term exposure to alcohol in rats affects brain levels of anandamide, other N-acylethanolamines and 2-arachidonoyl-glycerol. Neurosci Lett 421:270\u2013274", "journal-title": "Neurosci Lett"}, {"key": "9555_CR141", "doi-asserted-by": "crossref", "first-page": "976", "DOI": "10.1016/j.neuropharm.2008.02.005", "volume": "54", "author": "M Rubio", "year": "2008", "unstructured": "Rubio M, Fernandez-Ruiz J, de Miguel R, Maestro B, Michael Walker J, Ramos JA (2008) CB1 receptor blockade reduces the anxiogenic-like response and ameliorates the neurochemical imbalances associated with alcohol withdrawal in rats. Neuropharmacology 54:976\u2013988", "journal-title": "Neuropharmacology"}, {"key": "9555_CR142", "doi-asserted-by": "crossref", "first-page": "354", "DOI": "10.1016/j.drugalcdep.2008.08.004", "volume": "99", "author": "M Rubio", "year": "2009", "unstructured": "Rubio M, de Miguel R, Fernandez-Ruiz J, Gutierrez-Lopez D, Carai MA, Ramos JA (2009) Effects of a short-term exposure to alcohol in rats on FAAH enzyme and CB1 receptor in different brain areas. Drug Alcohol Depend 99:354\u2013358", "journal-title": "Drug Alcohol Depend"}, {"key": "9555_CR143", "doi-asserted-by": "crossref", "first-page": "e23690", "DOI": "10.1371/journal.pone.0023690", "volume": "6", "author": "M Rubio", "year": "2011", "unstructured": "Rubio M, Villain H, Docagne F, Roussel BD, Ramos JA, Vivien D, Fernandez-Ruiz J, Ali C (2011) Pharmacological activation/inhibition of the cannabinoid system affects alcohol withdrawal-induced neuronal hypersensitivity to excitotoxic insults. PLoS One 6:e23690", "journal-title": "PLoS One"}, {"key": "9555_CR144", "doi-asserted-by": "crossref", "first-page": "1092", "DOI": "10.1038/sj.bjp.0707460", "volume": "152", "author": "E Ryberg", "year": "2007", "unstructured": "Ryberg E, Larsson N, Sjogren S, Hjorth S, Hermansson NO, Leonova J, Elebring T, Nilsson K, Drmota T, Greasley PJ (2007) The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol 152:1092\u20131101", "journal-title": "Br J Pharmacol"}, {"key": "9555_CR145", "doi-asserted-by": "crossref", "first-page": "627", "DOI": "10.1586/ern.11.47", "volume": "11", "author": "J Sastre-Garriga", "year": "2011", "unstructured": "Sastre-Garriga J, Vila C, Clissold S, Montalban X (2011) THC and CBD oromucosal spray (Sativex(R)) in the management of spasticity associated with multiple sclerosis. Expert Rev Neurother 11:627\u2013637", "journal-title": "Expert Rev Neurother"}, {"key": "9555_CR146", "doi-asserted-by": "crossref", "first-page": "576", "DOI": "10.1037/1064-1297.15.6.576", "volume": "15", "author": "JS Saults", "year": "2007", "unstructured": "Saults JS, Cowan N, Sher KJ, Moreno MV (2007) Differential effects of alcohol on working memory: distinguishing multiple processes. Exp Clin Psychopharmacol 15:576\u2013587", "journal-title": "Exp Clin Psychopharmacol"}, {"key": "9555_CR147", "doi-asserted-by": "crossref", "first-page": "95", "DOI": "10.1016/S0014-2999(02)01594-7", "volume": "443", "author": "S Serra", "year": "2002", "unstructured": "Serra S, Brunetti G, Pani M, Vacca G, Carai MA, Gessa GL, Colombo G (2002) Blockade by the cannabinoid CB(1) receptor antagonist, SR 141716, of alcohol deprivation effect in alcohol-preferring rats. Eur J Pharmacol 443:95\u201397", "journal-title": "Eur J Pharmacol"}, {"key": "9555_CR148", "first-page": "4322", "volume": "16", "author": "M Shen", "year": "1996", "unstructured": "Shen M, Piser TM, Seybold VS, Thayer SA (1996) Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J Neurosci 16:4322\u20134334", "journal-title": "J Neurosci"}, {"key": "9555_CR149", "doi-asserted-by": "crossref", "first-page": "164", "DOI": "10.1016/j.jpain.2007.09.002", "volume": "9", "author": "RQ Skrabek", "year": "2008", "unstructured": "Skrabek RQ, Galimova L, Ethans K, Perry D (2008) Nabilone for the treatment of pain in fibromyalgia. J Pain 9:164\u2013173", "journal-title": "J Pain"}, {"key": "9555_CR150", "doi-asserted-by": "crossref", "first-page": "190", "DOI": "10.1007/s12640-014-9465-0", "volume": "26", "author": "I Smaga", "year": "2014", "unstructured": "Smaga I, Bystrowska B, Gawlinski D, Pomierny B, Stankowicz P, Filip M (2014a) Antidepressants and changes in concentration of endocannabinoids and N-acylethanolamines in rat brain structures. Neurotox Res 26:190\u2013206", "journal-title": "Neurotox Res"}, {"key": "9555_CR151", "doi-asserted-by": "crossref", "first-page": "462", "DOI": "10.2174/1570159X12666140923205412", "volume": "12", "author": "I Smaga", "year": "2014", "unstructured": "Smaga I, Bystrowska B, Gawlinski D, Przegalinski E, Filip M (2014b) The endocannabinoid/endovanilloid system and depression. Curr Neuropharmacol 12:462\u2013474", "journal-title": "Curr Neuropharmacol"}, {"key": "9555_CR152", "doi-asserted-by": "crossref", "first-page": "S38", "DOI": "10.1055/s-0029-1220690", "volume": "42", "author": "B S\u00f6derpalm", "year": "2009", "unstructured": "S\u00f6derpalm B, L\u00f6f E, Ericson M (2009) Mechanistic studies of ethanol\u2019s interaction with the mesolimbic dopamine reward system. Pharmacopsychiatry 42:S38\u2013S94", "journal-title": "Pharmacopsychiatry"}, {"key": "9555_CR153", "doi-asserted-by": "crossref", "first-page": "317", "DOI": "10.1097/JCP.0b013e318172b8bc", "volume": "28", "author": "M Soyka", "year": "2008", "unstructured": "Soyka M, Koller G, Schmidt P, Lesch OM, Leweke M, Fehr C, Gann H, Mann KF (2008) Cannabinoid receptor 1 blocker rimonabant (SR 141716) for treatment of alcohol dependence: results from a placebo-controlled, double-blind trial. J Clin Psychopharmacol 28:317\u2013324", "journal-title": "J Clin Psychopharmacol"}, {"key": "9555_CR154", "doi-asserted-by": "crossref", "first-page": "89", "DOI": "10.1006/bbrc.1995.2437", "volume": "215", "author": "T Sugiura", "year": "1995", "unstructured": "Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A, Waku K (1995) 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 215:89\u201397", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9555_CR155", "doi-asserted-by": "crossref", "first-page": "873", "DOI": "10.1017/S1355617702870011", "volume": "8", "author": "SF Tapert", "year": "2002", "unstructured": "Tapert SF, Granholm E, Leedy NG, Brown SA (2002) Substance use and withdrawal: neuropsychological functioning over 8\u00a0years in youth. J Int Neuropsychol Soc 8:873\u2013883", "journal-title": "J Int Neuropsychol Soc"}, {"key": "9555_CR156", "doi-asserted-by": "crossref", "first-page": "206", "DOI": "10.1016/j.bbr.2005.06.021", "volume": "164", "author": "PK Thanos", "year": "2005", "unstructured": "Thanos PK, Dimitrakakis ES, Rice O, Gifford A, Volkow ND (2005) Ethanol self-administration and ethanol conditioned place preference are reduced in mice lacking cannabinoid CB1 receptors. Behav Brain Res 164:206\u2013213", "journal-title": "Behav Brain Res"}, {"key": "9555_CR157", "doi-asserted-by": "crossref", "first-page": "16", "DOI": "10.1136/bmj.323.7303.16", "volume": "323", "author": "MR Tram\u00e8r", "year": "2001", "unstructured": "Tram\u00e8r MR, Carroll D, Campbell FA, Reynolds DJM, Moore RA, McQuay HJ (2001) Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. BMJ 323:16", "journal-title": "BMJ"}, {"key": "9555_CR158", "doi-asserted-by": "crossref", "first-page": "2669", "DOI": "10.2174/092986706778201512", "volume": "13", "author": "SA Tucci", "year": "2006", "unstructured": "Tucci SA, Halford JC, Harrold JA, Kirkham TC (2006) Therapeutic potential of targeting the endocannabinoids: implications for the treatment of obesity, metabolic syndrome, drug abuse and smoking cessation. Curr Med Chem 13:2669\u20132680", "journal-title": "Curr Med Chem"}, {"key": "9555_CR159", "doi-asserted-by": "crossref", "first-page": "164", "DOI": "10.1016/j.ejphar.2005.08.013", "volume": "520", "author": "Y Ueda", "year": "2005", "unstructured": "Ueda Y, Miyagawa N, Matsui T, Kaya T, Iwamura H (2005) Involvement of cannabinoid CB(2) receptor-mediated response and efficacy of cannabinoid CB(2) receptor inverse agonist, JTE-907, in cutaneous inflammation in mice. Eur J Pharmacol 520:164\u2013171", "journal-title": "Eur J Pharmacol"}, {"key": "9555_CR160", "doi-asserted-by": "crossref", "first-page": "64", "DOI": "10.1016/j.drugalcdep.2012.08.001", "volume": "128", "author": "R Vandrey", "year": "2013", "unstructured": "Vandrey R, Stitzer ML, Mintzer MZ, Huestis MA, Murray JA, Lee D (2013) The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users. Drug Alcohol Depend 128:64\u201370", "journal-title": "Drug Alcohol Depend"}, {"key": "9555_CR161", "doi-asserted-by": "crossref", "first-page": "4537", "DOI": "10.1021/jm400268b", "volume": "56", "author": "T Vasiljevik", "year": "2013", "unstructured": "Vasiljevik T, Franks LN, Ford BM, Douglas JT, Prather PL, Fantegrossi WE, Prisinzano TE (2013) Design, synthesis, and biological evaluation of aminoalkylindole derivatives as cannabinoid receptor ligands with potential for treatment of alcohol abuse. J Med Chem 56:4537\u20134550", "journal-title": "J Med Chem"}, {"key": "9555_CR162", "doi-asserted-by": "crossref", "first-page": "579", "DOI": "10.1001/archneur.1959.03840060001001", "volume": "1", "author": "M Victor", "year": "1959", "unstructured": "Victor M, Adams RD, Mancall EL (1959) A restricted form of cerebellar cortical degeneration occurring in alcoholic patients. Arch Neurol 1:579\u2013688", "journal-title": "Arch Neurol"}, {"key": "9555_CR163", "first-page": "1", "volume": "7", "author": "M Victor", "year": "1971", "unstructured": "Victor M, Adams RD, Collins GH (1971) The Wernicke-Korsakoff syndrome: a clinical and pathological study of 245 patients, 82 with post-mortem examinations. Contemp Neurol Ser 7:1\u2013206", "journal-title": "Contemp Neurol Ser"}, {"key": "9555_CR164", "doi-asserted-by": "crossref", "first-page": "480", "DOI": "10.1016/j.biopsych.2004.11.033", "volume": "57", "author": "KY Vinod", "year": "2005", "unstructured": "Vinod KY, Arango V, Xie S, Kassir SA, Mann JJ, Cooper TB, Hungund BL (2005) Elevated levels of endocannabinoids and CB1 receptor-mediated G-protein signaling in the prefrontal cortex of alcoholic suicide victims. Biol Psychiatry 57:480\u2013486", "journal-title": "Biol Psychiatry"}, {"key": "9555_CR165", "doi-asserted-by": "crossref", "first-page": "619", "DOI": "10.1016/j.neuint.2006.05.002", "volume": "49", "author": "KY Vinod", "year": "2006", "unstructured": "Vinod KY, Yalamanchili R, Xie S, Cooper TB, Hungund BL (2006) Effect of chronic ethanol exposure and its withdrawal on the endocannabinoid system. Neurochem Int 49:619\u2013625", "journal-title": "Neurochem Int"}, {"key": "9555_CR166", "first-page": "233", "volume": "104", "author": "KY Vinod", "year": "2008", "unstructured": "Vinod KY, Sanguino E, Yalamanchili R, Manzanares J, Hungund BL (2008a) Manipulation of fatty acid amide hydrolase functional activity alters sensitivity and dependence to ethanol. J Neurochem 104:233\u2013243", "journal-title": "J Neurochem"}, {"key": "9555_CR167", "doi-asserted-by": "crossref", "first-page": "574", "DOI": "10.1002/syn.20533", "volume": "62", "author": "KY Vinod", "year": "2008", "unstructured": "Vinod KY, Yalamanchili R, Thanos PK, Vadasz C, Cooper TB, Volkow ND, Hungund BL (2008b) Genetic and pharmacological manipulations of the CB(1) receptor alter ethanol preference and dependence in ethanol preferring and nonpreferring mice. Synapse 62:574\u2013581", "journal-title": "Synapse"}, {"key": "9555_CR168", "doi-asserted-by": "crossref", "first-page": "591", "DOI": "10.1016/j.jpsychires.2009.11.013", "volume": "44", "author": "KY Vinod", "year": "2010", "unstructured": "Vinod KY, Kassir SA, Hungund BL, Cooper TB, Mann JJ, Arango V (2010) Selective alterations of the CB1 receptors and the fatty acid amide hydrolase in the ventral striatum of alcoholics and suicides. J Psychiatr Res 44:591\u2013597", "journal-title": "J Psychiatr Res"}, {"key": "9555_CR169", "doi-asserted-by": "crossref", "first-page": "2072", "DOI": "10.2174/13816128113199990433", "volume": "20", "author": "S Vlachou", "year": "2014", "unstructured": "Vlachou S, Panagis G (2014) Regulation of brain reward by the endocannabinoid system: a critical review of behavioral studies in animals. Curr Pharm Des 20:2072\u20132088", "journal-title": "Curr Pharm Des"}, {"key": "9555_CR170", "doi-asserted-by": "crossref", "first-page": "561", "DOI": "10.1016/j.ejim.2007.06.033", "volume": "19", "author": "L Vonghia", "year": "2008", "unstructured": "Vonghia L, Leggio L, Ferrulli A, Bertini M, Gasbarrini G, Addolorato G (2008) Acute alcohol intoxication. Eur J Intern Med 19:561\u2013567", "journal-title": "Eur J Intern Med"}, {"key": "9555_CR171", "doi-asserted-by": "crossref", "first-page": "1393", "DOI": "10.1073/pnas.0336351100", "volume": "100", "author": "L Wang", "year": "2003", "unstructured": "Wang L, Liu J, Harvey-White J, Zimmer A, Kunos G (2003) Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice. Proc Natl Acad Sci USA 100:1393\u20131398", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "9555_CR172", "doi-asserted-by": "crossref", "first-page": "653", "DOI": "10.1038/sj.npp.1301440", "volume": "33", "author": "EM Weerts", "year": "2008", "unstructured": "Weerts EM, Kim YK, Wand GS, Dannals RF, Lee JS, Frost JJ, McCaul ME (2008) Differences in delta- and mu-opioid receptor blockade measured by positron emission tomography in naltrexone-treated recently abstinent alcohol-dependent subjects. Neuropsychopharmacology 33:653\u2013665", "journal-title": "Neuropsychopharmacology"}, {"key": "9555_CR173", "first-page": "186", "volume": "27", "author": "AM White", "year": "2003", "unstructured": "White AM (2003) What happened? Alcohol, memory blackouts, and the brain. Alcohol Res Health 27:186\u2013196", "journal-title": "Alcohol Res Health"}, {"key": "9555_CR174", "doi-asserted-by": "crossref", "first-page": "13079", "DOI": "10.1074/jbc.M113.536953", "volume": "289", "author": "K Wilhelmsen", "year": "2014", "unstructured": "Wilhelmsen K, Khakpour S, Tran A, Sheehan K, Schumacher M, Xu F, Hellman J (2014) The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells. J Biol Chem 289:13079\u201313100", "journal-title": "J Biol Chem"}, {"key": "9555_CR175", "doi-asserted-by": "crossref", "first-page": "191", "DOI": "10.1016/j.neuroscience.2012.03.038", "volume": "213", "author": "AR Wilson-Poe", "year": "2012", "unstructured": "Wilson-Poe AR, Morgan MM, Aicher SA, Hegarty DM (2012) Distribution of CB1 cannabinoid receptors and their relationship with mu-opioid receptors in the rat periaqueductal gray. Neuroscience 213:191\u2013200", "journal-title": "Neuroscience"}, {"key": "9555_CR176", "doi-asserted-by": "crossref", "first-page": "784", "DOI": "10.1017/S1355617714000666", "volume": "20", "author": "JL Winward", "year": "2014", "unstructured": "Winward JL, Hanson KL, Tapert SF, Brown SA (2014) Heavy alcohol use, marijuana use, and concomitant use by adolescents are associated with unique and shared cognitive decrements. J Int Neuropsychol Soc 20:784\u2013795", "journal-title": "J Int Neuropsychol Soc"}, {"key": "9555_CR177", "author": "World Health Organization", "year": "2012", "unstructured": "World Health Organization (2012) World Drug Report. United Nations, New York", "volume-title": "World Drug Report"}, {"key": "9555_CR178", "doi-asserted-by": "crossref", "first-page": "260", "DOI": "10.1016/j.freeradbiomed.2013.12.026", "volume": "68", "author": "L Yang", "year": "2014", "unstructured": "Yang L, Rozenfeld R, Wu D, Devi LA, Zhang Z, Cederbaum A (2014) Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy. Free Radic Biol Med 68:260\u2013267", "journal-title": "Free Radic Biol Med"}, {"key": "9555_CR179", "doi-asserted-by": "crossref", "first-page": "509", "DOI": "10.1017/S1461145713001247", "volume": "17", "author": "JB Zawilska", "year": "2014", "unstructured": "Zawilska JB, Wojcieszak J (2014) Spice/K2 drugs-more than innocent substitutes for marijuana. Int J Neuropsychopharmacol 17:509\u2013525", "journal-title": "Int J Neuropsychopharmacol"}, {"key": "9555_CR180", "doi-asserted-by": "crossref", "first-page": "331", "DOI": "10.1111/j.1365-2125.2010.03846.x", "volume": "71", "author": "RW Zoethout", "year": "2011", "unstructured": "Zoethout RW, Delgado WL, Ippel AE, Dahan A, van Gerven JM (2011) Functional biomarkers for the acute effects of alcohol on the central nervous system in healthy volunteers. Br J Clin Pharmacol 71:331\u2013350", "journal-title": "Br J Clin Pharmacol"}], "container-title": ["Neurotoxicity Research"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s12640-015-9555-7", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 7, 27]], "date-time": "2018-07-27T12:45:38Z", "timestamp": 1532695538000}, "score": 18.910501, "issued": {"date-parts": [[2015, 9, 9]]}, "references-count": 181, "journal-issue": {"published-print": {"date-parts": [[2016, 1]]}, "issue": "1"}, "alternative-id": ["9555"], "URL": "http://dx.doi.org/10.1007/s12640-015-9555-7", "relation": {"cites": []}, "ISSN": ["1029-8428", "1476-3524"], "issn-type": [{"value": "1029-8428", "type": "print"}, {"value": "1476-3524", "type": "electronic"}], "subject": ["Toxicology", "General Neuroscience"]}, {"indexed": {"date-parts": [[2018, 11, 24]], "date-time": "2018-11-24T16:42:38Z", "timestamp": 1543077758261}, "reference-count": 225, "publisher": "Springer Nature", "issue": "4", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2016, 8, 2]], "date-time": "2016-08-02T00:00:00Z", "timestamp": 1470096000000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Neurotox Res"], "published-print": {"date-parts": [[2016, 11]]}, "DOI": "10.1007/s12640-016-9655-z", "type": "journal-article", "created": {"date-parts": [[2016, 8, 2]], "date-time": "2016-08-02T10:00:29Z", "timestamp": 1470132029000}, "page": "698-714", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Are Alcohol Anti-relapsing and Alcohol Withdrawal Drugs Useful in Cannabinoid Users?"], "prefix": "10.1007", "volume": "30", "author": [{"given": "Patrycja", "family": "Kleczkowska", "sequence": "first", "affiliation": []}, {"given": "Irena", "family": "Smaga", "sequence": "additional", "affiliation": []}, {"given": "Ma\u0142gorzata", "family": "Filip", "sequence": "additional", "affiliation": []}, {"given": "Magdalena", "family": "Bujalska-Zadrozny", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2016, 8, 2]]}, "reference": [{"key": "9655_CR1", "doi-asserted-by": "crossref", "first-page": "195", "DOI": "10.1111/j.1530-0277.1995.tb01492.x", "volume": "19", "author": "ML Adams", "year": "1995", "unstructured": "Adams ML, Sewing BN, Chen J, Meyer ER, Cicero TJ (1995) Nitric oxide-related agents alter alcohol withdrawal in male rats. Alcohol Clin Exp Res 19:195\u2013199", "journal-title": "Alcohol Clin Exp Res"}, {"key": "9655_CR2", "doi-asserted-by": "crossref", "first-page": "226", "DOI": "10.1016/S0002-9343(01)01088-9", "volume": "112", "author": "G Addolorato", "year": "2002", "unstructured": "Addolorato G, Caputo F, Capristo E et al (2002) Rapid suppression of alcohol withdrawal syndrome by baclofen. Am J Med 112:226\u2013229", "journal-title": "Am J Med"}, {"key": "9655_CR3", "doi-asserted-by": "crossref", "first-page": "258", "DOI": "10.1097/00002826-200309000-00010", "volume": "26", "author": "G Addolorato", "year": "2003", "unstructured": "Addolorato G, Leggio L, Abenavoli L et al (2003) Suppression of alcohol delirium tremens by baclofen administration: a case report. Clin Neuropharmacol 26:258\u2013262", "journal-title": "Clin Neuropharmacol"}, {"key": "9655_CR4", "first-page": "e213", "volume": "276", "author": "G Addolorato", "year": "2006", "unstructured": "Addolorato G, Leggio L, Abenavoli L et al (2006) Baclofen in the treatment of alcohol withdrawal syndrome: a comparative study vs diazepam. Am J Med 276:e213\u2013e278", "journal-title": "Am J Med"}, {"key": "9655_CR5", "doi-asserted-by": "crossref", "first-page": "312", "DOI": "10.1093/alcalc/agr017", "volume": "46", "author": "G Addolorato", "year": "2011", "unstructured": "Addolorato G, Leggio L, Ferrulli A et al (2011) Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial. Alcohol Alcohol 46:312\u2013317", "journal-title": "Alcohol Alcohol"}, {"key": "9655_CR6", "doi-asserted-by": "crossref", "first-page": "873", "DOI": "10.1111/j.1530-0277.1994.tb00053.x", "volume": "18", "author": "B Adinoff", "year": "1994", "unstructured": "Adinoff B (1994) Double-blind study of alprazolam, diazepam, clonidine, and placebo in the alcohol withdrawal syndrome: preliminary findings. Alcohol Clin Exp Res 18:873\u2013878", "journal-title": "Alcohol Clin Exp Res"}, {"key": "9655_CR7", "doi-asserted-by": "crossref", "first-page": "140", "DOI": "10.3389/fnins.2014.00140", "volume": "8", "author": "R Agabio", "year": "2014", "unstructured": "Agabio R, Colombo G (2014) GABAB receptor ligands for the treatment of alcohol use disorder: preclinical and clinical evidence. Front Neurosci 8:140", "journal-title": "Front Neurosci"}, {"key": "9655_CR8", "doi-asserted-by": "crossref", "first-page": "73", "DOI": "10.1016/0031-9384(91)90233-E", "volume": "49", "author": "A Agmo", "year": "1991", "unstructured": "Agmo A, Contreras JL, Paredes R (1991) Sexual behavior and copulatory thrusting patterns in male rabbits treated with GABA transaminase inhibitors. Physiol Behav 49:73\u201378", "journal-title": "Physiol Behav"}, {"key": "9655_CR9", "doi-asserted-by": "crossref", "first-page": "37", "DOI": "10.1111/j.1471-4159.2009.06301.x", "volume": "111", "author": "L Alvarez-Jaimes", "year": "2009", "unstructured": "Alvarez-Jaimes L, Stouffer DG, Parsons LH (2009) Chronic ethanol treatment potentiates ethanol-induced increases in interstitial nucleus accumbens endocannabinoid levels in rats. J Neurochem 111:37\u201348", "journal-title": "J Neurochem"}, {"key": "9655_CR10", "unstructured": "Amato L, Minozzi S, Vecchi S, Davoli M (2010) Benzodiazepines for alcohol withdrawal. Cochrane Database Syst Rev 3 CD005063", "DOI": "10.1002/14651858.CD005063.pub3", "doi-asserted-by": "crossref"}, {"key": "9655_CR11", "first-page": "1758", "volume": "156", "author": "RF Anton", "year": "1999", "unstructured": "Anton RF, Moak DH, Waid LR, Latham PK, Malcolm RJ, Dias JK (1999) Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial. Am J Psychiatry 156:1758\u20131764", "journal-title": "Am J Psychiatry"}, {"key": "9655_CR12", "doi-asserted-by": "crossref", "first-page": "421", "DOI": "10.1097/01.jcp.0000130555.63254.73", "volume": "24", "author": "RF Anton", "year": "2004", "unstructured": "Anton RF, Pettinati H, Zweben A et al (2004) A multi-site dose ranging study of nalmefene in the treatment of alcohol dependence. J Clin Psychopharmacol 24:421\u2013428", "journal-title": "J Clin Psychopharmacol"}, {"key": "9655_CR13", "doi-asserted-by": "crossref", "first-page": "2003", "DOI": "10.1001/jama.295.17.2003", "volume": "295", "author": "RF Anton", "year": "2006", "unstructured": "Anton RF, O\u2019Malley SS, Ciraulo DA et al (2006) Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 295:2003\u20132017", "journal-title": "JAMA"}, {"key": "9655_CR14", "doi-asserted-by": "crossref", "first-page": "709", "DOI": "10.1176/appi.ajp.2011.10101436", "volume": "168", "author": "RF Anton", "year": "2011", "unstructured": "Anton RF, Myrick H, Wright TM, Latham PK, Baros AM, Waid LR, Randall PK (2011) Gabapentin combined with naltrexone for the treatment of alcohol dependence. Am J Psychiatry 168:709\u2013717", "journal-title": "Am J Psychiatry"}, {"key": "9655_CR15", "first-page": "8", "volume": "38", "author": "B Arbaizar", "year": "2010", "unstructured": "Arbaizar B, Diersen-Sotos T, G\u00f3mez-Acebo I, Llorca J (2010) Topiramate in the treatment of alcohol dependence: a meta-analysis. Actas Esp Psiquiatr 38:8\u201312", "journal-title": "Actas Esp Psiquiatr"}, {"key": "9655_CR16", "doi-asserted-by": "crossref", "first-page": "419", "DOI": "10.1016/0753-3322(92)90047-B", "volume": "46", "author": "D Bailly", "year": "1992", "unstructured": "Bailly D, Servant D, Blandin N, Beuscart R, Parquet PJ (1992) Effects of beta-blocking drugs in alcohol withdrawal: a double-blind comparative study with propranolol and diazepam. Biomed Pharmacother 46:419\u2013424", "journal-title": "Biomed Pharmacother"}, {"key": "9655_CR17", "doi-asserted-by": "crossref", "first-page": "202", "DOI": "10.1016/j.drugalcdep.2006.08.016", "volume": "87", "author": "JR Baker", "year": "2007", "unstructured": "Baker JR, Jatlow P, McCance-Katz EF (2007) Disulfiram effects on responses to intravenous cocaine administration. Drug Alcohol Depend 87:202\u2013209", "journal-title": "Drug Alcohol Depend"}, {"key": "9655_CR18", "doi-asserted-by": "crossref", "first-page": "2035", "DOI": "10.1111/j.1360-0443.2008.02355.x", "volume": "103", "author": "DA Baltieri", "year": "2008", "unstructured": "Baltieri DA, Daro FR, Ribeiro PL, de Andrade AG (2008) Comparing topiramate with naltrexone in the treatment of alcohol dependence. Addiction 103:2035\u20132044", "journal-title": "Addiction"}, {"key": "9655_CR19", "doi-asserted-by": "crossref", "first-page": "419", "DOI": "10.1007/BF02245942", "volume": "118", "author": "RL Barrett", "year": "1995", "unstructured": "Barrett RL, Wiley JL, Balster RL, Martin BR (1995) Pharmacological specificity of Delta9-tetrahydrocannabinol discrimination in rats. Psychopharmacology 118:419\u2013424", "journal-title": "Psychopharmacology"}, {"key": "9655_CR20", "doi-asserted-by": "crossref", "first-page": "209", "DOI": "10.1056/NEJM197208032870501", "volume": "287", "author": "P Beaconsfield", "year": "1972", "unstructured": "Beaconsfield P, Ginsburg J, Rainsbury R (1972) Marihuana smoking: cardiovascular effects in man and possible mechanisms. N Engl J Med 287:209\u2013212", "journal-title": "N Engl J Med"}, {"key": "9655_CR21", "doi-asserted-by": "crossref", "first-page": "319", "DOI": "10.1016/S0741-8329(97)87949-9", "volume": "14", "author": "HC Becker", "year": "1997", "unstructured": "Becker HC, Diaz-Granados JL, Weathersby RT (1997) Repeated ethanol withdrawal experience increases the severity and duration of subsequent withdrawal seizures in mice. Alcohol 14:319\u2013326", "journal-title": "Alcohol"}, {"key": "9655_CR22", "first-page": "12", "volume": "45", "author": "IB Belousov", "year": "2005", "unstructured": "Belousov IB, Egorova NA, Sidorenko BA, Ivleva AIu, Ageev FT, Ole\u012dnikov VE (2005) Confirmation of safety and therapeutic effect of betaxolol in the treatment of mild and moderate hypertension in general medical practice. Kardiologia 45:12\u201317", "journal-title": "Kardiologia"}, {"key": "9655_CR23", "doi-asserted-by": "crossref", "first-page": "383", "DOI": "10.1001/archpsyc.1991.01810280099018", "volume": "48", "author": "C Benkelfat", "year": "1991", "unstructured": "Benkelfat C, Murphy DL, Hill JL, George DT, Nutt D, Linnoila M (1991) Ethanollike properties of the serotonergic partial agonist m-chlorophenylpiperazine in chronic alcoholic patients. Arch Gen Psychiatry 48:383", "journal-title": "Arch Gen Psychiatry"}, {"key": "9655_CR24", "doi-asserted-by": "crossref", "first-page": "25", "DOI": "10.1016/j.drugalcdep.2005.10.008", "volume": "83", "author": "A Bisaga", "year": "2006", "unstructured": "Bisaga A, Evans SM (2006) The acute effects of gabapentin in combination with alcohol in heavy drinkers. Drug Alcohol Depend 83:25\u201332", "journal-title": "Drug Alcohol Depend"}, {"key": "9655_CR25", "doi-asserted-by": "crossref", "first-page": "148108", "DOI": "10.1111/acer.12411", "volume": "38", "author": "JC Blodgett", "year": "2014", "unstructured": "Blodgett JC, Del Re AC, Maisel NC, Finney JW (2014) A meta-analysis of topiramate\u2019s effects for individuals with alcohol use disorder. Alcohol Clin Exp Res 38:148108", "journal-title": "Alcohol Clin Exp Res"}, {"key": "9655_CR26", "doi-asserted-by": "crossref", "first-page": "197", "DOI": "10.1016/S0278-5846(01)00234-2", "volume": "26", "author": "V Bozikas", "year": "2002", "unstructured": "Bozikas V, Petrikis P, Gamvrula K, Savvidou I, Karavatos A (2002) Treatment of alcohol withdrawal with gabapentin. Prog Neuropsychopharmacol Biol Psychiatry 26:197\u2013199", "journal-title": "Prog Neuropsychopharmacol Biol Psychiatry"}, {"key": "9655_CR27", "doi-asserted-by": "crossref", "first-page": "923", "DOI": "10.1016/S0306-4522(01)00210-X", "volume": "104", "author": "D Braida", "year": "2001", "unstructured": "Braida D, Pozzi M, Cavallini R, Sala M (2001) Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid system. Neurosci 104:923\u2013926", "journal-title": "Neurosci"}, {"key": "9655_CR28", "doi-asserted-by": "crossref", "first-page": "63", "DOI": "10.1016/j.ejphar.2004.10.043", "volume": "506", "author": "D Braida", "year": "2004", "unstructured": "Braida D, Iosue S, Pegorini S, Sala M (2004) Delta9-tetrahydrocannabinol-induced conditioned place preference and intracerebroventricular self-administration in rats. Eur J Pharmacol 506:63\u201369", "journal-title": "Eur J Pharmacol"}, {"key": "9655_CR29", "doi-asserted-by": "crossref", "first-page": "1662", "DOI": "10.1038/sj.npp.1300706", "volume": "30", "author": "GR Breese", "year": "2005", "unstructured": "Breese GR, Overstreet DH, Knapp DJ, Navarro M (2005) Prior multiple ethanol withdrawals enhance stress-induced anxiety-like behavior: inhibition by CRF1- and benzodiazepine-receptor antagonists and a 5-HT1a-receptor agonist. Neuropsychopharmacology 30:1662\u20131669", "journal-title": "Neuropsychopharmacology"}, {"key": "9655_CR30", "author": "RP Bright", "first-page": "1737", "year": "1971", "unstructured": "Bright RP, Kiplinger GF, Brown D, Philips J, Forney RB (1971) Effects of beta adrenergic blockade on marijuana induced tachycardia. National Academy of Science-National Research Council, Reported to the committee on Problems of Drug Dependence, p 1737", "volume-title": "Effects of beta adrenergic blockade on marijuana induced tachycardia"}, {"key": "9655_CR31", "doi-asserted-by": "crossref", "first-page": "376", "DOI": "10.1016/j.neuroscience.2008.09.010", "volume": "157", "author": "SP Brooks", "year": "2008", "unstructured": "Brooks SP, Croft AP, Norman G, Shaw SG, Little HJ (2008) Nimodipine prior to alcohol withdrawal prevents memory deficits during the abstinence phase. Neuroscience 157:376\u2013384", "journal-title": "Neuroscience"}, {"key": "9655_CR32", "doi-asserted-by": "crossref", "first-page": "1429", "DOI": "10.1111/j.1530-0277.2008.00706.x", "volume": "32", "author": "KJ Brower", "year": "2008", "unstructured": "Brower KJ, Myra Kim H, Strobbe S, Karam-Hage MA, Consens F, Zucker RA (2008) A randomized double-blind pilot trial of gabapentin versus placebo to treat alcohol dependence and comorbid insomnia. Alcohol Clin Exp Res 32:1429\u20131438", "journal-title": "Alcohol Clin Exp Res"}, {"key": "9655_CR33", "doi-asserted-by": "crossref", "first-page": "1863", "DOI": "10.1111/j.1530-0277.2009.01024.x", "volume": "33", "author": "SE Brown", "year": "2009", "unstructured": "Brown SE, Carmody TJ, Schmitz JM et al (2009) A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence. Alcohol Clin Exp Res 33:1863\u20131869", "journal-title": "Alcohol Clin Exp Res"}, {"key": "9655_CR34", "doi-asserted-by": "crossref", "first-page": "53", "DOI": "10.1016/j.brainresbull.2016.04.006", "volume": "125", "author": "R Camarini", "year": "2016", "unstructured": "Camarini R, Pautassi RM (2016) Behavioral sensitization to ethanol: neural basis and factors that influence its acquisition and expression. Brain Res Bull 125:53\u201378", "journal-title": "Brain Res Bull"}, {"key": "9655_CR35", "doi-asserted-by": "crossref", "first-page": "2118", "DOI": "10.2174/138161210791516468", "volume": "16", "author": "F Caputo", "year": "2010", "unstructured": "Caputo F, Bernardi M (2010) Medications acting on the GABA system in the treatment of alcoholic patients. Curr Pharm Des 16:2118\u20132125", "journal-title": "Curr Pharm Des"}, {"key": "9655_CR36", "doi-asserted-by": "crossref", "first-page": "450", "DOI": "10.1016/j.euroneuro.2010.12.005", "volume": "21", "author": "F Caputo", "year": "2011", "unstructured": "Caputo F, Francini S, Brambilla R et al (2011) Sodium oxybate in maintaining alcohol abstinence in alcoholic patients with and without psychiatric comorbidity. Eur Neuropsychopharmacol 21:450\u2013456", "journal-title": "Eur Neuropsychopharmacol"}, {"key": "9655_CR37", "doi-asserted-by": "crossref", "first-page": "53", "DOI": "10.1080/10550490802408936", "volume": "18", "author": "KM Carpenter", "year": "2009", "unstructured": "Carpenter KM, McDowell D, Brooks DJ, Cheng WY, Levin FR (2009) A preliminary trial: double-blind comparison of nefazodone, bupropion-SR, and placebo in the treatment of cannabis dependence. Am J Addict 18:53\u201364", "journal-title": "Am J Addict"}, {"key": "9655_CR38", "doi-asserted-by": "crossref", "first-page": "82", "DOI": "10.1016/j.neulet.2011.06.008", "volume": "500", "author": "AF Carvalho", "year": "2011", "unstructured": "Carvalho AF, Van Bockstaele EJ (2011) Direct intra-accumbal infusion of a beta-adrenergic receptor antagonist abolishes WIN 55,212-2-induced aversion. Neurosci Lett 500:82\u201385", "journal-title": "Neurosci Lett"}, {"key": "9655_CR39", "doi-asserted-by": "crossref", "first-page": "1582", "DOI": "10.1007/s00259-013-2456-1", "volume": "40", "author": "J Ceccarini", "year": "2013", "unstructured": "Ceccarini J, Casteels C, Koole M, Bormans G, Van Laere K (2013) Transient changes in the endocannabinoid system after acute and chronic ethanol exposure and abstinence in the rat: a combined PET and microdialysis study. Eur J Nucl Med Mol Imaging 40:1582\u20131594", "journal-title": "Eur J Nucl Med Mol Imaging"}, {"key": "9655_CR40", "doi-asserted-by": "crossref", "first-page": "2822", "DOI": "10.1523/JNEUROSCI.0849-13.2014", "volume": "34", "author": "J Ceccarini", "year": "2014", "unstructured": "Ceccarini J, Hompes T, Verhaeghen A et al (2014) Changes in cerebral CB1 receptor availability after acute and chronic alcohol abuse and monitored abstinence. J Neurosci 34:2822\u20132831", "journal-title": "J Neurosci"}, {"key": "9655_CR41", "doi-asserted-by": "crossref", "first-page": "528", "DOI": "10.1016/j.pnpbp.2010.12.009", "volume": "35", "author": "IK Celikyurt", "year": "2011", "unstructured": "Celikyurt IK, Kayir H, Ulak G, Erden FB, Ulusoy GK, Uzbay TI (2011) Effects of risperidone, quetiapine and ziprasidone on ethanol withdrawal syndrome in rats. Prog Neuropsychopharmacol Biol Psychiatry 35:528\u2013536", "journal-title": "Prog Neuropsychopharmacol Biol Psychiatry"}, {"key": "9655_CR42", "doi-asserted-by": "crossref", "first-page": "67", "DOI": "10.1037/0022-006X.70.1.67", "volume": "70", "author": "L Chassin", "year": "2002", "unstructured": "Chassin L, Pitts SC, Prost J (2002) Binge drinking trajectories from adolesence to emerging adulthood in a high-risk sample: predictors and substance abuse outcomes. J Consult Clin Psychol 70:67\u201378", "journal-title": "J Consult Clin Psychol"}, {"key": "9655_CR43", "doi-asserted-by": "crossref", "first-page": "587", "DOI": "10.1093/alcalc/35.6.587", "volume": "35", "author": "J Chick", "year": "2000", "unstructured": "Chick J, Anton R, Checinski K et al (2000) A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse. Alcohol Alcohol 35:587\u2013593", "journal-title": "Alcohol Alcohol"}, {"key": "9655_CR45", "doi-asserted-by": "crossref", "first-page": "137", "DOI": "10.1016/j.pbb.2007.12.002", "volume": "89", "author": "CS Chung", "year": "2008", "unstructured": "Chung CS, Wang J, Wehman M, Rhoads DE (2008) Severity of alcohol withdrawal symptoms depends on developmental stage of Long-Evans rats. Pharmacol Biochem Behav 89:137\u2013144", "journal-title": "Pharmacol Biochem Behav"}, {"key": "9655_CR46", "doi-asserted-by": "crossref", "first-page": "825", "DOI": "10.1016/S0196-0644(97)70059-3", "volume": "30", "author": "TR Coomes", "year": "1997", "unstructured": "Coomes TR, Smith SW (1997) Successful use of propofol in refractory delirium tremens. Ann Emerg Med 30:825\u2013828", "journal-title": "Ann Emerg Med"}, {"key": "9655_CR47", "doi-asserted-by": "crossref", "first-page": "141", "DOI": "10.1007/s00213-010-1875-y", "volume": "211", "author": "ZD Cooper", "year": "2010", "unstructured": "Cooper ZD, Haney M (2010) Opioid antagonism enhances marijuana\u2019s effects in heavy marijuana smokers. Psychopharmacology 211:141\u2013148", "journal-title": "Psychopharmacology"}, {"key": "9655_CR48", "doi-asserted-by": "crossref", "first-page": "843", "DOI": "10.1016/S0024-3205(98)00341-5", "volume": "63", "author": "J Corchero", "year": "1998", "unstructured": "Corchero J, Garc\u00eda-Gil L, Manzanares J, Fern\u00e1ndez-Ruiz JJ, Fuentes JA, Ramos JA (1998) Perinatal delta9-tetrahydrocannabinol exposure reduces proenkephalin gene expression in the caudate-putamen of adult female rats. Life Sci 63:843\u2013850", "journal-title": "Life Sci"}, {"key": "9655_CR49", "doi-asserted-by": "crossref", "first-page": "339", "DOI": "10.1016/0091-3057(90)90414-D", "volume": "36", "author": "B Costall", "year": "1990", "unstructured": "Costall B, Jones BJ, Kelly ME, Naylor RJ, Onaivi ES, Tyers MB (1990) Ondansetron inhibits a behavioural consequence of withdrawing from drugs of abuse. Pharmacol Biochem Behav 36:339\u2013344", "journal-title": "Pharmacol Biochem Behav"}, {"key": "9655_CR50", "doi-asserted-by": "crossref", "first-page": "343", "DOI": "10.1016/S0301-0082(99)00031-3", "volume": "60", "author": "A Dahchour", "year": "2000", "unstructured": "Dahchour A, De Witte P (2000) Ethanol and amino acids in the central nervous system: assessment of the pharmacological actions of acamprosate. Prog Neurobiol 60:343\u2013362", "journal-title": "Prog Neurobiol"}, {"key": "9655_CR51", "doi-asserted-by": "crossref", "first-page": "298", "DOI": "10.1002/cpt1975183298", "volume": "18", "author": "WS Dalton", "year": "1975", "unstructured": "Dalton WS, Martz R, Lemberger L, Rodda BE, Forney RB (1975) Effects of marihuana combined with secobarbital. Clin Pharmacol Ther 18:298\u2013304", "journal-title": "Clin Pharmacol Ther"}, {"key": "9655_CR52", "doi-asserted-by": "crossref", "first-page": "12", "DOI": "10.1186/1940-0640-8-12", "volume": "8", "author": "AC Re Del", "year": "2013", "unstructured": "Del Re AC, Gordon AJ, Lembke A, Harris AH (2013) Prescription of topiramate to treat alcohol use disorders in the Veterans Health Administration. Addict Sci Clin Pract 8:12", "journal-title": "Addict Sci Clin Pract"}, {"key": "9655_CR53", "doi-asserted-by": "crossref", "first-page": "545", "DOI": "10.1093/alcalc/agh187", "volume": "40", "author": "A Desousa", "year": "2005", "unstructured": "Desousa A (2005) An open randomized study comparing disulfiram and acamprosate in the treatment of alcohol dependence. Alcohol Alcohol 40:545\u2013548", "journal-title": "Alcohol Alcohol"}, {"key": "9655_CR54", "doi-asserted-by": "crossref", "first-page": "5", "DOI": "10.15288/jsad.2008.69.5", "volume": "69", "author": "DM Donovan", "year": "2008", "unstructured": "Donovan DM, Anton RF, Miller WR, Longabaugh R, Hosking JD, Youngblood M (2008) Combined pharmacotherapies and behavioral interventions for alcohol dependence (The COMBINE Study): examination of posttreatment drinking outcomes. J Stud Alcohol Drugs 69:5\u201313", "journal-title": "J Stud Alcohol Drugs"}, {"key": "9655_CR55", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/j.pneurobio.2009.09.004", "volume": "90", "author": "E Drews", "year": "2010", "unstructured": "Drews E, Zimmer A (2010) Modulation of alcohol and nicotine responses through the endogenous opioid system. Prog Neurobiol 90:1\u201315", "journal-title": "Prog Neurobiol"}, {"key": "9655_CR56", "doi-asserted-by": "crossref", "first-page": "117", "DOI": "10.1016/j.ejphar.2006.08.051", "volume": "550", "author": "N Egashira", "year": "2006", "unstructured": "Egashira N, Matsuda T, Koushi E, Mishima K, Iwasaki K, Shoyama Y, Fujiwara M (2006) Involvement of 5-hydroxytryptamine1A receptors in Delta9-tetrahydrocannabinol-induced catalepsy-like immobilization in mice. Eur J Pharmacol 550:117\u2013122", "journal-title": "Eur J Pharmacol"}, {"key": "9655_CR57", "first-page": "17", "volume": "29", "author": "A Elkashef", "year": "2008", "unstructured": "Elkashef A, Vocci F, Huestis M, Haney M, Budney A, Gruber A, El-Guebaly N (2008) Marijuana neurobiology and treatment. Subst Abuse 29:17\u201329", "journal-title": "Marijuana neurobiology and treatment. Subst Abuse"}, {"key": "9655_CR58", "doi-asserted-by": "crossref", "first-page": "107", "DOI": "10.1093/oxfordjournals.alcalc.a045088", "volume": "26", "author": "F Fadda", "year": "1991", "unstructured": "Fadda F, Garau B, Marchei F, Colombo G, Gessa GL (1991) MDL 72222, a selective 5-HT3 receptor antagonist, suppresses voluntary ethanol consumption in alcohol-preferring rats. Alcohol Alcohol 26:107\u2013110", "journal-title": "Alcohol Alcohol"}, {"key": "9655_CR59", "first-page": "100", "volume": "31", "author": "D Falk", "year": "2008", "unstructured": "Falk D, Yi H, Hiller-Sturmh\u00f6fel S (2008) An epidemiologicanalysis of co-occuring alcohol and other drug use and disorders. Alcohol Res Curr Rev 31:100\u2013110", "journal-title": "Alcohol Res Curr Rev"}, {"key": "9655_CR60", "doi-asserted-by": "crossref", "first-page": "267", "DOI": "10.1016/j.physbeh.2008.05.020", "volume": "95", "author": "JM Farook", "year": "2008", "unstructured": "Farook JM, Krazem A, Lewis B, Morrell DJ, Littleton JM, Barron S (2008) Acamprosate attenuates the handling induced convulsions during alcohol withdrawal in Swiss Webster mice. Physiol Behav 95:267\u2013270", "journal-title": "Physiol Behav"}, {"key": "9655_CR61", "first-page": "495", "volume": "2", "author": "SE File", "year": "1993", "unstructured": "File SE, Andrews N, al-Farhan M, Wu PY (1993) The role of 5-HT in the anxiogenic effects of acute ethanol withdrawal and in the long-lasting cognitive deficits. Alcohol Alcohol 2:495\u2013499", "journal-title": "Alcohol Alcohol"}, {"key": "9655_CR62", "doi-asserted-by": "crossref", "first-page": "1251", "DOI": "10.1111/j.1530-0277.2008.00680.x", "volume": "32", "author": "G Fl\u00f3rez", "year": "2008", "unstructured": "Fl\u00f3rez G, Garc\u00eda-Portilla P, Alvarez S, Saiz PA, Nogueiras L, Bobes J (2008) Using topiramate or naltrexone for the treatment of\u00a0alcohol-dependent patients. Alcohol Clin Exp Res 32:1251", "journal-title": "Alcohol Clin Exp Res"}, {"key": "9655_CR63", "doi-asserted-by": "crossref", "first-page": "488", "DOI": "10.1001/jama.2013.8268", "volume": "310", "author": "EB Foa", "year": "2013", "unstructured": "Foa EB, Yusko DA, McLean CP et al (2013) Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial. JAMA 310:488\u2013495", "journal-title": "JAMA"}, {"key": "9655_CR64", "doi-asserted-by": "crossref", "first-page": "253", "DOI": "10.1093/qjmed/90.4.253", "volume": "90", "author": "A Foy", "year": "1997", "unstructured": "Foy A, Kay J, Taylor A (1997) The course of alcohol withdrawal in a general hospital. QJM 90:253\u2013261", "journal-title": "QJM"}, {"key": "9655_CR65", "doi-asserted-by": "crossref", "first-page": "185", "DOI": "10.1007/s004060170039", "volume": "251", "author": "M Frantz", "year": "2001", "unstructured": "Frantz M, Dlabal H, Kunz S, Ulferts J, Gruppe H, Gallhofer B (2001) Treatment of alcohol withdrawal: tiapride and carbamazepine versus clomethiazole. A pilot study. Eur Arch Psychiatry Clin Neurosci 251:185\u2013192", "journal-title": "Eur Arch Psychiatry Clin Neurosci"}, {"key": "9655_CR66", "unstructured": "Frewen A, Montebello ME, Baillie A, Rea F (2007) Effects of mirtazapine on withdrawal from dependent cannabis use. Proceedings of the 69th Annual Scientific Meeting of the College on Problems of Drug Dependence; Quebec City, 2007, p. 21"}, {"key": "9655_CR67", "doi-asserted-by": "crossref", "first-page": "385", "DOI": "10.1016/0091-3057(90)90174-G", "volume": "35", "author": "JC Froehlich", "year": "1990", "unstructured": "Froehlich JC, Harts J, Lumeng L, Li TK (1990) Naloxone attenuates voluntary ethanol intake in rats selectively bred for high ethanol preference. Pharmacol Biochem Behav 35:385\u2013390", "journal-title": "Pharmacol Biochem Behav"}, {"key": "9655_CR68", "doi-asserted-by": "crossref", "first-page": "1691", "DOI": "10.4088/JCP.v68n1108", "volume": "68", "author": "FA Furieri", "year": "2007", "unstructured": "Furieri FA, Nakamura-Palacios EM (2007) Gabapentin reduces alcohol consumption and craving: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 68:1691\u20131700", "journal-title": "J Clin Psychiatry"}, {"key": "9655_CR69", "doi-asserted-by": "crossref", "first-page": "293", "DOI": "10.1093/alcalc/agn122", "volume": "44", "author": "JC Garbutt", "year": "2009", "unstructured": "Garbutt JC, Osborne M, Gallop R et al (2009) Sweet liking phenotype, alcohol craving and response to naltrexone treatment in alcohol dependence. Alcohol Alcohol 44:293\u2013300", "journal-title": "Alcohol Alcohol"}, {"key": "9655_CR70", "doi-asserted-by": "crossref", "first-page": "175", "DOI": "10.1124/mi.9.4.6", "volume": "9", "author": "M Gaval-Cruz", "year": "2009", "unstructured": "Gaval-Cruz M, Weinshenker D (2009) Mechanisms of disulfiram-induced cocaine abstinence: antabuse and cocaine relapse. Mol Interv 9:175\u2013187", "journal-title": "Mol Interv"}, {"key": "9655_CR71", "doi-asserted-by": "crossref", "first-page": "798", "DOI": "10.1001/archpsyc.1973.01750360034004", "volume": "28", "author": "JR Gerrein", "year": "1973", "unstructured": "Gerrein JR, Rosenberg CM, Manohar V (1973) Disulfiram maintenance in outpatient treatment of alcoholism. Arch Gen Psychiatry 28:798\u2013802", "journal-title": "Arch Gen Psychiatry"}, {"key": "9655_CR72", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/j.bbr.2011.06.013", "volume": "225", "author": "M Ghiasvand", "year": "2011", "unstructured": "Ghiasvand M, Rezayof A, Ahmadi S, Zarrindast MR (2011) \u03b21-noradrenergic system of the central amygdala is involved in state-dependent memory induced by a cannabinoid agonist, WIN55,212-2, in rat. Behav Brain Res 225:1\u20136", "journal-title": "Behav Brain Res"}, {"key": "9655_CR73", "first-page": "1146", "volume": "22", "author": "S Ghozland", "year": "2002", "unstructured": "Ghozland S, Matthes HW, Simonin F, Filliol D, Kieffer BL, Maldonado R (2002) Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors. J Neurosci 22:1146\u20131154", "journal-title": "J Neurosci"}, {"key": "9655_CR74", "doi-asserted-by": "crossref", "first-page": "73", "DOI": "10.1016/S0006-8993(02)03344-9", "volume": "954", "author": "S Gonzalez", "year": "2002", "unstructured": "Gonzalez S, Cascio MG, Fernandez-Ruiz J, Fezza F, Di Marzo V, Ramos JA (2002) Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine. Brain Res 954:73\u201381", "journal-title": "Brain Res"}, {"key": "9655_CR75", "doi-asserted-by": "crossref", "first-page": "410", "DOI": "10.1111/j.1530-0277.1994.tb00034.x", "volume": "18", "author": "KA Grant", "year": "1994", "unstructured": "Grant KA, Hellevuo K, Tabakoff B (1994) The 5-HT3 antagonist MDL-72222 exacerbates ethanol withdrawal seizures in mice. Alcohol Clin Exp Res 18:410\u2013414", "journal-title": "Alcohol Clin Exp Res"}, {"key": "9655_CR76", "doi-asserted-by": "crossref", "first-page": "261", "DOI": "10.1016/S0376-8716(99)00128-3", "volume": "59", "author": "MK Greenwald", "year": "2000", "unstructured": "Greenwald MK, Stitzer ML (2000) Antinociceptive, subjective and behavioral effects of smoked marijuana in humans. Drug Alcohol Depend 59:261\u2013275", "journal-title": "Drug Alcohol Depend"}, {"key": "9655_CR77", "doi-asserted-by": "crossref", "first-page": "1432", "DOI": "10.1016/j.euroneuro.2013.02.006", "volume": "23", "author": "A Gual", "year": "2013", "unstructured": "Gual A, He Y, Torup L, van den Brink W, Mann K (2013) A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence. Eur Neuropsychopharmacol 23:1432\u20131442", "journal-title": "Eur Neuropsychopharmacol"}, {"key": "9655_CR78", "doi-asserted-by": "crossref", "first-page": "587", "DOI": "10.1016/0277-9536(91)90216-Y", "volume": "33", "author": "C Gudex", "year": "1991", "unstructured": "Gudex C (1991) Adverse effects of benzodiazepines. Soc Sci Med 33:587\u2013596", "journal-title": "Soc Sci Med"}, {"key": "9655_CR79", "doi-asserted-by": "crossref", "first-page": "947", "DOI": "10.1007/s12325-012-0061-5", "volume": "29", "author": "R Guglielmo", "year": "2012", "unstructured": "Guglielmo R, Martinotti G, Clerici M, Janiri L (2012) Pregabalin for alcohol dependence: a critical review of the literature. Adv Ther 29:947\u2013957", "journal-title": "Adv Ther"}, {"key": "9655_CR80", "doi-asserted-by": "crossref", "first-page": "55", "DOI": "10.1007/BF03161171", "volume": "2", "author": "JB Hack", "year": "2006", "unstructured": "Hack JB, Hoffmann RS, Nelson LS (2006) Resistant alcohol withdrawal: does an unexpectedly large sedative requirement identify these patients early? J Med Toxicol 2:55\u201360", "journal-title": "J Med Toxicol"}, {"key": "9655_CR81", "doi-asserted-by": "crossref", "first-page": "39", "DOI": "10.1080/09595230500126698", "volume": "24", "author": "WD Hall", "year": "2005", "unstructured": "Hall WD, Lynskey M (2005) Is cannabis a gateway drug? Testing hypotheses about the relationship between cannabis use and the use of other illicit drugs. Drug Alcohol Rev 24:39\u201348", "journal-title": "Drug Alcohol Rev"}, {"key": "9655_CR82", "doi-asserted-by": "crossref", "first-page": "1391", "DOI": "10.1038/sj.npp.1301243", "volume": "32", "author": "M Haney", "year": "2007", "unstructured": "Haney M (2007) Opioid antagonism of cannabinoid effects: differences between marijuana smokers and nonmarijuana smokers. Neuropsychopharmacology 32:1391\u20131403", "journal-title": "Neuropsychopharmacology"}, {"key": "9655_CR83", "doi-asserted-by": "crossref", "first-page": "77", "DOI": "10.1007/s00213-002-1279-8", "volume": "166", "author": "M Haney", "year": "2003", "unstructured": "Haney M, Bisage A, Foltin RW (2003) Interaction between naltrexone and oral THC in heavy marijuana smokers. Psychopharmacology 166:77\u201385", "journal-title": "Psychopharmacology"}, {"key": "9655_CR84", "doi-asserted-by": "crossref", "first-page": "158", "DOI": "10.1038/sj.npp.1300310", "volume": "29", "author": "M Haney", "year": "2004", "unstructured": "Haney M, Hart CL, Vosburg SK et al (2004) Marijuana withdrawal in humans: effects of oral THC or divalproex. Neuropsychopharmacology 29:158\u2013170", "journal-title": "Neuropsychopharmacology"}, {"key": "9655_CR85", "doi-asserted-by": "crossref", "first-page": "875", "DOI": "10.1592/phco.29.7.875", "volume": "29", "author": "CE Hayner", "year": "2009", "unstructured": "Hayner CE, Wuestefeld NL, Bolton PJ (2009) Phenobarbital treatment in a patient with resistant alcohol withdrawal syndrome. Pharmacotherapy 29:875\u2013878", "journal-title": "Pharmacotherapy"}, {"key": "9655_CR86", "doi-asserted-by": "crossref", "first-page": "781", "DOI": "10.1038/npp.2013.272", "volume": "39", "author": "M Heilig", "year": "2014", "unstructured": "Heilig M (2014) Acamprosate: an alcoholism treatment that may not be what we thought. Neuropsychopharmacology 39:781\u2013782", "journal-title": "Neuropsychopharmacology"}, {"key": "9655_CR87", "doi-asserted-by": "crossref", "first-page": "287", "DOI": "10.1097/00004714-200106000-00006", "volume": "21", "author": "P Hein\u00e4l\u00e4", "year": "2001", "unstructured": "Hein\u00e4l\u00e4 P, Alho H, Kiianmaa K, L\u00f6nnqvist J, Kuoppasalmi K, Sinclair JD (2001) Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial. J Clin Psychopharmacol 21:287\u2013292", "journal-title": "J Clin Psychopharmacol"}, {"key": "9655_CR88", "doi-asserted-by": "crossref", "first-page": "111", "DOI": "10.1111/j.1530-0277.1998.tb03623.x", "volume": "22", "author": "A Helander", "year": "1998", "unstructured": "Helander A (1998) Monitoring relapse drinking during disulfiram therapy by assay of urinary 5-hydroxytryptophol. Alcohol Clin Exp Res 22:111\u2013114", "journal-title": "Alcohol Clin Exp Res"}, {"key": "9655_CR89", "doi-asserted-by": "crossref", "first-page": "382", "DOI": "10.1016/j.ajem.2009.10.010", "volume": "29", "author": "GW Hendey", "year": "2011", "unstructured": "Hendey GW, Dery RA, Barnes RL, Snowden B, Mentler P (2011) A prospective, randomized, trial of phenobarbital versus benzodiazepines for acute alcohol withdrawal. Am J Emerg Med 29:382\u2013385", "journal-title": "Am J Emerg Med"}, {"key": "9655_CR90", "doi-asserted-by": "crossref", "first-page": "44", "DOI": "10.1007/s002130050688", "volume": "139", "author": "D Hersh", "year": "1998", "unstructured": "Hersh D, Van Kirk JR, Kranzler HR (1998) Naltrexone treatment of comorbid alcohol and cocaine use disorders. Psychopharmacology 139:44\u201352", "journal-title": "Psychopharmacology"}, {"key": "9655_CR91", "doi-asserted-by": "crossref", "first-page": "267", "DOI": "10.4088/PCC.08l00714", "volume": "11", "author": "M Hertzman", "year": "2009", "unstructured": "Hertzman M, Patt IS, Spielman LA (2009) Open-label trial of acamprostae as a treatment for anxiety. Prim Care Companion J Clin Psychiatry 11:267", "journal-title": "Prim Care Companion J Clin Psychiatry"}, {"key": "9655_CR92", "first-page": "793", "volume": "19", "author": "EC Hoff", "year": "1955", "unstructured": "Hoff EC (1955) The use of disulfiram (antabuse) in the comprehensive therapy of a group of 1,020 alcoholics. Conn State Med J 19:793\u2013798", "journal-title": "Conn State Med J"}, {"key": "9655_CR93", "doi-asserted-by": "crossref", "first-page": "285", "DOI": "10.1111/bcp.12023", "volume": "77", "author": "SD Hood", "year": "2014", "unstructured": "Hood SD, Norman A, Hince DA, Melichar JK, Hulse GK (2014) Benzodiazepine dependence and its treatment with low dose flumazenil. Br J Clin Pharmacol 77:285\u2013294", "journal-title": "Br J Clin Pharmacol"}, {"key": "9655_CR94", "doi-asserted-by": "crossref", "first-page": "1089", "DOI": "10.1001/archinte.1989.00390050075015", "volume": "149", "author": "RI Horwitz", "year": "1989", "unstructured": "Horwitz RI, Gottlieb LD, Kraus ML (1989) The efficacy of atenolol in the outpatient management of the alcohol withdrawal syndrome. Results of a randomized clinical trial. Arch Intern Med 149:1089\u20131093", "journal-title": "Arch Intern Med"}, {"key": "9655_CR95", "doi-asserted-by": "crossref", "first-page": "e113", "DOI": "10.1016/j.ajem.2013.08.044", "volume": "32", "author": "DW Hughes", "year": "2014", "unstructured": "Hughes DW, Vanwert E, Lepori L, Adams BD (2014) Propofol for benzodiazepine-refractory alcohol withdrawal in a non-mechanically ventilated patient. Am J Emerg Med 32:e113\u2013e114", "journal-title": "Am J Emerg Med"}, {"key": "9655_CR96", "doi-asserted-by": "crossref", "first-page": "392", "DOI": "10.1016/j.phrs.2005.05.012", "volume": "52", "author": "P Huguelet", "year": "2005", "unstructured": "Huguelet P, Morand-Collomb S (2005) Effect of topiramate augmentation on two patients suffering from schizophrenia or bipolar disorder with comorbid alcohol abuse. Pharmacol Res 52:392\u2013394", "journal-title": "Pharmacol Res"}, {"key": "9655_CR97", "doi-asserted-by": "crossref", "first-page": "50", "DOI": "10.1177/2045125313512324", "volume": "4", "author": "B Imbert", "year": "2014", "unstructured": "Imbert B, Labrune N, Lancon C, Simon N (2014) Baclofen in the management of cannabis dependence syndrome. Ther Adv Psychopharmacol 4:50\u201352", "journal-title": "Ther Adv Psychopharmacol"}, {"key": "9655_CR98", "first-page": "328", "volume": "94", "author": "TU J\u00e4rbe", "year": "1988", "unstructured": "J\u00e4rbe TU, Hiltunen AJ (1988) Limited stimulus generalization between delta 9-THC and diazepam in pigeons and gerbils. Psychopharmacology 94:328\u2013331", "journal-title": "Psychopharmacology"}, {"key": "9655_CR99", "doi-asserted-by": "crossref", "first-page": "193", "DOI": "10.1007/BF00426779", "volume": "54", "author": "TU J\u00e4rbe", "year": "1977", "unstructured": "J\u00e4rbe TU, Ohlin GC (1977) Stimulus effects of delta(9)-THC and its interaction with naltrexone and catecholamine blockers in rats. Psychopharmacology 54:193\u2013195", "journal-title": "Psychopharmacology"}, {"key": "9655_CR100", "doi-asserted-by": "crossref", "first-page": "713", "DOI": "10.1016/j.ejpain.2009.11.008", "volume": "14", "author": "T Jochum", "year": "2010", "unstructured": "Jochum T, Boettger MK, Burkhardt C, Juckel G, Bar KJ (2010) Increased pain sensitivity in alcohol withdrawal syndrome. Eur J Pain 14:713\u2013718", "journal-title": "Eur J Pain"}, {"key": "9655_CR101", "doi-asserted-by": "crossref", "first-page": "327", "DOI": "10.1007/s002130000371", "volume": "149", "author": "BA Johnson", "year": "2000", "unstructured": "Johnson BA, Ait-Daoud N (2000) Neuropharmacological treatments for alcoholism: scientific basis and clinical findings. Psychopharmacology 149:327\u2013344", "journal-title": "Psychopharmacology"}, {"key": "9655_CR102", "doi-asserted-by": "crossref", "first-page": "2103", "DOI": "10.2174/138161210791516404", "volume": "16", "author": "BA Johnson", "year": "2010", "unstructured": "Johnson BA, Ait-Daoud N (2010) Topiramate in the new generation of drugs: efficacy in the treatment of alcoholic patients. Curr Pharm Des 16:2103\u20132112", "journal-title": "Curr Pharm Des"}, {"key": "9655_CR103", "doi-asserted-by": "crossref", "first-page": "1677", "DOI": "10.1016/S0140-6736(03)13370-3", "volume": "361", "author": "BA Johnson", "year": "2003", "unstructured": "Johnson BA, Ait-Daoud N, Bowden CL et al (2003) Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet 361:1677\u20131685", "journal-title": "Lancet"}, {"key": "9655_CR104", "doi-asserted-by": "crossref", "first-page": "1641", "DOI": "10.1001/jama.298.14.1641", "volume": "298", "author": "BA Johnson", "year": "2007", "unstructured": "Johnson BA, Rosenthal N, Capece JA et al (2007) Topiramate for treating alcohol dependence: a randomized controlled trial. JAMA 298:1641\u20131651", "journal-title": "JAMA"}, {"key": "9655_CR105", "doi-asserted-by": "crossref", "first-page": "674", "DOI": "10.1097/00000542-197506000-00009", "volume": "42", "author": "RE Johnstone", "year": "1975", "unstructured": "Johnstone RE, Lief PL, Kulp RA, Smith TC (1975) Combination of delta-9-tetrahydrocannabinol with oxymorphone or pentobarbital: effects on ventilator control and cardiovascular dynamics. Anesthesiology 42:674\u2013684", "journal-title": "Anesthesiology"}, {"key": "9655_CR106", "doi-asserted-by": "crossref", "first-page": "186", "DOI": "10.1007/s00213-003-1693-6", "volume": "173", "author": "Z Justinova", "year": "2004", "unstructured": "Justinova Z, Tanda G, Munzar P, Goldberg S (2004) The opioid antagonist naltrexone reduces the reinforcing effects of 9-tetrahydrocannabinol (THC) in squirrel monkeys. Psychopharmacology 173:186\u2013194", "journal-title": "Psychopharmacology"}, {"key": "9655_CR107", "doi-asserted-by": "crossref", "first-page": "196", "DOI": "10.1007/s00417-002-0614-4", "volume": "241", "author": "D Kamal", "year": "2003", "unstructured": "Kamal D, Garway-Heath D, Ruben S et al (2003) Results of the betaxolol versus placebo treatment trial in ocular hypertension. Graefes Arch Clin Exp Ophthalmol 241:196\u2013203", "journal-title": "Graefes Arch Clin Exp Ophthalmol"}, {"key": "9655_CR108", "doi-asserted-by": "crossref", "first-page": "344", "DOI": "10.1097/JCP.0b013e3180ca86e5", "volume": "27", "author": "KM Kampman", "year": "2007", "unstructured": "Kampman KM, Pettinati HM, Lynch KG et al (2007) A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism. J Clin Psychopharmacol 27:344\u2013351", "journal-title": "J Clin Psychopharmacol"}, {"key": "9655_CR109", "doi-asserted-by": "crossref", "first-page": "94", "DOI": "10.1016/j.drugalcdep.2013.05.026", "volume": "133", "author": "KM Kampman", "year": "2013", "unstructured": "Kampman KM, Pettinati HM, Lynch KG, Spratt K, Wierzbicki MR, O\u2019Brien CP (2013) A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence. Drug Alcohol Depend 133:94\u201399", "journal-title": "Drug Alcohol Depend"}, {"key": "9655_CR110", "doi-asserted-by": "crossref", "first-page": "619", "DOI": "10.1093/alcalc/agn052", "volume": "43", "author": "H Kayir", "year": "2008", "unstructured": "Kayir H, Uzbay T (2008) Effects of clozapine on ethanol withdrawal syndrome in rats. Alcohol Alcohol 43:619\u2013625", "journal-title": "Alcohol Alcohol"}, {"key": "9655_CR111", "doi-asserted-by": "crossref", "first-page": "63", "DOI": "10.1007/s40261-013-0158-x", "volume": "34", "author": "GM Keating", "year": "2014", "unstructured": "Keating GM (2014) Sodium oxybate: a review of its use in alcohol withdrawal syndrome and in the maintenance of abstinence in alcohol dependence. Clin Drug Investig 34:63\u201380", "journal-title": "Clin Drug Investig"}, {"key": "9655_CR112", "doi-asserted-by": "crossref", "first-page": "478", "DOI": "10.1111/j.1530-0277.1991.tb00546.x", "volume": "15", "author": "AC King", "year": "1991", "unstructured": "King AC, Errico AL, Parsons OA, Lovallo WR (1991) Blood pressure dysregulation associated with alcohol withdrawal. Alcohol Clin Exp Res 15:478\u2013482", "journal-title": "Alcohol Clin Exp Res"}, {"key": "9655_CR113", "doi-asserted-by": "crossref", "first-page": "387", "DOI": "10.1016/0741-8329(96)00029-8", "volume": "13", "author": "AC King", "year": "1996", "unstructured": "King AC, Bernardy NC, Parsons OA, Lovallo WR (1996) Hemodynamic alterations in alcohol-related transitory hypertension. Alcohol 13:387\u2013393", "journal-title": "Alcohol"}, {"key": "9655_CR114", "first-page": "408", "volume": "22", "author": "AD Korczyn", "year": "1982", "unstructured": "Korczyn AD, Eshel Y (1982) Mydriasis induced by tetrahydrocannabinol (THC) in rats. Invest Ophthalmol Visual Sci 22:408\u2013410", "journal-title": "Invest Ophthalmol Visual Sci"}, {"key": "9655_CR115", "doi-asserted-by": "crossref", "first-page": "369", "DOI": "10.1016/0741-8329(93)90022-G", "volume": "10", "author": "W Kostowski", "year": "1993", "unstructured": "Kostowski W, Dyr W, Krzascik P (1993) The abilities of 5-HT3 receptor antagonist ICS 205-930 to inhibit alcohol preference and withdrawal seizures in rats. Alcohol 10:369\u2013373", "journal-title": "Alcohol"}, {"key": "9655_CR116", "doi-asserted-by": "crossref", "first-page": "2076", "DOI": "10.2174/138161210791516431", "volume": "16", "author": "H Krampe", "year": "2010", "unstructured": "Krampe H, Ehrenreich H (2010) Supervised disulfiram as adjunct to psychotherapy in alcoholism treatment. Curr Pharm Des 16:2076\u20132090", "journal-title": "Curr Pharm Des"}, {"key": "9655_CR117", "doi-asserted-by": "crossref", "first-page": "445", "DOI": "10.1176/appi.ajp.2013.13081014", "volume": "171", "author": "HR Kranzler", "year": "2014", "unstructured": "Kranzler HR, Covault J, Feinn R et al (2014) Topiramate treatment for heavy drinkers: moderation by a GRIK1 polymorphism. Am J Psychiatry 171:445\u2013452", "journal-title": "Am J Psychiatry"}, {"key": "9655_CR118", "doi-asserted-by": "crossref", "first-page": "905", "DOI": "10.1056/NEJM198510103131501", "volume": "313", "author": "ML Kraus", "year": "1985", "unstructured": "Kraus ML, Gottlieb LD, Horwitz RI, Anscher M (1985) Randomized clinical trial of atenolol in patients with alcohol withdrawal. N Engl J Med 313:905\u2013909", "journal-title": "N Engl J Med"}, {"key": "9655_CR119", "doi-asserted-by": "crossref", "first-page": "83", "DOI": "10.1176/ajp.153.1.83", "volume": "153", "author": "JH Krystal", "year": "1996", "unstructured": "Krystal JH, Webb E, Cooney NL, Kranzler HR, Southwick SW, Heninger GR, Charney DS (1996) Serotonergic and noradrenergic dysregulation in alcoholism: m-chlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects. Am J Psychiatry 153:83\u201392", "journal-title": "Am J Psychiatry"}, {"key": "9655_CR120", "doi-asserted-by": "crossref", "first-page": "1734", "DOI": "10.1056/NEJMoa011127", "volume": "345", "author": "JH Krystal", "year": "2001", "unstructured": "Krystal JH, Cramer JA, Krol WF, Kirk GF, Rosenheck RA (2001) Naltrexone in the treatment of alcohol dependence. N Engl J Med 345:1734\u20131739", "journal-title": "N Engl J Med"}, {"key": "9655_CR121", "doi-asserted-by": "crossref", "first-page": "1793", "DOI": "10.1038/sj.npp.1300994", "volume": "31", "author": "JH Krystal", "year": "2006", "unstructured": "Krystal JH, Madonick S, Perry E et al (2006) Potentiation of low dose ketamine effects by naltrexone: potential implications for the pharmacotherapy of alcoholism. Neuropsychopharmacology 31:1793\u20131800", "journal-title": "Neuropsychopharmacology"}, {"key": "9655_CR122", "doi-asserted-by": "crossref", "first-page": "1037", "DOI": "10.1016/j.eurpsy.2015.09.003", "volume": "30", "author": "TA Kurko", "year": "2015", "unstructured": "Kurko TA, Saastamoinen LK, Tahkapaa S et al (2015) Long-term use of benzodiazepines: definitions, prevalence and usage patterns\u2014a systematic review of register-based studies. Eur Psychiatry 30:1037\u20131047", "journal-title": "Eur Psychiatry"}, {"key": "9655_CR123", "doi-asserted-by": "crossref", "first-page": "53", "DOI": "10.1093/alcalc/agm136", "volume": "43", "author": "E Laaksonen", "year": "2008", "unstructured": "Laaksonen E, Koski-Jannes A, Salaspuro M, Ahtinen H, Alho H (2008) A randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence. Alcohol Alcohol 43:53\u201361", "journal-title": "Alcohol Alcohol"}, {"key": "9655_CR124", "first-page": "242", "volume": "140", "author": "RB Lacoursiere", "year": "1983", "unstructured": "Lacoursiere RB, Swatek R (1983) Adverse interaction between disulfiram and marijuana: a case report. Am J Psychiatry 140:242\u2013244", "journal-title": "Am J Psychiatry"}, {"key": "9655_CR125", "doi-asserted-by": "crossref", "first-page": "238", "DOI": "10.1111/j.1471-4159.2004.02725.x", "volume": "91", "author": "P Laeng", "year": "2004", "unstructured": "Laeng P, Pitts RL, Lemire AL et al (2004) The mood stabilizer valproic acid stimulates GABA neurogenesis from rat forebrain stem cells. J Neurochem 91:238\u2013251", "journal-title": "J Neurochem"}, {"key": "9655_CR126", "doi-asserted-by": "crossref", "first-page": "1106", "DOI": "10.1016/j.pnpbp.2007.09.021", "volume": "32", "author": "L Leggio", "year": "2008", "unstructured": "Leggio L, Kenna GA, Swift RM (2008) New developments for the pharmacological treatment of alcohol withdrawal syndrome. A focus on non-benzodiazepine GABAergic medications. Prog Neuropsychopharmacol Biol Psychiatry 32:1106\u20131117", "journal-title": "Prog Neuropsychopharmacol Biol Psychiatry"}, {"key": "9655_CR127", "first-page": "23", "volume": "7", "author": "DM Li", "year": "1980", "unstructured": "Li DM (1980) The lack of beta-adrenoceptor involvement in the cardiac action of delta 1-tetrahydrocannabinol in rats. Clin Exp Pharmacol Physiol 7:23\u201329", "journal-title": "Clin Exp Pharmacol Physiol"}, {"key": "9655_CR128", "doi-asserted-by": "crossref", "first-page": "55", "DOI": "10.1016/j.pnpbp.2004.10.005", "volume": "29", "author": "J Liappas", "year": "2005", "unstructured": "Liappas J, Paparrigopoulos T, Tzavellas E, Rabavilas A (2005) Mirtazapine and venlafaxine in the management of collateral psychopathology during alcohol detoxification. Prog Neuropsychopharmacol Biol Psychiatry 29:55\u201360", "journal-title": "Prog Neuropsychopharmacol Biol Psychiatry"}, {"key": "9655_CR129", "doi-asserted-by": "crossref", "first-page": "440", "DOI": "10.1016/j.drugalcdep.2013.06.032", "volume": "133", "author": "S Likhitsathian", "year": "2013", "unstructured": "Likhitsathian S, Uttawichai K, Booncharoen H, Wittayanookulluk A, Angkurawaranon C, Srisurapanont M (2013) Topiramate treatment for alcoholic outpatients recently receiving residential treatment programs: a 12-week, randomized, placebo-controlled trial. Drug Alcohol Depend 133:440\u2013446", "journal-title": "Drug Alcohol Depend"}, {"key": "9655_CR130", "doi-asserted-by": "crossref", "first-page": "141", "DOI": "10.1016/j.drugalcdep.2014.07.016", "volume": "143", "author": "JA Lile", "year": "2014", "unstructured": "Lile JA, Hays LR, Kelly TH (2014) Separate and combined effects of the GABAA positive allosteric modulator diazepam and \u03949-THC in humans discriminating \u03949-THC. Drug Alcohol Depend 143:141\u2013148", "journal-title": "Drug Alcohol Depend"}, {"key": "9655_CR131", "doi-asserted-by": "crossref", "first-page": "294", "DOI": "10.1097/00003246-198803000-00018", "volume": "16", "author": "WC Lineaweaver", "year": "1988", "unstructured": "Lineaweaver WC, Anderson K, Hing DN (1988) Massive doses of midazolam infusion for delirium tremens without respiratory depression. Crit Care Med 16:294\u2013295", "journal-title": "Crit Care Med"}, {"key": "9655_CR132", "doi-asserted-by": "crossref", "first-page": "87", "DOI": "10.1016/0149-7634(85)90034-X", "volume": "9", "author": "RG Lister", "year": "1985", "unstructured": "Lister RG (1985) The amnesic action of benzodiazepines in man. Neurosci Biobehav Rev 9:87\u201394", "journal-title": "Neurosci Biobehav Rev"}, {"key": "9655_CR133", "doi-asserted-by": "crossref", "first-page": "387", "DOI": "10.1007/BF02244612", "volume": "100", "author": "JM Littleton", "year": "1990", "unstructured": "Littleton JM, Little HJ, Whittington MA (1990) Effects of dihydropyridine calcium channel antagonists in ethanol withdrawal; doses required, stereospecificity and actions of Bay K 8644. Psychopharmacology 100:387\u2013392", "journal-title": "Psychopharmacology"}, {"key": "9655_CR134", "first-page": "A4807", "volume": "61", "author": "K Lorentzen", "year": "2014", "unstructured": "Lorentzen K, Lauritsen AO, Bendtsen AO (2014) Use of propofol infusion in alcohol withdrawal-induced refractory delirium tremens. Dan Med J 61:A4807", "journal-title": "Dan Med J"}, {"key": "9655_CR135", "first-page": "114", "volume": "21", "author": "DM Lovinger", "year": "1997", "unstructured": "Lovinger DM (1997) Serotonin\u2019s role in alcohol\u2019s effects on the brain. Alcohol Health Res World 21:114\u2013120", "journal-title": "Alcohol Health Res World"}, {"key": "9655_CR136", "author": "Lovinger DM, Peoples RW", "first-page": "157", "year": "1993", "unstructured": "Lovinger DM, Peoples RW (1993) Actions of alcohols and other sedative/hypnotic compounds on cation channels associated with glutamate and 5-HT3 receptors. In: Alling C, Diamond I, Leslie SW, Sun GY, Wood WG (eds) Alcohol, cell membranes and signal transduction in brain. Plenum Press, New York, pp 157\u2013168", "volume-title": "Alcohol, cell membranes and signal transduction in brain", "DOI": "10.1007/978-1-4615-2470-0_14", "doi-asserted-by": "crossref"}, {"key": "9655_CR137", "doi-asserted-by": "crossref", "first-page": "139", "DOI": "10.1016/j.alcohol.2007.03.008", "volume": "41", "author": "DM Lovinger", "year": "2007", "unstructured": "Lovinger DM, Homanics GE (2007) Tonic for what ails us? High-affinity GABAA receptors and alcohol. Alcohol 41:139\u2013143", "journal-title": "Alcohol"}, {"key": "9655_CR138", "doi-asserted-by": "crossref", "first-page": "469", "DOI": "10.1002/jhm.928", "volume": "6", "author": "JE Lyon", "year": "2011", "unstructured": "Lyon JE, Khan RA, Gessert CE, Larson PM, Renier CM (2011) Treating alcohol withdrawal with oral baclofen: a randomized, double-blind, placebo-controlled trial. J Hosp Med 6:469\u2013474", "journal-title": "J Hosp Med"}, {"key": "9655_CR139", "doi-asserted-by": "crossref", "first-page": "58", "DOI": "10.4103/0972-6748.77641", "volume": "19", "author": "R Mahajan", "year": "2010", "unstructured": "Mahajan R, Singh R, Bansal PD, Bala R (2010) Use of propofol as adjuvant therapy in refractory delirium tremens. Ind Psychiatry J 19:58\u201359", "journal-title": "Ind Psychiatry J"}, {"key": "9655_CR140", "doi-asserted-by": "crossref", "first-page": "275", "DOI": "10.1111/j.1360-0443.2012.04054.x", "volume": "108", "author": "NC Maisel", "year": "2013", "unstructured": "Maisel NC, Blodgett JC, Wilbourne PL, Humphreys K, Finney JW (2013) Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful? Addiction 108:275\u2013293", "journal-title": "Addiction"}, {"key": "9655_CR141", "doi-asserted-by": "crossref", "first-page": "159", "DOI": "10.1016/S0741-8329(00)00114-2", "volume": "22", "author": "R Malcolm", "year": "2000", "unstructured": "Malcolm R, Roberts JS, Wang W, Myrick H, Anton RF (2000) Multiple previous detoxifications are associated with less responsive treatment and heavier drinking during an index outpatient detoxification. Alcohol 22:159\u2013164", "journal-title": "Alcohol"}, {"key": "9655_CR142", "doi-asserted-by": "crossref", "first-page": "349", "DOI": "10.1007/s11606-002-0038-1", "volume": "17", "author": "R Malcolm", "year": "2002", "unstructured": "Malcolm R, Myrick H, Roberts J, Wang W, Anton RF, Ballenger JC (2002) The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial. J Gen Intern Med 17:349\u2013350", "journal-title": "J Gen Intern Med"}, {"key": "9655_CR143", "doi-asserted-by": "crossref", "first-page": "13", "DOI": "10.1016/S0014-2999(99)00393-3", "volume": "377", "author": "B Malinowska", "year": "1999", "unstructured": "Malinowska B, Napiorkowska-Pawlak D, Pawlak R, Buczko W, Gothert M (1999) Ifenprodil influences changes in mouse behaviour related to acute and chronic ethanol administration. Eur J Pharmacol 377:13\u201319", "journal-title": "Eur J Pharmacol"}, {"key": "9655_CR144", "doi-asserted-by": "crossref", "first-page": "706", "DOI": "10.1016/j.biopsych.2012.10.020", "volume": "73", "author": "K Mann", "year": "2013", "unstructured": "Mann K, Bladstrom A, Torup L, Gual A, van den Brink W (2013) Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene. Biol Psychiatry 73:706\u2013713", "journal-title": "Biol Psychiatry"}, {"key": "9655_CR146", "doi-asserted-by": "crossref", "first-page": "109", "DOI": "10.1080/10550490902772785", "volume": "18", "author": "P Mannelli", "year": "2009", "unstructured": "Mannelli P, Patkar AA, Peindl K, Gottheil E, Wu LT, Gorelick DA (2009) Early outcomes following low dose naltrexone enhancement of opiod detoxificaion. Am J Addict 18:109\u2013116", "journal-title": "Am J Addict"}, {"key": "9655_CR147", "unstructured": "Marshall K, Gowing L, Ali R, Le Foll B (2014) Pharmacotherapies for cannabis dependence. Cochrane Database Syst Rev 12:CD008940", "DOI": "10.1002/14651858.CD008940.pub2", "doi-asserted-by": "crossref"}, {"key": "9655_CR148", "doi-asserted-by": "crossref", "first-page": "709", "DOI": "10.1097/JCP.0000000000000228", "volume": "34", "author": "G Martinotti", "year": "2014", "unstructured": "Martinotti G, Di Nicola M, De Vita O et al (2014) Low-dose topiramate in alcohol dependence: a single-blind, placebo-controlled study. J Clin Psychopharmacol 34:709\u2013715", "journal-title": "J Clin Psychopharmacol"}, {"key": "9655_CR149", "doi-asserted-by": "crossref", "first-page": "469", "DOI": "10.1016/j.euroneuro.2003.08.009", "volume": "13", "author": "BJ Mason", "year": "2003", "unstructured": "Mason BJ (2003) Acamprosate and naltrexone treatment for alcohol dependence: an evidence-based risk-benefits assessment. Eur Neuropsychopharmacol 13:469\u2013475", "journal-title": "Eur Neuropsychopharmacol"}, {"key": "9655_CR150", "doi-asserted-by": "crossref", "first-page": "1162", "DOI": "10.1111/j.1530-0277.1994.tb00098.x", "volume": "18", "author": "BJ Mason", "year": "1994", "unstructured": "Mason BJ, Ritvo EC, Morgan RO, Salvato FR, Goldberg G, Welch B, Mantero-Atienza E (1994) A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence. Alcohol Clin Exp Res 18:1162\u20131167", "journal-title": "Alcohol Clin Exp Res"}, {"key": "9655_CR151", "doi-asserted-by": "crossref", "first-page": "719", "DOI": "10.1001/archpsyc.56.8.719", "volume": "56", "author": "BJ Mason", "year": "1999", "unstructured": "Mason BJ, Salvato FR, Williams LD, Ritvo EC, Cutler RB (1999) A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence. Arch Gen Psychiatry 56:719\u2013724", "journal-title": "Arch Gen Psychiatry"}, {"key": "9655_CR152", "doi-asserted-by": "crossref", "first-page": "73", "DOI": "10.1111/j.1369-1600.2008.00133.x", "volume": "14", "author": "BJ Mason", "year": "2009", "unstructured": "Mason BJ, Light JM, Williams LD, Drobes DJ (2009) Proof-of-concept human laboratory study for protracted abstinence in alcohol dependence: effects of gabapentin. Addict Biol 14:73\u201383", "journal-title": "Addict Biol"}, {"key": "9655_CR153", "doi-asserted-by": "crossref", "first-page": "1689", "DOI": "10.1038/npp.2012.14", "volume": "37", "author": "BJ Mason", "year": "2012", "unstructured": "Mason BJ, Crean R, Goodell V et al (2012) A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adults. Neuropsychopharmacology 37:1689\u20131698", "journal-title": "Neuropsychopharmacology"}, {"key": "9655_CR154", "doi-asserted-by": "crossref", "first-page": "70", "DOI": "10.1001/jamainternmed.2013.11950", "volume": "174", "author": "BJ Mason", "year": "2014", "unstructured": "Mason BJ, Quello S, Goodell V, Shadan F, Kyle M, Begovic A (2014) Gabapentin treatment for alcohol dependence: a randomized clinical trial. JAMA Intern Med 174:70\u201377", "journal-title": "JAMA Intern Med"}, {"key": "9655_CR155", "doi-asserted-by": "crossref", "first-page": "144", "DOI": "10.1001/jama.1997.03550020076042", "volume": "278", "author": "MF Mayo-Smith", "year": "1997", "unstructured": "Mayo-Smith MF (1997) Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. JAMA 278:144\u2013151", "journal-title": "JAMA"}, {"key": "9655_CR156", "doi-asserted-by": "crossref", "first-page": "1405", "DOI": "10.1001/archinte.164.13.1405", "volume": "164", "author": "MF Mayo-Smith", "year": "2004", "unstructured": "Mayo-Smith MF, Beecher LH, Fischer TL et al (2004) Management of alcohol withdrawal delirium. An evidence-based practice guideline. Arch Intern Med 164:1405\u20131412", "journal-title": "Arch Intern Med"}, {"key": "9655_CR157", "doi-asserted-by": "crossref", "first-page": "1781", "DOI": "10.1097/00003246-200006000-00014", "volume": "28", "author": "C McCowan", "year": "2000", "unstructured": "McCowan C, Marik P (2000) Refractory delirium tremens treated with propofol: a case series. Crit Care Med 28:1781\u20131784", "journal-title": "Crit Care Med"}, {"key": "9655_CR158", "doi-asserted-by": "crossref", "first-page": "854", "DOI": "10.1136/jnnp.2007.128322", "volume": "79", "author": "A McKeon", "year": "2008", "unstructured": "McKeon A, Frye MA, Delanty N (2008) The alcohol withdrawal syndrome. J Neurol Neurosurg Psychiatry 79:854\u2013862", "journal-title": "J Neurol Neurosurg Psychiatry"}, {"key": "9655_CR159", "doi-asserted-by": "crossref", "first-page": "404", "DOI": "10.1080/10550490600860635", "volume": "15", "author": "AL McRae", "year": "2006", "unstructured": "McRae AL, Brady KT, Carter RE (2006) Buspirone for treatment of marijuana dependence: a\u00a0pilot study. Am J Addict 15:404", "journal-title": "Am J Addict"}, {"key": "9655_CR160", "first-page": "3", "volume": "73", "author": "A Michalak", "year": "2016", "unstructured": "Michalak A, Bia\u0142a G (2016) Alcohol dependence - neurobiology and treatment. Acta Pol Pharm 73:3\u201312", "journal-title": "Acta Pol Pharm"}, {"key": "9655_CR161", "author": "SJ Mihic", "first-page": "51", "year": "1996", "unstructured": "Mihic SJ, Harris RA (1996) Alcohol actions at the GABAA receptor/Chloride channel complex. In: Deitrich RA, Erwin VG (eds) Pharmacological effects of ethanol on the nervous system. CRC Press, Boca Raton, pp 51\u201372", "volume-title": "Pharmacological effects of ethanol on the nervous system"}, {"key": "9655_CR162", "doi-asserted-by": "crossref", "first-page": "145", "DOI": "10.1007/s40429-016-0098-7", "volume": "3", "author": "R Miranda Jr", "year": "2016", "unstructured": "Miranda R Jr, Treloar H (2016) Emerging pharmacologic treatments for adolescent substance use: challenges and new directions. Curr Addict Rep 3:145\u2013156", "journal-title": "Curr Addict Rep"}, {"key": "9655_CR163", "author": "R Miranda Jr", "year": "2016", "unstructured": "Miranda R Jr, Treloar H, Blanchard A et al (2016) Topiramate and motivational enhancement therapy for cannabis use among youth: a randomized placebo-controlled pilot study. Addict Biol. doi: 10.1111/adb.12350 [Epub ahead of print]", "journal-title": "Addict Biol", "DOI": "10.1111/adb.12350", "doi-asserted-by": "publisher"}, {"key": "9655_CR164", "doi-asserted-by": "crossref", "first-page": "1228", "DOI": "10.1016/0140-6736(91)92903-F", "volume": "337", "author": "N Moore", "year": "1991", "unstructured": "Moore N, Libert C (1991) Acamprosate, citalopram, and alcoholism. Lancet 337:1228", "journal-title": "Lancet"}, {"key": "9655_CR165", "doi-asserted-by": "crossref", "first-page": "1451", "DOI": "10.1111/j.1360-0443.2006.01555.x", "volume": "101", "author": "KC Morley", "year": "2006", "unstructured": "Morley KC, Teesson M, Reid SC et al (2006) Naltrexone versus acamprosate in the treatment of alcohol dependence: a multi-centre, randomized, double-blind, placebo-controlled trial. Addiction 101:1451\u20131462", "journal-title": "Addiction"}, {"key": "9655_CR166", "doi-asserted-by": "crossref", "first-page": "44", "DOI": "10.3109/00952990.2012.677889", "volume": "39", "author": "J Mutschler", "year": "2013", "unstructured": "Mutschler J, Eifler S, Dirican G, Grosshans M, Kiefer F, R\u00f6ssler W, Diehl A (2013) Functional social support within a medical supervised outpatient treatment program. Am J Drug Alcohol Abuse 39:44\u201349", "journal-title": "Am J Drug Alcohol Abuse"}, {"key": "9655_CR167", "doi-asserted-by": "crossref", "first-page": "1582", "DOI": "10.1111/j.1530-0277.2009.00986.x", "volume": "33", "author": "H Myrick", "year": "2009", "unstructured": "Myrick H, Malcolm R, Randall PK, Boyle E, Anton RF, Becker HC, Randall CL (2009) A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal. Alcohol Clin Exp Res 33:1582\u20131588", "journal-title": "Alcohol Clin Exp Res"}, {"key": "9655_CR168", "doi-asserted-by": "crossref", "first-page": "296", "DOI": "10.1097/ADM.0b013e31828e1881", "volume": "7", "author": "N Nacca", "year": "2013", "unstructured": "Nacca N, Vatti D, Sullivan R, Sud P, Su M, Marraffa J (2013) The synthetic cannabinoid withdrawal syndrome. J Addict Med 7:296\u2013298", "journal-title": "J Addict Med"}, {"key": "9655_CR169", "doi-asserted-by": "crossref", "first-page": "39", "DOI": "10.2174/157015908783769662", "volume": "6", "author": "J Nagy", "year": "2008", "unstructured": "Nagy J (2008) Alcohol related changes in regulation of NMDA receptor functions. Curr Neuropharmacol 6:39\u201354", "journal-title": "Curr Neuropharmacol"}, {"key": "9655_CR170", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1016/j.biopsych.2010.03.033", "volume": "68", "author": "SB Nanjayya", "year": "2010", "unstructured": "Nanjayya SB, Shivappa M, Chand PK, Murthy P, Benegal V (2010) Baclofen in cannabis dependence syndrome. Biol Psychiatry 68:9\u201310", "journal-title": "Biol Psychiatry"}, {"key": "9655_CR171", "first-page": "5344", "volume": "21", "author": "M Navarro", "year": "2001", "unstructured": "Navarro M, Carrera MR, Fratta W et al (2001) Functional interaction between opioid and cannabinoid receptors in drug self-administration. J Neurosci 21:5344\u20135350", "journal-title": "J Neurosci"}, {"key": "9655_CR172", "doi-asserted-by": "crossref", "first-page": "295", "DOI": "10.1080/0959523031000154436", "volume": "22", "author": "H Niederhofer", "year": "2003", "unstructured": "Niederhofer H, Staffen W (2003) Comparison of disulfiram and placebo in treatment of alcohol dependence of adolescents. Drug Alcohol Rev 22:295\u2013297", "journal-title": "Drug Alcohol Rev"}, {"key": "9655_CR173", "doi-asserted-by": "crossref", "first-page": "333", "DOI": "10.1080/1355621961000124956", "volume": "1", "author": "EP Noble", "year": "1996", "unstructured": "Noble EP (1996) Alcoholism and the dopaminergic system: a review. Addict Biol 1:333\u2013348", "journal-title": "Addict Biol"}, {"key": "9655_CR174", "doi-asserted-by": "crossref", "first-page": "1475", "DOI": "10.1345/aph.1L157", "volume": "42", "author": "CL Olmsted", "year": "2008", "unstructured": "Olmsted CL, Kockler DR (2008) Topiramate for alcohol dependence. Ann Pharmacother 42:1475\u20131480", "journal-title": "Ann Pharmacother"}, {"key": "9655_CR175", "doi-asserted-by": "crossref", "first-page": "175", "DOI": "10.1016/0028-3908(94)00133-D", "volume": "34", "author": "H Ovadia", "year": "1995", "unstructured": "Ovadia H, Wohlman A, Mechoulam R, Weidenfeld J (1995) Characterization of the hypothermic effect of the synthetic cannabinoid HU-210 in the rat. Relation to the adrenergic system and endogenous pyrogens. Neuropharmacology 34:175\u2013180", "journal-title": "Neuropharmacology"}, {"key": "9655_CR176", "doi-asserted-by": "crossref", "first-page": "344", "DOI": "10.1007/s00213-003-1425-y", "volume": "167", "author": "DH Overstreet", "year": "2003", "unstructured": "Overstreet DH, Knapp DJ, Moy SS, Breese GR (2003) A 5-HT1A agonist and a 5-HT2c antagonist reduce social interaction deficit induced by multiple ethanol withdrawals in rats. Psychopharmacology 167:344\u2013352", "journal-title": "Psychopharmacology"}, {"key": "9655_CR177", "first-page": "215", "volume": "20", "author": "SC Pandey", "year": "1995", "unstructured": "Pandey SC, Davis JM, Pandey GN (1995) Phosphoinositide system-linked serotonin receptor subtypes and their pharmacological properties and clinical correlates. J Psych Neurosci 20:215\u2013225", "journal-title": "J Psych Neurosci"}, {"key": "9655_CR178", "doi-asserted-by": "crossref", "first-page": "41", "DOI": "10.1186/1471-244X-11-41", "volume": "11", "author": "T Paparrigopoulos", "year": "2011", "unstructured": "Paparrigopoulos T, Tzavellas E, Karaiskos D, Kourlaba G, Liappas I (2011) Treatment of alcohol dependence with low-dose topiramate. BMC Psychiatry 11:41", "journal-title": "BMC Psychiatry"}, {"key": "9655_CR179", "doi-asserted-by": "crossref", "first-page": "429", "DOI": "10.1016/j.disamonth.2014.05.003", "volume": "60", "author": "G Patel", "year": "2014", "unstructured": "Patel G (2014) The management of substance abuse in the critically ill. Dis Mon 60:429\u2013441", "journal-title": "Dis Mon"}, {"key": "9655_CR180", "doi-asserted-by": "crossref", "first-page": "46", "DOI": "10.1016/j.jflm.2013.11.002", "volume": "21", "author": "BN Patra", "year": "2014", "unstructured": "Patra BN, Sharma A, Mehra A, Singh S (2014) Complicated alcohol withdrawal presenting as self mutilation. J Forensic Leg Med 21:46\u201347", "journal-title": "J Forensic Leg Med"}, {"key": "9655_CR181", "first-page": "485", "volume": "27", "author": "RG Pertwee", "year": "1988", "unstructured": "Pertwee RG, Greentree SG (1988) Delta-9-tetrahydrocannabinol-induced catalepsy in mice is enhanced by pretreatment with flurazepam or chlordiazepoxide. Neuropsychopharmacology 27:485\u2013491", "journal-title": "Neuropsychopharmacology"}, {"key": "9655_CR182", "doi-asserted-by": "crossref", "first-page": "581", "DOI": "10.1016/0091-3057(91)90366-A", "volume": "40", "author": "RG Pertwee", "year": "1991", "unstructured": "Pertwee RG, Browne SE, Ross TM, Stretton CD (1991) An investigation of the involvement of GABA in certain pharmacological effects of delta-9-tetrahydrocannabinol. Pharmacol Biochem Behav 40:581\u2013585", "journal-title": "Pharmacol Biochem Behav"}, {"key": "9655_CR183", "doi-asserted-by": "crossref", "first-page": "1392", "DOI": "10.3390/ijerph7041392", "volume": "7", "author": "M Pompili", "year": "2010", "unstructured": "Pompili M, Serafini G, Innamorati M, Dominici G, Ferracuti S, Kotzalidis GD et al (2010) Suicidal behavior and alcohol abuse. Int J Environ Res Public Health 7:1392\u20131431", "journal-title": "Int J Environ Res Public Health"}, {"key": "9655_CR184", "first-page": "711", "volume": "49", "author": "S Potvin", "year": "2004", "unstructured": "Potvin S, Stip E, Roy JY (2004) The effects of quetiapine on cannabis use in 8 psychosis petients with drug dependency. Can J Psychiatry 49:711", "journal-title": "Can J Psychiatry"}, {"key": "9655_CR185", "doi-asserted-by": "crossref", "first-page": "117", "DOI": "10.1007/BF02244975", "volume": "107", "author": "WR Prescott", "year": "1992", "unstructured": "Prescott WR, Gold LH, Martin BR (1992) Evidence for separate neuronal mechanisms for the discriminative stimulus and catalepsy induced by delta 9-THC in the rat. Psychopharmacology 107:117\u2013124", "journal-title": "Psychopharmacology"}, {"key": "9655_CR186", "doi-asserted-by": "crossref", "first-page": "301", "DOI": "10.1080/10550490902927785", "volume": "18", "author": "WN Raby", "year": "2009", "unstructured": "Raby WN, Carpenter KC, Rothenberg J et al (2009) Intermittent marijuana use in associated with improved retention of naltrexone treatment for opiate-dependence. Am J Addict 18:301\u2013308", "journal-title": "Am J Addict"}, {"key": "9655_CR187", "doi-asserted-by": "crossref", "first-page": "401", "DOI": "10.1016/j.ajp.2013.05.003", "volume": "6", "author": "V Rajmohan", "year": "2013", "unstructured": "Rajmohan V, Sushil K, Mohandas E (2013) A double blind randomised comparison of chlordiazepoxide and lorazepam in alcohol withdrawal. Asian J Psychiatry 6:401\u2013403", "journal-title": "Asian J Psychiatry"}, {"key": "9655_CR188", "doi-asserted-by": "crossref", "first-page": "1251", "DOI": "10.1017/S1461145711001830", "volume": "15", "author": "M Ranganathan", "year": "2012", "unstructured": "Ranganathan M, Carbuto M, Braley G et al (2012) Naltrexone does not attenuate the effects of intravenous \u03949-tetrahydrocannabinol in healthy humans. Int J Neuropsychopharmacol 15:1251\u20131264", "journal-title": "Int J Neuropsychopharmacol"}, {"key": "9655_CR189", "doi-asserted-by": "crossref", "first-page": "824", "DOI": "10.1111/j.1553-2712.2002.tb02171.x", "volume": "9", "author": "NK Rathlev", "year": "2002", "unstructured": "Rathlev NK, Ulrich A, Shieh TC, Callum MG, Bernstein E, D\u2019Onofrio G (2002) Etiology and weekly occurrence of alcohol-related seizures. Acad Emerg Med 9:824\u2013828", "journal-title": "Acad Emerg Med"}, {"key": "9655_CR190", "doi-asserted-by": "crossref", "first-page": "372", "DOI": "10.4103/0253-7613.135947", "volume": "46", "author": "VK Reddy", "year": "2014", "unstructured": "Reddy VK, Girish K, Lakshmi P, Vijendra R, Kumar A, Harsha R (2014) Cost-effectiveness analysis of baclofen and chlordiazepoxide in uncomplicated alcohol-withdrawal syndrome. Indian J Pharmacol 46:372\u2013377", "journal-title": "Indian J Pharmacol"}, {"key": "9655_CR191", "doi-asserted-by": "crossref", "first-page": "953", "DOI": "10.1111/j.1360-0443.2008.02215.x", "volume": "103", "author": "K Richardson", "year": "2008", "unstructured": "Richardson K, Baillie A, Reid S et al (2008) Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol? Addiction 103:953\u2013959", "journal-title": "Addiction"}, {"key": "9655_CR192", "doi-asserted-by": "crossref", "first-page": "254", "DOI": "10.1111/j.1600-0447.1981.tb00781.x", "volume": "64", "author": "E Ritola", "year": "1981", "unstructured": "Ritola E, Malinen L (1981) A double-blind comparison of carbamazepine and clomethiazole in the treatment of alcohol withdrawal syndrome. Acta Psychiatr Scand 64:254\u2013259", "journal-title": "Acta Psychiatr Scand"}, {"key": "9655_CR193", "doi-asserted-by": "crossref", "first-page": "592", "DOI": "10.1016/j.jemermed.2012.07.056", "volume": "44", "author": "J Rosenson", "year": "2013", "unstructured": "Rosenson J, Clements C, Simon B et al (2013) Phenobarbital for acute alcohol withdrawal: a prospective randomized double-blind placebo-controlled study. J Emerg Med 44:592\u2013598", "journal-title": "J Emerg Med"}, {"key": "9655_CR194", "unstructured": "Rosner S, Hackl-Herrwerth A, Leucht S, Vecchi S, Srisurapanont M, Soyka M (2010) Opioid antagonists for alcohol dependence. Cochrane Database Syst Rev CD001867", "DOI": "10.1002/14651858.CD001867.pub3", "doi-asserted-by": "crossref"}, {"key": "9655_CR195", "doi-asserted-by": "crossref", "first-page": "45S", "DOI": "10.1111/j.1365-2125.1984.tb02581.x", "volume": "18", "author": "T Roth", "year": "1984", "unstructured": "Roth T, Roehrs T, Witig R, Zorick F (1984) Benzodiazepines and emory. Br J Clin Pharmacol 18:45S\u201349S", "journal-title": "Br J Clin Pharmacol"}, {"key": "9655_CR196", "doi-asserted-by": "crossref", "first-page": "37", "DOI": "10.1055/s-2004-815473", "volume": "37", "author": "G Rubio", "year": "2004", "unstructured": "Rubio G, Ponce G, Jimenez-Arriero MA, Palomo T, Manzanares J, Ferre F (2004) Effects of topiramate in the treatment of alcohol dependence. Pharmacopsychiatry 37:37\u201340", "journal-title": "Pharmacopsychiatry"}, {"issue": "9", "key": "9655_CR197", "first-page": "VE01", "volume": "9", "author": "A Sachdeva", "year": "2015", "unstructured": "Sachdeva A, Choudhary M, Chandra M (2015) Alcohol Withdrawal syndrome: benzodiazepines and beyond. J Clin Diagn Res 9(9):VE01\u2013VE07", "journal-title": "J Clin Diagn Res"}, {"key": "9655_CR198", "doi-asserted-by": "crossref", "first-page": "3698", "DOI": "10.1523/JNEUROSCI.4394-15.2016", "volume": "36", "author": "AG Schindler", "year": "2016", "unstructured": "Schindler AG, Soden ME, Zweifel LS, Clark JJ (2016) Reversal of alcohol-induced dysregulation in dopamine network dynamics may rescue maladaptive decision-making. J Neurosci 36:3698\u20133708", "journal-title": "J Neurosci"}, {"key": "9655_CR199", "doi-asserted-by": "crossref", "first-page": "389", "DOI": "10.1177/1060028016629161", "volume": "50", "author": "KJ Schmidt", "year": "2016", "unstructured": "Schmidt KJ, Doshi MR, Holzhausen JM, Natavio A, Cadiz M, Winegardner JE (2016) Treatment of Severe Alcohol Withdrawal. Ann Pharmacother 50:389\u2013401", "journal-title": "Ann Pharmacother"}, {"key": "9655_CR200", "doi-asserted-by": "crossref", "first-page": "2096", "DOI": "10.15288/jsa.1977.38.2096", "volume": "38", "author": "EM Sellers", "year": "1977", "unstructured": "Sellers EM, Zilm DH, Degani NC (1977) Comparative efficacy of propranolol and chlordiazepoxide in alcohol withdrawal. J Stud Alcohol 38:2096\u20132108", "journal-title": "J Stud Alcohol"}, {"key": "9655_CR201", "doi-asserted-by": "crossref", "first-page": "e87366", "DOI": "10.1371/journal.pone.0087366", "volume": "9", "author": "MD Skinner", "year": "2014", "unstructured": "Skinner MD, Lahmek P, Pham H, Aubin HJ (2014) Disulfiram efficacy in the treatment of alcohol dependence: a meta-analysis. PLoS ONE 9:e87366", "journal-title": "PLoS ONE"}, {"key": "9655_CR202", "doi-asserted-by": "crossref", "first-page": "804", "DOI": "10.1007/s00213-004-2118-x", "volume": "179", "author": "M Solinas", "year": "2005", "unstructured": "Solinas M, Goldberg SR (2005) Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats. Psychopharmacology 179:804\u2013812", "journal-title": "Psychopharmacology"}, {"key": "9655_CR203", "doi-asserted-by": "crossref", "first-page": "395", "DOI": "10.1007/s00406-006-0644-8", "volume": "256", "author": "M Soyka", "year": "2006", "unstructured": "Soyka M, Schmidt P, Franz M et al (2006) Treatment of alcohol withdrawal syndrome with a combination of tiapride/carbamazepine: results of a pooled analysis in 540 patients. Eur Arch Psychiatry Clin Neurosci 256:395\u2013401", "journal-title": "Eur Arch Psychiatry Clin Neurosci"}, {"key": "9655_CR204", "doi-asserted-by": "crossref", "first-page": "45", "DOI": "10.1016/0014-2999(96)00175-6", "volume": "305", "author": "R Spanagel", "year": "1996", "unstructured": "Spanagel R, Putzke J, Stefferl A, Schobitz B, Zieglgansberger W (1996) Acamprosate and alcohol: iI. Effects on alcohol withdrawal in the rat. Eur J Pharmacol 305:45\u201350", "journal-title": "Eur J Pharmacol"}, {"key": "9655_CR205", "doi-asserted-by": "crossref", "first-page": "783", "DOI": "10.1038/npp.2013.264", "volume": "39", "author": "R Spanagel", "year": "2014", "unstructured": "Spanagel R, Vengeliene V, Jandeleit B et al (2014) Acamprosate produces its anti-relapse effects via calcium. Neuropsychopharmacology 39:783\u2013791", "journal-title": "Neuropsychopharmacology"}, {"key": "9655_CR206", "doi-asserted-by": "crossref", "first-page": "12518", "DOI": "10.1073/pnas.0705368104", "volume": "104", "author": "P Steensland", "year": "2007", "unstructured": "Steensland P, Simms JA, Holgate J, Richards JK, Bartlett SE (2007) Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking. Proc Natl Acad Sci USA 104:12518\u201312523", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "9655_CR207", "doi-asserted-by": "crossref", "first-page": "961", "DOI": "10.1345/aph.1R751", "volume": "47", "author": "CJ Stock", "year": "2013", "unstructured": "Stock CJ, Carpenter L, Ying J, Greene T (2013) Gabapentin versus chlordiazepoxide for outpatient alcohol detoxification treatment. Ann Pharmacother 47:961\u2013969", "journal-title": "Ann Pharmacother"}, {"key": "9655_CR208", "doi-asserted-by": "crossref", "first-page": "47", "DOI": "10.1007/BF00426599", "volume": "52", "author": "A Sulkowski", "year": "1977", "unstructured": "Sulkowski A, Vachon L, Rich ES Jr (1977) Propranolol effects on acute marihuana intoxication in man. Psychopharmacology 52:47\u201353", "journal-title": "Psychopharmacology"}, {"key": "9655_CR209", "doi-asserted-by": "crossref", "first-page": "1482", "DOI": "10.1056/NEJM199905133401907", "volume": "340", "author": "RM Swift", "year": "1999", "unstructured": "Swift RM (1999) Drug therapy for alcohol dependence. N Engl J Med 340:1482\u20131490", "journal-title": "N Engl J Med"}, {"key": "9655_CR210", "doi-asserted-by": "crossref", "first-page": "94", "DOI": "10.1111/ajad.12346", "volume": "25", "author": "LG Sylvia", "year": "2016", "unstructured": "Sylvia LG, Gold AK, Stange JP et al (2016) Brief report: a randomized, placebo-controlled proof-of-concept trial of adjunctive topiramate for alcohol use disorders in bipolar disorder. Am J Addict 25:94\u201398", "journal-title": "Am J Addict"}, {"key": "9655_CR211", "first-page": "447", "volume": "105", "author": "G Testino", "year": "2014", "unstructured": "Testino G, Leone S, Borro P (2014) Treatment of alcohol dependence: recent progress and reduction of consumption. Minerva Med 105:447\u2013466", "journal-title": "Minerva Med"}, {"key": "9655_CR212", "doi-asserted-by": "crossref", "first-page": "95", "DOI": "10.1016/0149-7634(85)90035-1", "volume": "9", "author": "MH Thi\u00e9bot", "year": "1985", "unstructured": "Thi\u00e9bot MH (1985) Some evidence for amnesic-like effects of benzodiazepines in animals. Neurosci Biobehav Rev 9:95\u2013100", "journal-title": "Neurosci Biobehav Rev"}, {"key": "9655_CR213", "doi-asserted-by": "crossref", "first-page": "1311", "DOI": "10.1136/bmj.318.7194.1311", "volume": "318", "author": "H Tonnesen", "year": "1999", "unstructured": "Tonnesen H, Rosenberg J, Nielsen HJ, Rasmussen V, Hauge C, Pedersen IK, Kehlet H (1999) Effect of preoperative abstinence on poor postoperative outcome in alcohol misusers: randomised controlled trial. BMJ 318:1311\u20131316", "journal-title": "BMJ"}, {"key": "9655_CR214", "doi-asserted-by": "crossref", "first-page": "219", "DOI": "10.1016/0014-2999(81)90217-X", "volume": "70", "author": "FC Tulunay", "year": "1981", "unstructured": "Tulunay FC, Ayhan IH, Portoghese PS, Takemori AE (1981) Antagonism by chlornaltrexamine of some effects of \u03949-tetrahydrocannabinol in rats. Eur J Pharmacol 70:219\u2013224", "journal-title": "Eur J Pharmacol"}, {"key": "9655_CR215", "doi-asserted-by": "crossref", "first-page": "356", "DOI": "10.3109/08039481003686180", "volume": "64", "author": "J Ulrichsen", "year": "2010", "unstructured": "Ulrichsen J, Nielsen MK, Ulrichsen M (2010) Disulfiram in severe alcoholism\u2013an open controlled study. Nord J Psychiatry 64:356\u2013362", "journal-title": "Nord J Psychiatry"}, {"key": "9655_CR216", "doi-asserted-by": "crossref", "first-page": "1178", "DOI": "10.1038/npp.2010.253", "volume": "36", "author": "JC Umhau", "year": "2011", "unstructured": "Umhau JC, Schwandt ML, Usala J, Geyer C, Singley E, George DT, Heilig M (2011) Pharmacologically induced alcohol craving in treatment seeking alcoholics correlates with alcoholism severity, but is insensitive to acamprosate. Neuropsychopharmacology 36:1178\u20131186", "journal-title": "Neuropsychopharmacology"}, {"key": "9655_CR217", "doi-asserted-by": "crossref", "first-page": "2197", "DOI": "10.1016/S0024-3205(97)00922-3", "volume": "61", "author": "IT Uzbay", "year": "1997", "unstructured": "Uzbay IT, Erden BF, Tapanyigit EE, Kayaalp SO (1997) Nitric oxide synthase inhibition attenuates signs of ethanol withdrawal in rats. Life Sci 61:2197\u20132209", "journal-title": "Life Sci"}, {"key": "9655_CR218", "doi-asserted-by": "crossref", "first-page": "299", "DOI": "10.1038/bjp.2008.30", "volume": "154", "author": "V Vengeliene", "year": "2008", "unstructured": "Vengeliene V, Bilbao A, Molander A, Spanagel R (2008) Neuropharmacology of alcohol addiction. Br J Pharmacol 154:299\u2013315", "journal-title": "Br J Pharmacol"}, {"key": "9655_CR219", "doi-asserted-by": "crossref", "first-page": "251", "DOI": "10.1016/S0376-8716(99)00127-1", "volume": "59", "author": "SR Wachtel", "year": "2000", "unstructured": "Wachtel SR, de Wit H (2000) Naltrexone doses not block the subjective effects of oral Delta(9)-tetrahydrocannabinol in humans. Drug Alcohol Depend 59:251\u2013260", "journal-title": "Drug Alcohol Depend"}, {"key": "9655_CR220", "doi-asserted-by": "crossref", "first-page": "91", "DOI": "10.1016/j.alcohol.2007.12.002", "volume": "42", "author": "BM Walker", "year": "2008", "unstructured": "Walker BM, Rasmussen DD, Raskind MA, Koob GF (2008) Alpha1-noradrenergic receptor antagonism blocks dependence-induced increases in responding for ethanol. Alcohol 42:91\u201397", "journal-title": "Alcohol"}, {"key": "9655_CR221", "doi-asserted-by": "crossref", "first-page": "329", "DOI": "10.1007/BF02244856", "volume": "114", "author": "WP Watson", "year": "1994", "unstructured": "Watson WP, Little HJ (1994) Interactions between diltiazem and ethanol: differences from those seen with dihydropyridine calcium channel antagonists. Psychopharmacology 114:329\u2013336", "journal-title": "Psychopharmacology"}, {"key": "9655_CR222", "doi-asserted-by": "crossref", "first-page": "111", "DOI": "10.1016/S0006-8993(02)02236-9", "volume": "930", "author": "WP Watson", "year": "2002", "unstructured": "Watson WP, Little HJ (2002) Selectivity of the protective effects of dihydropyridine calcium channel antagonists against the ethanol withdrawal syndrome. Brain Res 930:111\u2013122", "journal-title": "Brain Res"}, {"key": "9655_CR223", "doi-asserted-by": "crossref", "first-page": "1669", "DOI": "10.1111/j.1476-5381.1991.tb09845.x", "volume": "103", "author": "MA Whittington", "year": "1991", "unstructured": "Whittington MA, Dolin SJ, Patch TL, Siarey RJ, Butterworth AR, Little HJ (1991) Chronic dihydropyridine treatment can reverse the behavioural consequences of and prevent adaptations to, chronic ethanol treatment. Br J Pharmacol 103:1669\u20131676", "journal-title": "Br J Pharmacol"}, {"key": "9655_CR224", "doi-asserted-by": "crossref", "first-page": "357", "DOI": "10.1007/s00702-005-0333-1", "volume": "113", "author": "J Wilhelm", "year": "2006", "unstructured": "Wilhelm J, Bayerlein K, Hillemacher T et al (2006) Short-term cognition deficits during early alcohol withdrawal are associated with elevated plasma homocysteine levels in patients with alcoholism. J Neural Transm 113:357\u2013363", "journal-title": "J Neural Transm"}, {"key": "9655_CR225", "doi-asserted-by": "crossref", "first-page": "115", "DOI": "10.3109/00952999409084061", "volume": "20", "author": "TM Worner", "year": "1994", "unstructured": "Worner TM (1994) Propranolol versus diazepam in the management of the alcohol withdrawal syndrome: double-blind controlled trial. Am J Drug Alcohol Abuse 20:115\u2013124", "journal-title": "Am J Drug Alcohol Abuse"}, {"key": "9655_CR226", "doi-asserted-by": "crossref", "first-page": "572", "DOI": "10.1111/acer.12278", "volume": "38", "author": "A Yoshimura", "year": "2014", "unstructured": "Yoshimura A, Kimura M, Nakayama H et al (2014) Efficacy of disulfiram for the treatment of alcohol dependence assessed with a multicenter randomized controlled trial. Alcohol Clin Exp Res 38:572\u2013578", "journal-title": "Alcohol Clin Exp Res"}, {"key": "9655_CR227", "first-page": "885", "volume": "118", "author": "CW Zwilich", "year": "1978", "unstructured": "Zwilich CW, Doekel R, Hammill S, Weil JV (1978) The effects of smoked marijuana on metabolism and respiratory control. Am Rev Respir Dis 118:885\u2013891", "journal-title": "Am Rev Respir Dis"}], "container-title": ["Neurotoxicity Research"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s12640-016-9655-z.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s12640-016-9655-z/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s12640-016-9655-z.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 24]], "date-time": "2017-06-24T19:43:57Z", "timestamp": 1498333437000}, "score": 18.910501, "issued": {"date-parts": [[2016, 8, 2]]}, "references-count": 225, "journal-issue": {"published-print": {"date-parts": [[2016, 11]]}, "issue": "4"}, "alternative-id": ["9655"], "URL": "http://dx.doi.org/10.1007/s12640-016-9655-z", "relation": {"cites": []}, "ISSN": ["1029-8428", "1476-3524"], "issn-type": [{"value": "1029-8428", "type": "print"}, {"value": "1476-3524", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 9]], "date-time": "2018-05-09T13:02:26Z", "timestamp": 1525870946943}, "reference-count": 41, "publisher": "Wiley", "issue": "2", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 232, "content-version": "tdm"}], "funder": [{"name": "National Science Center", "award": ["DEC-2011/03/N/NZ4/03765"]}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clin Exp Pharmacol Physiol"], "published-print": {"date-parts": [[2015, 2]]}, "DOI": "10.1111/1440-1681.12346", "type": "journal-article", "created": {"date-parts": [[2014, 11, 25]], "date-time": "2014-11-25T13:35:55Z", "timestamp": 1416922555000}, "page": "213-219", "source": "Crossref", "is-referenced-by-count": 7, "title": ["Antinociceptive properties of esculetin in non-inflammatory and inflammatory models of pain in rats"], "prefix": "10.1111", "volume": "42", "author": [{"given": "Przemyslaw", "family": "Rzodkiewicz", "sequence": "first", "affiliation": [{"name": "Department of Biochemistry and Molecular Biology; Institute of Rheumatology; Warsaw Poland"}, {"name": "Department of Pharmacodynamics; Centre for Preclinical Research and Technology; Medical University of Warsaw; Warsaw Poland"}]}, {"given": "Emilia", "family": "Gasinska", "sequence": "additional", "affiliation": [{"name": "Department of Pharmacodynamics; Centre for Preclinical Research and Technology; Medical University of Warsaw; Warsaw Poland"}]}, {"given": "Slawomir", "family": "Maslinski", "sequence": "additional", "affiliation": [{"name": "Department of General and Experimental Pathology; Medical University of Warsaw; Warsaw Poland"}]}, {"given": "Magdalena", "family": "Bujalska-Zadrozny", "sequence": "additional", "affiliation": [{"name": "Department of Pharmacodynamics; Centre for Preclinical Research and Technology; Medical University of Warsaw; Warsaw Poland"}]}], "member": "311", "published-online": {"date-parts": [[2015, 1, 12]]}, "reference": [{"key": "10.1111/1440-1681.12346-BIB0001|cep12346-cit-0001", "doi-asserted-by": "crossref", "first-page": "482", "DOI": "10.1007/s00221-002-1323-2", "article-title": "Contribution of 5- and 12-lipoxygenase products to mechanical hyperalgesia induced by prostaglandin E(2) and epinephrine in the rat", "volume": "148", "author": "Aley", "year": "2003", "journal-title": "Exp. Brain Res."}, {"key": "10.1111/1440-1681.12346-BIB0002|cep12346-cit-0002", "doi-asserted-by": "crossref", "first-page": "263", "DOI": "10.1016/j.molbrainres.2005.02.029", "article-title": "Expression of BLT1 leukotriene B4 receptor on the dorsal root ganglion neurons in mice", "volume": "137", "author": "Andoh", "year": "2005", "journal-title": "Brain Res. Mol. Brain Res."}, {"key": "10.1111/1440-1681.12346-BIB0003|cep12346-cit-0003", "doi-asserted-by": "crossref", "first-page": "5331", "DOI": "10.1073/pnas.83.14.5331", "article-title": "Hyperalgesic properties of 15-lipoxygenase products of arachidonic acid", "volume": "83", "author": "Levine", "year": "1986", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "10.1111/1440-1681.12346-BIB0004|cep12346-cit-0004", "doi-asserted-by": "crossref", "first-page": "433", "DOI": "10.1016/j.pbb.2005.03.015", "article-title": "Differential effect of zileuton, a 5-lipoxygenase inhibitor, against nociceptive paradigms in mice and rats", "volume": "81", "author": "Singh", "year": "2005", "journal-title": "Pharmacol. Biochem. Behav."}, {"key": "10.1111/1440-1681.12346-BIB0005|cep12346-cit-0005", "doi-asserted-by": "crossref", "first-page": "122", "DOI": "10.1189/jlb.0207123", "article-title": "Involvement of LTB4 in zymosan-induced joint nociception in mice: Participation of neutrophils and PGE2", "volume": "83", "author": "Guerrero", "year": "2008", "journal-title": "J. Leukoc. Biol."}, {"key": "10.1111/1440-1681.12346-BIB0006|cep12346-cit-0006", "doi-asserted-by": "crossref", "first-page": "791", "DOI": "10.1016/0090-6980(85)90007-3", "article-title": "Leukotriene B4 produces hyperalgesia in humans", "volume": "30", "author": "Bisgaard", "year": "1985", "journal-title": "Prostaglandins"}, {"key": "10.1111/1440-1681.12346-BIB0007|cep12346-cit-0007", "doi-asserted-by": "crossref", "first-page": "365", "DOI": "10.1111/j.1398-9995.1986.tb00314.x", "article-title": "Chemotactic activity of LTB4 in man", "volume": "41", "author": "Bisgaard", "year": "1986", "journal-title": "Allergy"}, {"key": "10.1111/1440-1681.12346-BIB0008|cep12346-cit-0008", "doi-asserted-by": "crossref", "first-page": "59", "DOI": "10.1016/j.ejphar.2009.06.058", "article-title": "CJ-13610, an orally active inhibitor of 5-lipoxygenase is efficacious in preclinical models of pain", "volume": "617", "author": "Cortes-Burgos", "year": "2009", "journal-title": "Eur. J. Pharmacol."}, {"key": "10.1111/1440-1681.12346-BIB0009|cep12346-cit-0009", "doi-asserted-by": "crossref", "first-page": "501", "DOI": "10.1136/ard.62.6.501", "article-title": "Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs", "volume": "62", "author": "Martel-Pelletier", "year": "2003", "journal-title": "Ann. Rheum. Dis."}, {"key": "10.1111/1440-1681.12346-BIB0010|cep12346-cit-0010", "doi-asserted-by": "crossref", "first-page": "49", "DOI": "10.1016/j.intimp.2008.09.009", "article-title": "Coumarinic derivatives show anti-inflammatory effects on alveolar macrophages, but their anti-elastase activity is essential to reduce lung inflammation in vivo", "volume": "9", "author": "Bissonnette", "year": "2009", "journal-title": "Int. Immunopharmacol."}, {"key": "10.1111/1440-1681.12346-BIB0011|cep12346-cit-0011", "doi-asserted-by": "crossref", "first-page": "130", "DOI": "10.1016/0005-2760(83)90106-6", "article-title": "Inhibitory effect of esculetin on 5-lipoxygenase and leukotriene biosynthesis", "volume": "753", "author": "Neichi", "year": "1983", "journal-title": "Biochim. Biophys. Acta"}, {"key": "10.1111/1440-1681.12346-BIB0012|cep12346-cit-0012", "doi-asserted-by": "crossref", "first-page": "245", "DOI": "10.1530/JME-10-0154", "article-title": "Esculetin induced changes in Mmp13 and Bmp6 gene expression and histone H3 modifications attenuate development of glomerulosclerosis in diabetic rats", "volume": "46", "author": "Surse", "year": "2011", "journal-title": "J. Mol. Endocrinol."}, {"key": "10.1111/1440-1681.12346-BIB0013|cep12346-cit-0013", "doi-asserted-by": "crossref", "first-page": "1247", "DOI": "10.1002/bmc.2686", "article-title": "Determination of the esculetin contents of medicinal plants by liquid chromatography-tandem mass spectrometry", "volume": "26", "author": "Yun", "year": "2012", "journal-title": "Biomed. Chromatogr."}, {"key": "10.1111/1440-1681.12346-BIB0014|cep12346-cit-0014", "doi-asserted-by": "crossref", "first-page": "39", "DOI": "10.1016/0014-2999(93)90090-5", "article-title": "Antiproliferative effect of esculetin on vascular smooth muscle cells: Possible roles of signal transduction pathways", "volume": "237", "author": "Huang", "year": "1993", "journal-title": "Eur. J. Pharmacol."}, {"key": "10.1111/1440-1681.12346-BIB0015|cep12346-cit-0015", "doi-asserted-by": "crossref", "first-page": "467", "DOI": "10.1007/s002040000148", "article-title": "Inhibitory effect of esculetin on oxidative damage induced by t-butyl hydroperoxide in rat liver", "volume": "74", "author": "Lin", "year": "2000", "journal-title": "Arch. Toxicol."}, {"key": "10.1111/1440-1681.12346-BIB0016|cep12346-cit-0016", "doi-asserted-by": "crossref", "first-page": "1897", "DOI": "10.1016/S0006-2952(03)00161-8", "article-title": "Esculetin inhibits Ras-mediated cell proliferation and attenuates vascular restenosis following angioplasty in rats", "volume": "65", "author": "Pan", "year": "2003", "journal-title": "Biochem. Pharmacol."}, {"key": "10.1111/1440-1681.12346-BIB0017|cep12346-cit-0017", "doi-asserted-by": "crossref", "first-page": "1007", "DOI": "10.1111/j.1471-4159.2012.07744.x", "article-title": "A natural coumarin derivative esculetin offers neuroprotection on cerebral ischemia/reperfusion injury in mice", "volume": "121", "author": "Wang", "year": "2012", "journal-title": "J. Neurochem."}, {"key": "10.1111/1440-1681.12346-BIB0018|cep12346-cit-0018", "doi-asserted-by": "crossref", "first-page": "25", "DOI": "10.1016/S0014-2999(01)00859-7", "article-title": "Induction of apoptosis by esculetin in human leukemia cells", "volume": "416", "author": "Chu", "year": "2001", "journal-title": "Eur. J. Pharmacol."}, {"key": "10.1111/1440-1681.12346-BIB0019|cep12346-cit-0019", "doi-asserted-by": "crossref", "first-page": "453", "DOI": "10.1002/jnr.23164", "article-title": "Neuroprotective effects of umbelliferone and esculetin in a mouse model of Parkinson's disease", "volume": "91", "author": "Subramaniam", "year": "2013", "journal-title": "J. Neurosci. Res."}, {"key": "10.1111/1440-1681.12346-BIB0020|cep12346-cit-0020", "doi-asserted-by": "crossref", "first-page": "297", "DOI": "10.1016/S0014-2999(99)00143-0", "article-title": "Esculetin suppresses proteoglycan metabolism by inhibiting the production of matrix metalloproteinases in rabbit chondrocytes", "volume": "370", "author": "Watanabe", "year": "1999", "journal-title": "Eur. J. Pharmacol."}, {"key": "10.1111/1440-1681.12346-BIB0021|cep12346-cit-0021", "doi-asserted-by": "crossref", "first-page": "503", "DOI": "10.3109/03602539008991449", "article-title": "The pharmacology, metabolism, analysis, and applications of coumarin and coumarin-related compounds", "volume": "22", "author": "Egan", "year": "1990", "journal-title": "Drug Metab. Rev."}, {"key": "10.1111/1440-1681.12346-BIB0022|cep12346-cit-0022", "doi-asserted-by": "crossref", "first-page": "1385", "DOI": "10.1248/cpb.43.1385", "article-title": "Search for naturally occurring substances to prevent the complications of diabetes. II. Inhibitory effect of coumarin and flavonoid derivatives on bovine lens aldose reductase and rabbit platelet aggregation", "volume": "43", "author": "Okada", "year": "1995", "journal-title": "Chem. Pharm. Bull."}, {"key": "10.1111/1440-1681.12346-BIB0023|cep12346-cit-0023", "doi-asserted-by": "crossref", "first-page": "107", "DOI": "10.1211/jpp.58.1.0013", "article-title": "Antinociceptive properties of coumarins, steroid and dihydrostyryl-2-pyrones from Polygala sabulosa (Polygalaceae) in mice", "volume": "58", "author": "Meotti", "year": "2006", "journal-title": "J. Pharm. Pharmacol."}, {"key": "10.1111/1440-1681.12346-BIB0024|cep12346-cit-0024", "doi-asserted-by": "crossref", "first-page": "925", "DOI": "10.1248/bpb.b12-00905", "article-title": "Antinociceptive profiles and mechanisms of orally administered coumarin in mice", "volume": "36", "author": "Park", "year": "2013", "journal-title": "Biol. Pharm. Bull."}, {"key": "10.1111/1440-1681.12346-BIB0025|cep12346-cit-0025", "doi-asserted-by": "crossref", "first-page": "2013", "DOI": "10.1016/S0960-894X(00)00370-X", "article-title": "5-HETE congeners as modulators of cell proliferation", "volume": "10", "author": "Miller", "year": "2000", "journal-title": "Bioorg. Med. Chem. Lett."}, {"key": "10.1111/1440-1681.12346-BIB0026|cep12346-cit-0026", "doi-asserted-by": "crossref", "first-page": "154", "DOI": "10.1016/j.plipres.2005.04.002", "article-title": "Biochemistry, biology and chemistry of the 5-lipoxygenase product 5-oxo-ETE", "volume": "44", "author": "Powell", "year": "2005", "journal-title": "Prog. Lipid Res."}, {"key": "10.1111/1440-1681.12346-BIB0027|cep12346-cit-0027", "doi-asserted-by": "crossref", "first-page": "824", "DOI": "10.1189/jlb.0907654", "article-title": "Crucial role of neutrophils in the development of mechanical inflammatory hypernociception", "volume": "83", "author": "Cunha", "year": "2008", "journal-title": "J. Leukoc. Biol."}, {"key": "10.1111/1440-1681.12346-BIB0028|cep12346-cit-0028", "doi-asserted-by": "crossref", "first-page": "81", "DOI": "10.1016/j.ejphar.2004.06.025", "article-title": "Blockade of leukotriene B4 prevents articular incapacitation in rat zymosan-induced arthritis", "volume": "497", "author": "Rocha", "year": "2004", "journal-title": "Eur. J. Pharmacol."}, {"key": "10.1111/1440-1681.12346-BIB0029|cep12346-cit-0029", "first-page": "3007", "article-title": "Inside the neutrophil phagosome: Oxidants, myeloperoxidase, and bacterial killing", "volume": "92", "author": "Hampton", "year": "1998", "journal-title": "Blood"}, {"key": "10.1111/1440-1681.12346-BIB0030|cep12346-cit-0030", "doi-asserted-by": "crossref", "first-page": "85", "DOI": "10.1016/S0014-2999(01)01083-4", "article-title": "Role of cysteinyl leukotrienes in nociceptive and inflammatory conditions in experimental animals", "volume": "423", "author": "Jain", "year": "2001", "journal-title": "Eur. J. Pharmacol."}, {"key": "10.1111/1440-1681.12346-BIB0031|cep12346-cit-0031", "doi-asserted-by": "crossref", "first-page": "472", "DOI": "10.1016/S0736-0266(00)90032-9", "article-title": "Roles of thromboxane A2 and leukotriene B4 in radicular pain induced by herniated nucleus pulposus", "volume": "19", "author": "Kawakami", "year": "2001", "journal-title": "J. Orthop. Res."}, {"key": "10.1111/1440-1681.12346-BIB0032|cep12346-cit-0032", "doi-asserted-by": "crossref", "first-page": "21", "DOI": "10.1016/j.ejphar.2004.03.022", "article-title": "Involvement of spinal lipoxygenase metabolites in hyperalgesia and opioid tolerance", "volume": "491", "author": "Trang", "year": "2004", "journal-title": "Eur. J. Pharmacol."}, {"key": "10.1111/1440-1681.12346-BIB0033|cep12346-cit-0033", "doi-asserted-by": "crossref", "first-page": "743", "DOI": "10.1126/science.6087456", "article-title": "Leukotriene B4 produces hyperalgesia that is dependent on polymorphonuclear leukocytes", "volume": "225", "author": "Levine", "year": "1984", "journal-title": "Science"}, {"key": "10.1111/1440-1681.12346-BIB0034|cep12346-cit-0034", "doi-asserted-by": "crossref", "first-page": "81", "DOI": "10.1016/S0304-3959(99)00035-4", "article-title": "Tumour necrosis factor-alpha mediates carrageenin-induced knee-joint incapacitation and also triggers overt nociception in previously inflamed rat knee-joints", "volume": "82", "author": "Tonussi", "year": "1999", "journal-title": "Pain"}, {"key": "10.1111/1440-1681.12346-BIB0035|cep12346-cit-0035", "doi-asserted-by": "crossref", "first-page": "294", "DOI": "10.1124/jpet.110.166967", "article-title": "Pharmacology of PF-4191834, a novel, selective non-redox 5-lipoxygenase inhibitor effective in inflammation and pain", "volume": "334", "author": "Masferrer", "year": "2010", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10.1111/1440-1681.12346-BIB0036|cep12346-cit-0036", "doi-asserted-by": "crossref", "first-page": "596", "DOI": "10.1021/np100621c", "article-title": "Mechanisms involved in the antinociceptive effects of 7-hydroxycoumarin", "volume": "74", "author": "Lima", "year": "2011", "journal-title": "J. Nat. Prod."}, {"key": "10.1111/1440-1681.12346-BIB0037|cep12346-cit-0037", "doi-asserted-by": "crossref", "first-page": "31", "DOI": "10.1006/phrs.1997.0262", "article-title": "Esculetin prevents liver damage induced by paracetamol and CCL4", "volume": "37", "author": "Gilani", "year": "1998", "journal-title": "Pharmacol. Res."}, {"key": "10.1111/1440-1681.12346-BIB0038|cep12346-cit-0038", "doi-asserted-by": "crossref", "first-page": "41", "DOI": "10.1016/j.pbb.2009.12.004", "article-title": "H4 receptor antagonism exhibits anti-nociceptive effects in inflammatory and neuropathic pain models in rats", "volume": "95", "author": "Hsieh", "year": "2010", "journal-title": "Pharmacol. Biochem. Behav."}, {"key": "10.1111/1440-1681.12346-BIB0039|cep12346-cit-0039", "first-page": "409", "article-title": "A method for measurement of analgesic activity on inflamed tissue", "volume": "111", "author": "Randall", "year": "1957", "journal-title": "Arch. Int. Pharmacodyn. Ther."}, {"key": "10.1111/1440-1681.12346-BIB0040|cep12346-cit-0040", "first-page": "9", "article-title": "Models of nociception: Hot-plate, tail-flick, and formalin tests in rodents", "volume": "8", "author": "Bannon", "year": "2007", "journal-title": "Curr. Protoc. Neurosci."}, {"key": "10.1111/1440-1681.12346-BIB0041|cep12346-cit-0041", "doi-asserted-by": "crossref", "first-page": "77", "DOI": "10.1016/0304-3959(88)90026-7", "article-title": "A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia", "volume": "32", "author": "Hargreaves", "year": "1988", "journal-title": "Pain"}], "container-title": ["Clinical and Experimental Pharmacology and Physiology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2F1440-1681.12346", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2F1440-1681.12346", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://onlinelibrary.wiley.com/wol1/doi/10.1111/1440-1681.12346/fullpdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 23]], "date-time": "2017-06-23T00:53:51Z", "timestamp": 1498179231000}, "score": 18.910501, "issued": {"date-parts": [[2015, 1, 12]]}, "references-count": 41, "journal-issue": {"published-print": {"date-parts": [[2015, 2]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.1111/1440-1681.12346", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["0305-1870"], "issn-type": [{"value": "0305-1870", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 4, 17]], "date-time": "2018-04-17T09:26:30Z", "timestamp": 1523957190619}, "reference-count": 0, "publisher": "Bentham Science Publishers Ltd.", "issue": "8", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["CTMC"], "published-print": {"date-parts": [[2017, 1, 26]]}, "DOI": "10.2174/1568026616666160818152257", "type": "journal-article", "created": {"date-parts": [[2016, 8, 23]], "date-time": "2016-08-23T06:46:37Z", "timestamp": 1471934797000}, "page": "875-894", "source": "Crossref", "is-referenced-by-count": 0, "title": ["The Discovery and Development of Drug Combinations for the Treatment of Various Diseases from Patent Literature (1980-Present)"], "prefix": "10.2174", "volume": "17", "author": [{"given": "Patrycja", "family": "Kleczkowska", "sequence": "first", "affiliation": []}, {"given": "Agnieszka", "family": "Kowalczyk", "sequence": "additional", "affiliation": []}, {"given": "Anna", "family": "Lesniak", "sequence": "additional", "affiliation": []}, {"given": "Magdalena", "family": "Bujalska-Zadrozny", "sequence": "additional", "affiliation": []}], "member": "965", "container-title": ["Current Topics in Medicinal Chemistry"], "language": "en", "link": [{"URL": "http://eurekaselect.com/article/download/144925", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 2, 22]], "date-time": "2017-02-22T19:22:42Z", "timestamp": 1487791362000}, "score": 18.910501, "issued": {"date-parts": [[2017, 1, 26]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2017, 1, 26]]}, "issue": "8"}, "alternative-id": ["LiveAll1"], "URL": "http://dx.doi.org/10.2174/1568026616666160818152257", "ISSN": ["1568-0266"], "issn-type": [{"value": "1568-0266", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 5, 2]], "date-time": "2018-05-02T20:14:07Z", "timestamp": 1525292047787}, "reference-count": 0, "publisher": "S. Karger AG", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Pharmacology"], "published-print": {"date-parts": [[2010]]}, "DOI": "10.1159/000268105", "type": "journal-article", "created": {"date-parts": [[2009, 12, 21]], "date-time": "2009-12-21T09:19:52Z", "timestamp": 1261387192000}, "page": "48-53", "source": "Crossref", "is-referenced-by-count": 6, "title": ["Modification of Fentanyl Analgesia by Antidepressants"], "prefix": "10.1159", "volume": "85", "author": [{"given": "Anna", "family": "Ju\u015b", "sequence": "first", "affiliation": []}, {"given": "Magdalena", "family": "Bujalska", "sequence": "additional", "affiliation": []}, {"given": "Helena E.", "family": "Makulska-Nowak", "sequence": "additional", "affiliation": []}], "member": "127", "container-title": ["Pharmacology"], "language": "en", "link": [{"URL": "http://www.karger.com/Article/Pdf/268105", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 10, 25]], "date-time": "2017-10-25T19:58:52Z", "timestamp": 1508961532000}, "score": 18.910501, "issued": {"date-parts": [[2010]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2010]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.1159/000268105", "ISSN": ["1423-0313", "0031-7012"], "issn-type": [{"value": "0031-7012", "type": "print"}, {"value": "1423-0313", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 9, 29]], "date-time": "2018-09-29T20:41:12Z", "timestamp": 1538253672264}, "reference-count": 47, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2015, 4, 1]], "date-time": "2015-04-01T00:00:00Z", "timestamp": 1427846400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Pharmacological Reports"], "published-print": {"date-parts": [[2015, 4]]}, "DOI": "10.1016/j.pharep.2014.08.023", "type": "journal-article", "created": {"date-parts": [[2014, 9, 16]], "date-time": "2014-09-16T06:33:07Z", "timestamp": 1410849187000}, "page": "209-216", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 8, "title": ["Influence of nitric oxide synthase or cyclooxygenase inhibitors on cannabinoids activity in streptozotocin-induced neuropathy"], "prefix": "10.1016", "volume": "67", "author": [{"given": "Magdalena", "family": "Bujalska-Zadro\u017cny", "sequence": "first", "affiliation": []}, {"given": "Anna", "family": "de Cord\u00e9", "sequence": "additional", "affiliation": []}, {"given": "Karolina", "family": "Pawlik", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Pharmacological Reports"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1734114014002849?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1734114014002849?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 9, 29]], "date-time": "2018-09-29T20:21:39Z", "timestamp": 1538252499000}, "score": 18.910501, "issued": {"date-parts": [[2015, 4]]}, "references-count": 47, "journal-issue": {"published-print": {"date-parts": [[2015, 4]]}, "issue": "2"}, "alternative-id": ["S1734114014002849"], "URL": "http://dx.doi.org/10.1016/j.pharep.2014.08.023", "ISSN": ["1734-1140"], "issn-type": [{"value": "1734-1140", "type": "print"}], "subject": ["Pharmacology", "General Medicine"], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Influence of nitric oxide synthase or cyclooxygenase inhibitors on cannabinoids activity in streptozotocin-induced neuropathy", "name": "articletitle", "label": "Article Title"}, {"value": "Pharmacological Reports", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.pharep.2014.08.023", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "Copyright \u00a9 2014 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2018, 5, 9]], "date-time": "2018-05-09T01:28:33Z", "timestamp": 1525829313698}, "reference-count": 48, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "7", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Behavioural Pharmacology"], "published-print": {"date-parts": [[2016, 10]]}, "DOI": "10.1097/fbp.0000000000000255", "type": "journal-article", "created": {"date-parts": [[2016, 8, 9]], "date-time": "2016-08-09T17:00:53Z", "timestamp": 1470762053000}, "page": "606-614", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Central antinociceptive effect of tapentadol is increased by nitric oxide synthase inhibitors"], "prefix": "10.1097", "volume": "27", "author": [{"given": "Magdalena", "family": "Bujalska-Zadro\u017cny", "sequence": "first", "affiliation": []}, {"given": "Renata", "family": "Woli\u0144ska", "sequence": "additional", "affiliation": []}, {"given": "Anna", "family": "Le\u015bniak", "sequence": "additional", "affiliation": []}, {"given": "Mariusz", "family": "Sacharczuk", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Behavioural Pharmacology"], "language": "en", "deposited": {"date-parts": [[2017, 6, 24]], "date-time": "2017-06-24T20:17:56Z", "timestamp": 1498335476000}, "score": 18.910501, "subtitle": [""], "issued": {"date-parts": [[2016, 10]]}, "references-count": 48, "journal-issue": {"issue": "7"}, "URL": "http://dx.doi.org/10.1097/fbp.0000000000000255", "ISSN": ["0955-8810"], "issn-type": [{"value": "0955-8810", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 8, 27]], "date-time": "2018-08-27T10:22:35Z", "timestamp": 1535365355020}, "reference-count": 40, "publisher": "S. Karger AG", "issue": "2", "license": [{"URL": "https://www.karger.com/Services/SiteLicenses", "start": {"date-parts": [[2007, 11, 7]], "date-time": "2007-11-07T00:00:00Z", "timestamp": 1194393600000}, "delay-in-days": 0, "content-version": "vor"}, {"URL": "https://www.karger.com/Services/SiteLicenses", "start": {"date-parts": [[2007, 11, 7]], "date-time": "2007-11-07T00:00:00Z", "timestamp": 1194393600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Pharmacology"], "published-print": {"date-parts": [[2008]]}, "DOI": "10.1159/000110787", "type": "journal-article", "created": {"date-parts": [[2007, 11, 7]], "date-time": "2007-11-07T10:12:54Z", "timestamp": 1194430374000}, "page": "151-157", "source": "Crossref", "is-referenced-by-count": 19, "title": ["Effect of Cyclooxygenase and Nitric Oxide Synthase Inhibitors on Streptozotocin-Induced Hyperalgesia in Rats"], "prefix": "10.1159", "volume": "81", "author": [{"given": "Magdalena", "family": "Bujalska", "sequence": "first", "affiliation": []}, {"given": "Jan", "family": "Tatarkiewicz", "sequence": "additional", "affiliation": []}, {"given": "Anna", "family": "de Cord\u00e9", "sequence": "additional", "affiliation": []}, {"given": "Stanis\u0142aw Witold", "family": "Gumu\u0142ka", "sequence": "additional", "affiliation": []}], "member": "127", "published-online": {"date-parts": [[2007, 11, 7]]}, "reference": [{"key": "sref_1_47", "author": "Holzer SE", "volume": "20", "first-page": "169", "year": "1998", "journal-title": "Clin Ther"}, {"key": "sref_2_48", "author": "Caputo GM", "volume": "331", "first-page": "854", "year": "1994", "journal-title": "N Engl J Med"}, {"key": "sref_3_49", "author": "Dyck PJ", "volume": "23", "first-page": "510", "year": "2000", "journal-title": "Diabetes Care"}, {"key": "sref_4_50", "author": "Dobretsov M", "volume": "960", "first-page": "174", "year": "2003", "journal-title": "Brain Res"}, {"key": "sref_5_51", "author": "Romanovsky D", "volume": "9", "first-page": "62", "year": "2004", "journal-title": "J Peripher Nerv Syst"}, {"key": "sref_6_52", "author": "Gabra BH", "volume": "64", "first-page": "782", "year": "2005", "journal-title": "J Neuropathol Exp Neurol"}, {"key": "sref_7_53", "author": "Hong S", "volume": "280", "first-page": "618", "year": "2005", "journal-title": "J Biol Chem", "DOI": "10.1074/jbc.M408500200", "doi-asserted-by": "crossref"}, {"key": "sref_8_54", "author": "Hong S", "volume": "279", "first-page": "29341", "year": "2004", "journal-title": "J Biol Chem"}, {"key": "sref_9_55", "author": "Suzuki Y", "volume": "43", "first-page": "171", "year": "2002", "journal-title": "Neurosci Res"}, {"key": "sref_10_56", "author": "Cellek S", "volume": "47", "first-page": "331", "year": "2004", "journal-title": "Diabetologia"}, {"key": "sref_11_57", "author": "Cellek S", "volume": "54", "first-page": "212", "year": "2005", "journal-title": "Diabetes"}, {"key": "sref_12_58", "author": "Cellek S", "volume": "10", "first-page": "3683", "year": "2004", "journal-title": "Curr Pharm Des"}, {"key": "sref_13_59", "author": "Bujalska M", "volume": "53", "first-page": "341", "year": "2001", "journal-title": "Pol J Pharmacol"}, {"key": "sref_14_60", "author": "Nakhoda A", "volume": "35", "first-page": "1679", "year": "1979", "journal-title": "Experientia"}, {"key": "sref_15_61", "author": "Randall LO", "volume": "111", "first-page": "409", "year": "1957", "journal-title": "Arch Int Pharmacodyn Ther"}, {"key": "sref_16_62", "unstructured": "Tallarida RJ, Murray RB: Manual of Pharmacologic Calculation with Computer Programs, ed 2. New York, Springer, 1986, pp 113-117."}, {"key": "sref_17_63", "author": "Fox A", "volume": "81", "first-page": "307", "year": "1999", "journal-title": "Pain"}, {"key": "sref_18_64", "author": "Aley KO", "volume": "111", "first-page": "389", "year": "2002", "journal-title": "Neuroscience"}, {"key": "sref_19_65", "author": "Freshwater JD", "volume": "51", "first-page": "2249", "year": "2002", "journal-title": "Diabetes"}, {"key": "sref_20_66", "author": "Liu J", "volume": "54", "first-page": "379", "year": "2002", "journal-title": "Sheng Li Xue Bao"}, {"key": "sref_21_67", "author": "Liu J", "volume": "48", "first-page": "536", "year": "1996", "journal-title": "Sheng Li Xue Bao"}, {"key": "sref_22_68", "author": "Matsunaga A", "volume": "554", "first-page": "12", "year": "2007", "journal-title": "Eur J Pharmacol"}, {"key": "sref_23_69", "author": "Kellogg AP", "volume": "7", "first-page": "1521", "year": "2005", "journal-title": "Antioxid Redox Signal"}, {"key": "sref_24_70", "author": "Ahlgren SC", "volume": "52", "first-page": "1049", "year": "1993", "journal-title": "Neuroscience"}, {"key": "sref_25_71", "author": "Fang C", "volume": "56", "first-page": "157", "year": "1997", "journal-title": "Prostaglandins Leukot Essent Fatty Acids"}, {"key": "sref_26_72", "author": "Attal N", "volume": "13", "first-page": "1153", "year": "2006", "journal-title": "Eur J Neurol"}, {"key": "sref_27_73", "author": "Gilron I", "volume": "175", "first-page": "265", "year": "2006", "journal-title": "CMAJ", "DOI": "10.1503/cmaj.060146", "doi-asserted-by": "crossref"}, {"key": "sref_28_74", "author": "Namaka M", "volume": "26", "first-page": "951", "year": "2004", "journal-title": "Clin Ther"}, {"key": "sref_29_75", "author": "Negus SS", "volume": "319", "first-page": "507", "year": "2006", "journal-title": "J Pharmacol Exp Ther"}, {"key": "sref_30_76", "author": "Timar-Peregrin A", "volume": "414", "first-page": "63", "year": "2001", "journal-title": "Eur J Pharmacol"}, {"key": "sref_31_77", "author": "Cameron NE", "volume": "31", "first-page": "125", "year": "2001", "journal-title": "Free Radic Biol Med"}, {"key": "sref_32_78", "DOI": "10.1002/(SICI)1096-9136(199704)14:4<284::AID-DIA348>3.0.CO;2-0", "doi-asserted-by": "publisher"}, {"key": "sref_33_79", "DOI": "10.1159/000080104", "doi-asserted-by": "publisher"}, {"key": "sref_34_80", "author": "Kim H", "volume": "52", "first-page": "2102", "year": "2003", "journal-title": "Diabetes"}, {"key": "sref_35_81", "DOI": "10.1016/S0006-8993(00)02235-6", "doi-asserted-by": "publisher"}, {"key": "sref_36_82", "author": "Sasaki T", "volume": "9", "first-page": "243", "year": "1998", "journal-title": "Neuroreport"}, {"key": "sref_37_83", "DOI": "10.1016/0014-2999(94)90377-8", "doi-asserted-by": "publisher"}, {"key": "sref_38_84", "author": "Thomsen K", "volume": "543", "first-page": "977", "year": "2002", "journal-title": "J Physiol"}, {"key": "sref_39_85", "author": "Joseph EK", "volume": "120", "first-page": "907", "year": "2003", "journal-title": "Neuroscience"}, {"key": "sref_40_86", "author": "Gabra BH", "volume": "53", "first-page": "653", "year": "2004", "journal-title": "Inflamm Res"}], "container-title": ["Pharmacology"], "language": "en", "link": [{"URL": "https://www.karger.com/Article/Pdf/110787", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://www.karger.com/Article/Pdf/110787", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 11, 8]], "date-time": "2017-11-08T23:10:43Z", "timestamp": 1510182643000}, "score": 18.910501, "issued": {"date-parts": [[2007, 11, 7]]}, "references-count": 40, "journal-issue": {"published-online": {"date-parts": [[2008, 1, 1]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.1159/000110787", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["0031-7012", "1423-0313"], "issn-type": [{"value": "0031-7012", "type": "print"}, {"value": "1423-0313", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 10, 6]], "date-time": "2018-10-06T14:10:18Z", "timestamp": 1538835018146}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2012, 3, 1]], "date-time": "2012-03-01T00:00:00Z", "timestamp": 1330560000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Pharmacological Reports"], "published-print": {"date-parts": [[2012, 3]]}, "DOI": "10.1016/s1734-1140(12)70844-7", "type": "journal-article", "created": {"date-parts": [[2014, 2, 19]], "date-time": "2014-02-19T22:27:44Z", "timestamp": 1392848864000}, "page": "506", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Dose-finding studies of orally-administered DHEA on the pain threshold. Attempt to explain its antinociceptive effect"], "prefix": "10.1016", "volume": "64", "author": [{"given": "Trzaska", "family": "Emilia", "sequence": "first", "affiliation": []}, {"given": "Bujalska-Zadro\u017cny", "family": "Magdalena", "sequence": "additional", "affiliation": []}, {"given": "Makulska-Nowak", "family": "Helena", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Pharmacological Reports"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1734114012708447?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1734114012708447?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 10, 6]], "date-time": "2018-10-06T13:55:25Z", "timestamp": 1538834125000}, "score": 18.910501, "issued": {"date-parts": [[2012, 3]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2012, 3]]}, "issue": "2"}, "alternative-id": ["S1734114012708447"], "URL": "http://dx.doi.org/10.1016/s1734-1140(12)70844-7", "ISSN": ["1734-1140"], "issn-type": [{"value": "1734-1140", "type": "print"}], "subject": ["Pharmacology", "General Medicine"]}, {"indexed": {"date-parts": [[2018, 10, 6]], "date-time": "2018-10-06T14:10:27Z", "timestamp": 1538835027758}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2010, 9, 1]], "date-time": "2010-09-01T00:00:00Z", "timestamp": 1283299200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Pharmacological Reports"], "published-print": {"date-parts": [[2010, 9]]}, "DOI": "10.1016/s1734-1140(10)71185-3", "type": "journal-article", "created": {"date-parts": [[2014, 2, 19]], "date-time": "2014-02-19T22:19:04Z", "timestamp": 1392848344000}, "page": "75", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Magnesium ions and opioid analgesia in diabetic-induced neuropathy"], "prefix": "10.1016", "volume": "62", "author": [{"given": "Magdalena", "family": "Bujalska-Zadro\u017cny", "sequence": "first", "affiliation": []}, {"given": "Kamila", "family": "Duda", "sequence": "additional", "affiliation": []}, {"given": "Helena E.", "family": "Makulska-Nowak", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Pharmacological Reports"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1734114010711853?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1734114010711853?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 10, 6]], "date-time": "2018-10-06T13:57:56Z", "timestamp": 1538834276000}, "score": 18.910501, "issued": {"date-parts": [[2010, 9]]}, "references-count": 0, "alternative-id": ["S1734114010711853"], "URL": "http://dx.doi.org/10.1016/s1734-1140(10)71185-3", "ISSN": ["1734-1140"], "issn-type": [{"value": "1734-1140", "type": "print"}], "subject": ["Pharmacology", "General Medicine"]}, {"indexed": {"date-parts": [[2018, 10, 6]], "date-time": "2018-10-06T14:40:18Z", "timestamp": 1538836818818}, "reference-count": 21, "publisher": "Elsevier BV", "issue": "4", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2012, 7, 1]], "date-time": "2012-07-01T00:00:00Z", "timestamp": 1341100800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Pharmacological Reports"], "published-print": {"date-parts": [[2012, 7]]}, "DOI": "10.1016/s1734-1140(12)70892-7", "type": "journal-article", "created": {"date-parts": [[2014, 2, 19]], "date-time": "2014-02-19T22:13:07Z", "timestamp": 1392847987000}, "page": "965-969", "source": "Crossref", "is-referenced-by-count": 3, "title": ["Influence of acute and subchronic oral administration of dehydroepiandrosterone (DHEA) on nociceptive threshold in rats"], "prefix": "10.1016", "volume": "64", "author": [{"given": "Emilia", "family": "G\u0105si\u0144ska", "sequence": "first", "affiliation": []}, {"given": "Magdalena", "family": "Bujalska-Zadro\u017cny", "sequence": "additional", "affiliation": []}, {"given": "Monika", "family": "Sar", "sequence": "additional", "affiliation": []}, {"given": "Helena", "family": "Makulska-Nowak", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Pharmacological Reports"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1734114012708927?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1734114012708927?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 10, 6]], "date-time": "2018-10-06T13:59:24Z", "timestamp": 1538834364000}, "score": 18.910501, "issued": {"date-parts": [[2012, 7]]}, "references-count": 21, "journal-issue": {"published-print": {"date-parts": [[2012, 7]]}, "issue": "4"}, "alternative-id": ["S1734114012708927"], "URL": "http://dx.doi.org/10.1016/s1734-1140(12)70892-7", "ISSN": ["1734-1140"], "issn-type": [{"value": "1734-1140", "type": "print"}], "subject": ["Pharmacology", "General Medicine"]}, {"indexed": {"date-parts": [[2018, 10, 6]], "date-time": "2018-10-06T14:40:23Z", "timestamp": 1538836823553}, "reference-count": 30, "publisher": "Elsevier BV", "issue": "6", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2009, 11, 1]], "date-time": "2009-11-01T00:00:00Z", "timestamp": 1257033600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Pharmacological Reports"], "published-print": {"date-parts": [[2009, 11]]}, "DOI": "10.1016/s1734-1140(09)70172-0", "type": "journal-article", "created": {"date-parts": [[2014, 2, 19]], "date-time": "2014-02-19T22:02:17Z", "timestamp": 1392847337000}, "page": "1096-1104", "source": "Crossref", "is-referenced-by-count": 11, "title": ["Magnesium ions and opioid agonists in vincristine-induced neuropathy"], "prefix": "10.1016", "volume": "61", "author": [{"given": "Magdalena", "family": "Bujalska.", "sequence": "first", "affiliation": []}, {"given": "Helena", "family": "Makulska-Nowak.", "sequence": "additional", "affiliation": []}, {"given": "Stanis\u0142aw", "family": "W. Gumu\u0142ka", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Pharmacological Reports"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1734114009701720?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1734114009701720?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 10, 6]], "date-time": "2018-10-06T14:22:33Z", "timestamp": 1538835753000}, "score": 18.910501, "issued": {"date-parts": [[2009, 11]]}, "references-count": 30, "journal-issue": {"published-print": {"date-parts": [[2009, 11]]}, "issue": "6"}, "alternative-id": ["S1734114009701720"], "URL": "http://dx.doi.org/10.1016/s1734-1140(09)70172-0", "ISSN": ["1734-1140"], "issn-type": [{"value": "1734-1140", "type": "print"}], "subject": ["Pharmacology", "General Medicine"]}, {"indexed": {"date-parts": [[2018, 10, 6]], "date-time": "2018-10-06T14:40:30Z", "timestamp": 1538836830572}, "reference-count": 29, "publisher": "Elsevier BV", "issue": "5", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2012, 9, 1]], "date-time": "2012-09-01T00:00:00Z", "timestamp": 1346457600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Pharmacological Reports"], "published-print": {"date-parts": [[2012, 9]]}, "DOI": "10.1016/s1734-1140(12)70923-4", "type": "journal-article", "created": {"date-parts": [[2014, 2, 19]], "date-time": "2014-02-19T22:14:23Z", "timestamp": 1392848063000}, "page": "1267-1275", "source": "Crossref", "is-referenced-by-count": 8, "title": ["Modification of morphine analgesia by venlafaxine in diabetic neuropathic pain model"], "prefix": "10.1016", "volume": "64", "author": [{"given": "Krystyna", "family": "Cegielska-Perun", "sequence": "first", "affiliation": []}, {"given": "Magdalena", "family": "Bujalska-Zadro\u017cny", "sequence": "additional", "affiliation": []}, {"given": "Helena E.", "family": "Makulska-Nowak", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Pharmacological Reports"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1734114012709234?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1734114012709234?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 10, 6]], "date-time": "2018-10-06T13:59:16Z", "timestamp": 1538834356000}, "score": 18.910501, "issued": {"date-parts": [[2012, 9]]}, "references-count": 29, "journal-issue": {"published-print": {"date-parts": [[2012, 9]]}, "issue": "5"}, "alternative-id": ["S1734114012709234"], "URL": "http://dx.doi.org/10.1016/s1734-1140(12)70923-4", "ISSN": ["1734-1140"], "issn-type": [{"value": "1734-1140", "type": "print"}], "subject": ["Pharmacology", "General Medicine"]}, {"indexed": {"date-parts": [[2018, 11, 28]], "date-time": "2018-11-28T15:41:09Z", "timestamp": 1543419669786}, "reference-count": 182, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2018, 11, 1]], "date-time": "2018-11-01T00:00:00Z", "timestamp": 1541030400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Pharmacology & Therapeutics"], "published-print": {"date-parts": [[2018, 11]]}, "DOI": "10.1016/j.pharmthera.2018.11.007", "type": "journal-article", "created": {"date-parts": [[2018, 11, 20]], "date-time": "2018-11-20T16:57:43Z", "timestamp": 1542733063000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Neurokinin-1 receptor-based bivalent drugs in pain management: The journey to nowhere?"], "prefix": "10.1016", "author": [{"given": "Patrycja", "family": "Kleczkowska", "sequence": "first", "affiliation": []}, {"given": "Katarzyna", "family": "Nowicka", "sequence": "additional", "affiliation": []}, {"given": "Magdalena", "family": "Bujalska-Zadrozny", "sequence": "additional", "affiliation": []}, {"given": "Emmanuel", "family": "Hermans", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Pharmacology & Therapeutics"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0163725818302109?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0163725818302109?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 11, 28]], "date-time": "2018-11-28T15:08:06Z", "timestamp": 1543417686000}, "score": 18.910501, "issued": {"date-parts": [[2018, 11]]}, "references-count": 182, "alternative-id": ["S0163725818302109"], "URL": "http://dx.doi.org/10.1016/j.pharmthera.2018.11.007", "ISSN": ["0163-7258"], "issn-type": [{"value": "0163-7258", "type": "print"}], "subject": ["Pharmacology (medical)", "Pharmacology"]}, {"indexed": {"date-parts": [[2018, 5, 8]], "date-time": "2018-05-08T10:29:25Z", "timestamp": 1525775365089}, "reference-count": 0, "publisher": "Mammal Research Institute", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Acta Theriol."], "published-print": {"date-parts": [[1962, 6, 30]]}, "DOI": "10.4098/at.arch.62-13", "type": "journal-article", "created": {"date-parts": [[2014, 4, 2]], "date-time": "2014-04-02T08:27:24Z", "timestamp": 1396427244000}, "page": "301-302", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Cases of sacralisation of the final lumbar vertebra in the European hare, Lepus europaeus Pallas, 1778"], "prefix": "10.4098", "volume": "6", "author": [{"given": "Gabriela", "family": "Bujalska", "sequence": "first", "affiliation": []}], "member": "2574", "published-online": {"date-parts": [[1962, 6, 30]]}, "container-title": ["Acta Theriologica"], "original-title": ["Przypadki sakralizacji ostatniego kr\u0119gu l\u0119d\u017awiowego u zaj\u0105ca szaraka, Lepus europaeus Pallas, 1778"], "deposited": {"date-parts": [[2014, 4, 2]], "date-time": "2014-04-02T08:27:34Z", "timestamp": 1396427254000}, "score": 18.074917, "issued": {"date-parts": [[1962, 6, 30]]}, "references-count": 0, "URL": "http://dx.doi.org/10.4098/at.arch.62-13", "ISSN": ["0001-7051", "2190-3743"], "issn-type": [{"value": "0001-7051", "type": "print"}, {"value": "2190-3743", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 8]], "date-time": "2018-05-08T10:20:00Z", "timestamp": 1525774800713}, "reference-count": 0, "publisher": "Mammal Research Institute", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Acta Theriol."], "published-print": {"date-parts": [[1960, 4, 10]]}, "DOI": "10.4098/at.arch.60-19", "type": "journal-article", "created": {"date-parts": [[2014, 3, 31]], "date-time": "2014-03-31T09:29:04Z", "timestamp": 1396258144000}, "page": "279-281", "source": "Crossref", "is-referenced-by-count": 1, "title": ["F\u00e4lle von Assymmetrie des Beckens und des Kreuzbeines beim Lepus europaeus Pallas 1778"], "prefix": "10.4098", "volume": "4", "author": [{"given": "Gabriela", "family": "Bujalska", "sequence": "first", "affiliation": []}], "member": "2574", "published-online": {"date-parts": [[1960, 4, 10]]}, "container-title": ["Acta Theriologica"], "original-title": ["Przypadki asymetrii miednicy i ko\u015bci krzy\u017cowej u Lepus europaeus Pallas 1778"], "deposited": {"date-parts": [[2014, 3, 31]], "date-time": "2014-03-31T09:29:13Z", "timestamp": 1396258153000}, "score": 18.074917, "issued": {"date-parts": [[1960, 4, 10]]}, "references-count": 0, "URL": "http://dx.doi.org/10.4098/at.arch.60-19", "ISSN": ["0001-7051", "2190-3743"], "issn-type": [{"value": "0001-7051", "type": "print"}, {"value": "2190-3743", "type": "electronic"}]}], "items-per-page": 25, "query": {"start-index": 0, "search-terms": null}}, "custom_name_alias": "BUJALSKA-ZAD-ROZNY MAGDALENA"}